
<html lang="en"     class="pb-page"  data-request-id="92989e54-a1fa-406d-af8a-cad0955f161f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm400312y;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-11;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand" /></meta><meta name="dc.Creator" content="Lei  Zhang" /></meta><meta name="dc.Creator" content="Anabella  Villalobos" /></meta><meta name="dc.Creator" content="Elizabeth M.  Beck" /></meta><meta name="dc.Creator" content="Thomas  Bocan" /></meta><meta name="dc.Creator" content="Thomas A.  Chappie" /></meta><meta name="dc.Creator" content="Laigao  Chen" /></meta><meta name="dc.Creator" content="Sarah  Grimwood" /></meta><meta name="dc.Creator" content="Steven D.  Heck" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Xinjun  Hou" /></meta><meta name="dc.Creator" content="John M.  Humphrey" /></meta><meta name="dc.Creator" content="Jiemin  Lu" /></meta><meta name="dc.Creator" content="Marc B.  Skaddan" /></meta><meta name="dc.Creator" content="Timothy J.  McCarthy" /></meta><meta name="dc.Creator" content="Patrick R.  Verhoest" /></meta><meta name="dc.Creator" content="Travis T.  Wager" /></meta><meta name="dc.Creator" content="Kenneth  Zasadny" /></meta><meta name="dc.Description" content="To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission tomography (PET) ligands, we aimed to define a property space that would facilitate ligand design ..." /></meta><meta name="Description" content="To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission tomography (PET) ligands, we aimed to define a property space that would facilitate ligand design ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 28, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400312y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400312y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400312y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400312y" /></link>
        
    
    

<title>Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400312y" /></meta><meta property="og:title" content="Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0014.jpeg" /></meta><meta property="og:description" content="To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission tomography (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development. Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as negative controls. A systematic analysis of these ligands identified a set of preferred parameters for physicochemical properties, brain permeability, and nonspecific binding (NSB). These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines. This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400312y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400312y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400312y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400312y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400312y&amp;href=/doi/10.1021/jm400312y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4568-4579</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400275h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400336x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Zhang">Lei Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anabella++Villalobos">Anabella Villalobos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+M.++Beck">Elizabeth M. Beck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Bocan">Thomas Bocan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+A.++Chappie">Thomas A. Chappie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laigao++Chen">Laigao Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Grimwood">Sarah Grimwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+D.++Heck">Steven D. Heck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun++Hou">Xinjun Hou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Humphrey">John M. Humphrey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiemin++Lu">Jiemin Lu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc+B.++Skaddan">Marc B. Skaddan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+J.++McCarthy">Timothy J. McCarthy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+R.++Verhoest">Patrick R. Verhoest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Travis+T.++Wager">Travis T. Wager</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Zasadny">Kenneth Zasadny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Neuroscience Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Neuroscience Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">BioImaging Center, Precision Medicine, Pfizer Inc., Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Neuroscience Research Unit, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">Data Analytical Group, Groton Center of Chemistry, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1 617 395 0640. Fax: +1 860 686 5285. E-mail: <a href="/cdn-cgi/l/email-protection#8bc7eee2a5d1e3eae5ecb8cbfbede2f1eef9a5e8e4e6"><span class="__cf_email__" data-cfemail="8fc3eae6a1d5e7eee1e8bccfffe9e6f5eafda1ece0e2">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400312y&amp;href=/doi/10.1021%2Fjm400312y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4568â4579</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 7, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 February 2013</li><li><span class="item_label"><b>Published</b> online</span>28 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400312y" title="DOI URL">https://doi.org/10.1021/jm400312y</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4568%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLei%2BZhang%252C%2BAnabella%2BVillalobos%252C%2BElizabeth%2BM.%2BBeck%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D11%26contentID%3Djm400312y%26title%3DDesign%2Band%2BSelection%2BParameters%2Bto%2BAccelerate%2Bthe%2BDiscovery%2Bof%2BNovel%2BCentral%2BNervous%2BSystem%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BLigands%2Band%2BTheir%2BApplication%2Bin%2Bthe%2BDevelopment%2Bof%2Ba%2BNovel%2BPhosphodiesterase%2B2A%2BPET%2BLigand%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4579%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400312y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4231</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">111</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400312y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Anabella&quot;,&quot;last_name&quot;:&quot;Villalobos&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;M. Beck&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Bocan&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;A. Chappie&quot;},{&quot;first_name&quot;:&quot;Laigao&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Grimwood&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;D. Heck&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Humphrey&quot;},{&quot;first_name&quot;:&quot;Jiemin&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;B. Skaddan&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;J. McCarthy&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;R. Verhoest&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;T. Wager&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Zasadny&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4568-4579&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400312y&quot;},&quot;abstract&quot;:&quot;To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission tomography (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development. Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as negative controls. A systematic analysis of these ligands identified a set of preferred parameters for physicochemical properties, brain permeability, and nonspecific binding (NSB). These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines. This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyr&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400312y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400312y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400312y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400312y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400312y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400312y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400312y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400312y&amp;href=/doi/10.1021/jm400312y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400312y" /></input><a href="/doi/pdf/10.1021/jm400312y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26pmid%3D23651455%26genre%3Darticle%26aulast%3DZhang%26date%3D2013%26atitle%3DDesign%2Band%2BSelection%2BParameters%2Bto%2BAccelerate%2Bthe%2BDiscovery%2Bof%2BNovel%2BCentral%2BNervous%2BSystem%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BLigands%2Band%2BTheir%2BApplication%2Bin%2Bthe%2BDevelopment%2Bof%2Ba%2BNovel%2BPhosphodiesterase%2B2A%2BPET%2BLigand%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D11%26spage%3D4568%26epage%3D4579%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291663" title="Positron emission tomography">Positron emission tomography</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jmcmar.2013.56.issue-11/production/jmcmar.2013.56.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission tomography (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development. Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as negative controls. A systematic analysis of these ligands identified a set of preferred parameters for physicochemical properties, brain permeability, and nonspecific binding (NSB). These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines. This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[<sup>18</sup>F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazol-4-yl}imidazo[5,1-<i>f</i>][1,2,4]triazine, [<sup>18</sup>F]PF-05270430 (<b>5</b>).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Positron emission tomography (PET) imaging is a noninvasive method that provides high resolution and quantitative information on specific target areas.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> For central nervous system (CNS) targets, PET is most frequently used to quantify the concentration of drug binding to a specific pharmacological target, providing receptor occupancy (RO) measurements. PET RO data can be effectively used in several ways to inform critical drug discovery and development decisions. For example, in conjunction with a biomarker for pharmacological effect, PET RO data can be used to determine whether a given mechanism has been adequately tested in the clinic (Proof of Mechanism).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> PET RO data can also be used to establish well-defined translatable clinical No Go criteria if the target RO cannot be achieved at a maximum tolerated dose. Furthermore, PET RO data are extremely useful in optimizing compound dose selection for accurate evaluation of efficacy and side effect profiles. Finally, in addition to providing RO measurements, PET imaging can be used as a diagnostic to assess disease stage and progression in longitudinal studies.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">To enable accurate clinical RO measurement, the availability of a PET ligand with favorable attributes is essential. With the rapid expansion of PET imaging applications in preclinical research and clinical drug development, effective CNS PET ligands have been developed for a wide range of targets including G-protein coupled receptors (GPCRs), ion channels, transporters, enzymes, and amyloid plaques (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). However, PET ligand development continues to be a fairly lengthy and costly process, partially due to the array of attributes required for an effective PET ligand and the empirical nature of the PET ligand discovery process.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CNS PET Ligand Database: target type distribution of validated CNS PET ligands (âYesâ category, <i>N</i> = 62) and negative controls (âNoâ category, <i>N</i> = 15).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From a chemical structure point of view, PET ligand candidates should have structure moieties amenable to efficient incorporation of short-lived positron emission radionuclides such as carbon-11 (<i>T</i><sub>1/2</sub> = 20.4 min) and/or fluorine-18 (<i>T</i><sub>1/2</sub> = 109.7 min). In terms of pharmacology, a viable PET ligand must be potent and selective toward its intended pharmacological target. The maximum concentration of target binding sites (<i>B</i><sub>max</sub>) is a key parameter for consideration, as it dictates the level of affinity (<i>K</i><sub>d</sub>) required for a successful radioligand. Most clinically successful PET ligands have an in vitro binding potential (<i>B</i><sub>max</sub>/<i>K</i><sub>d</sub>) â¥ 10.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Considering the low expression levels of most brain targets, PET ligands typically demand more stringent potency criteria than do drug candidates, with subnanomolar affinity often required.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The requisite selectivity over other targets is dependent not only on relative affinities but also on the brain distribution and expression levels of competing targets. Aiming for a high level of selectivity (>30- to 100-fold) is recommended, particularly against targets that are highly expressed in brain [e.g., the dopamine transporter (DAT)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>] and colocated with the target of interest. In addition to the aforementioned potency and selectivity criteria, a suitable CNS PET ligand should be brain-penetrant and exhibit low nonspecific binding (NSB) to avoid radioactivity signals in brain white matter and to achieve the requisite signal-to-noise ratio. Furthermore, a suitable PET ligand should not form brain permeable radioactive metabolites in vivo, which would be detrimental to the quantification of PET data due to the inability to distinguish signals from different radioactive chemical entities. More specifically, for fluorine-18 labeled PET ligands, extensive defluorination should be avoided as this would lead to high uptake of radioactivity in the skull and resulting spillover radio signal contamination in the underlying brain regions such as the neocortex.</div><div class="NLM_p">Poor brain permeability and high NSB are among the most frequent causes for failure in CNS PET ligand development.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Optimization of brain permeability may be achieved at the design stage by focusing on favorable physicochemical and absorption, distribution, metabolism, and excretion (ADME) properties.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> With regard to minimizing NSB, a common notion within the PET field is that lower lipophilicity generally leads to reduced NSB, with log <i>P</i> or log <i>D</i> being the most tracked physicochemical parameters. However, the often narrowly defined optimal ranges (log <i>P</i> 1.5â2.5<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> or log <i>D</i> 1â3<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a>) restrict the scope of potential candidates for PET ligand development. As an alternative, development of tools to predict NSB has become an area of increased focus in recent years, with efforts ranging from experimental (vesicle electrokinetic chromatography<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> or in vitro no-wash autoradiography<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>) to computational modeling approaches<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> being reported. While these analytical and computational methods may indeed be helpful in identifying compounds with low NSB, the process remains resource-intensive and empirical in nature.</div><div class="NLM_p last">In our strategy to prospectively design and select successful novel PET ligands in an accelerated timeline, we aimed to identify design parameters predictive of favorable brain permeability and reduced NSB risk by utilizing in silico models in combination with parameters that can be experimentally determined in a high-throughput fashion. Such design parameters, in conjunction with favorable potency and selectivity, should allow alignment of desirable PET attributes in one molecule, thereby accelerating the selection of novel CNS PET ligands biased toward a higher probability of success. In particular, this strategy would apply to the design and selection of carbon-11 and fluorine-18 small molecule PET ligands.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">CNS PET Ligand Database</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Our approach to optimize the design and selection of novel PET ligands, particularly around brain permeability and NSB properties, was underpinned by a systematic analysis of the physicochemical properties and ADME profiles of both successful and unsuccessful CNS PET ligands. Toward this end, a database of CNS PET ligands was built, which comprised 62 successful ligands validated for human clinical use and 15 PET ligands that failed in late stage development, primarily due to high NSB, as negative controls.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, the validated CNS PET ligands used in the analysis (âYesâ category) encompassed various target types, with G-protein coupled receptors (GPCRs) (63%), ion channels (6%), and transporters (21%) among the most populated target types. These are also the three target types (73%, 20%, and 7%, respectively) represented by the 15 failed PET ligands (âNoâ category) selected for our analysis. The physicochemical properties and ADME end points for this set of 77 ligands were either calculated using in silico models or experimentally derived. The results were analyzed utilizing a Spotfire visualization tool to identify key differences between these two categories of ligands as a way to define the desired property space for CNS PET ligands and facilitate ligand design, prioritization, and selection.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Physicochemical Properties</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For analysis of the physicochemical properties of the aforementioned 77 CNS PET ligands, we explored the use of a previously described central nervous system multiparameter optimization (CNS MPO) design tool<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> based on a set of six physicochemical properties commonly used by medicinal chemists in compound design: ClogP (calculated partition coefficient), ClogD (calculated distribution coefficient at pH = 7.4), MW (molecular weight), TPSA (topological polar surface area),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> HBD (number of hydrogen bond donors), and p<i>K</i><sub>a</sub> (ionization constant of the most basic center). The CNS MPO design tool, which utilizes the concept of transformed functions, employs monotonic decreasing functions for ClogP, ClogD, MW, HBD, and p<i>K</i><sub>a</sub> and a hump function for TPSA. Desirable ranges were defined based on the authorsâ and Pfizer scientistsâ medicinal chemistry experience for each physicochemical property in the corresponding transformed functions, which were given desirability scores ranging from 0.0 to 1.0 (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The summation of the individual transformed functions representing each of the six physicochemical properties yielded the final CNS MPO desirability score for each compound, which could range from 0.0 to 6.0. The majority of marketed CNS drugs (74% of 119 drugs analyzed) have a CNS MPO > 4. A higher CNS MPO score was also shown to lead to a higher probability of successfully aligning CNS drug-like properties such as permeability, clearance, and safety in a single molecule.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For the purpose of the CNS PET ligand analysis, we used the published CNS MPO desirability scores and a modified version of this tool, CNS PET MPO.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The inflection points and desirable ranges for the CNS PET MPO tool were derived exclusively from the physicochemical property data associated with the marketed CNS drugs described in the CNS MPO paper.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These inflection values were taken primarily from the actual median and the 75th percentile values exhibited by marketed CNS drugs and differ from the values used in the CNS MPO tool (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The option of modifying the inflection points in the CNS MPO tool enhances the flexibility of this method and consequently its utility in assessing property space for more narrowly defined medicinal chemistry data sets such as the ones associated with CNS PET ligands.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physicochemical Properties, Transformed Function Utilized, Weighting, and Parameter Ranges for CNS MPO and CNS PET MPO</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">CNS MPO<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">CNS PET MPO<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">properties</th><th class="colsep0 rowsep0" align="center">transformation (T0)</th><th class="colsep0 rowsep0" align="center" char=".">weight</th><th class="colsep0 rowsep0" align="center">more desirable range (T0Â =Â 1.0)</th><th class="colsep0 rowsep0" align="center">less desirable range (T0Â =Â 0.0)</th><th class="colsep0 rowsep0" align="center">more desirable range (T0Â =Â 1.0)</th><th class="colsep0 rowsep0" align="center">less desirable range <br /></br>(T0Â =Â 0.0)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">monotonicÂ decreasing</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">ClogPÂ â¤Â 3</td><td class="colsep0 rowsep0" align="left">ClogPÂ >Â 5</td><td class="colsep0 rowsep0" align="left">ClogPÂ â¤Â 2.8</td><td class="colsep0 rowsep0" align="left">ClogPÂ >Â 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogD</td><td class="colsep0 rowsep0" align="left">monotonicÂ decreasing</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">ClogDÂ â¤Â 2</td><td class="colsep0 rowsep0" align="left">ClogDÂ >Â 4</td><td class="colsep0 rowsep0" align="left">ClogDÂ â¤Â 1.7</td><td class="colsep0 rowsep0" align="left">ClogDÂ >Â 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">monotonicÂ decreasing</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">MWÂ â¤Â 360</td><td class="colsep0 rowsep0" align="left">MWÂ >Â 500</td><td class="colsep0 rowsep0" align="left">MWÂ â¤Â 305.3</td><td class="colsep0 rowsep0" align="left">MWÂ >Â 350.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="left">hump function</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">40Â <Â TPSAÂ â¤Â 90</td><td class="colsep0 rowsep0" align="left">TPSAÂ â¤Â 20;TPSAÂ >Â 120</td><td class="colsep0 rowsep0" align="left">44.8Â <Â TPSAÂ â¤Â 63.3</td><td class="colsep0 rowsep0" align="left">TPSAÂ â¤Â 32.3;Â TPSAÂ >Â 86.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HBD</td><td class="colsep0 rowsep0" align="left">monotonicÂ decreasing</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">HBDÂ â¤Â 0.5</td><td class="colsep0 rowsep0" align="left">HBDÂ >Â 3.5</td><td class="colsep0 rowsep0" align="left">HBDÂ â¤Â 1</td><td class="colsep0 rowsep0" align="left">HBDÂ >Â 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">monotonicÂ decreasing</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub>Â â¤Â 8</td><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub>Â >Â 10</td><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub>Â â¤Â 7.2</td><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub>Â >Â 9.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a> for the definitions of CNS MPO inflection values.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">CNS PET MPO inflection values are defined by a statistical analysis of the physicochemical properties of 119 marketed CNS drugs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Median values and the 75th percentile values are used to define the more desirable and less desirable ranges, respectively, for ClogP, ClogD, MW, HBD, and p<i>K</i><sub>a</sub>. The more desirable range of TPSA is defined by the median value (44.8) and the 75th percentile value (63.3), while the less desirable range is defined by 25th percentile (32.3) and 90th percentile (86.2) values.</p></div></div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">ADME Properties</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">With regard to the analysis of ADME space associated with the set of 77 CNS PET ligands, we became interested in ADME end points that help assess brain permeability and NSB. A number of high-throughput in vitro ADME assays have been developed that are routinely used in screening compounds to guide drug discovery efforts in an efficient manner.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In particular, we focused on high-throughput assays measuring passive permeability [e.g., RRCK <i>P</i><sub>app</sub> AB],<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> P-gp liability (e.g., MDR1 BA/AB ratio),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and unbound fraction in brain (Fu_b) and plasma (Fu_p),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as surrogate measures of brain permeability and NSB. On the basis of the wealth of experimental data from these high-throughput screening assays, which provide large training sets of data points for structurally diverse compounds, corresponding high-performing in silico models have been developed. For example, a calculated RRCK (cRRCK) in silico model was developed based on the RRCK passive permeability data for a diverse set of >100000 compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The prediction performance of the cRRCK model is continuously monitored prospectively, typically providing results within 2-fold of experimental values for 80% of new compounds meeting the prediction confidence cutoff. Such in silico models are particularly useful in that they offer opportunities for prospective design of drug-like molecules, with reasonable confidence in their pharmacokinetic (PK) properties, prior to synthesis. ADME values determined via high-throughput assays and/or in silico model-derived ADME values were used in the analysis of the PET ligand database.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Results of the physicochemical property analysis for the set of 77 PET ligands utilizing the CNS MPO and CNS PET MPO desirability tools are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. This analysis confirmed that the majority of ligands in the âYesâ category indeed had CNS MPO scores >4 (85%). However, a CNS MPO score >4 offered limited distinction from the ligands in the âNoâ category, as this score also captured more than half of the negative controls (60%). It is worth mentioning that PET ligands with CNS MPO scores >5 only appeared in the âYesâ category (45% of 62 PET ligands), with none in the âNoâ category. On the other hand, the more stringent CNS PET MPO tool offered an improved distinction between the two categories of PET ligands over the original CNS MPO. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, CNS PET MPO scores >3 captured the majority of the âYesâ category (79%) while CNS PET MPO â¤ 3 captured the majority of the âNoâ category (67%), suggesting that this parameter may be useful when designing novel PET compounds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CNS MPO and CNS PET MPO comparison of validated CNS PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To understand the origin of the distinction offered by the CNS PET MPO tool, we first examined the distribution pattern of the three physicochemical property parameters within the tool that are related to lipophilicity: ClogD, ClogP, and TPSA (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). ClogD and ClogP offered similar distinctions between PET ligands in the two different categories. Most of the clinically validated ligands displayed ClogD values â¤3 (47 out of 62, 76%) and ClogP values â¤4 (50 out of 62, 80%), while most of the failed ligands displayed ClogD values >3 (10 out of 15, 67%) and ClogP values >4 (10 out of 15, 67%). It is also worth noting that the literature values for preferred Log <i>D</i> (1â3) or ClogP ranges (1.5â2.5), partially driven by brain permeability considerations, appear to be overly stringent for PET ligand selection. In contrast, TPSA offered minimal distinction between successful and failed PET ligands, with the majority of successful (46 out of 62, 74%) and failed (13 out of 15, 87%) ligands residing in a range between 20 and 60 Ã<sup>2</sup>. Like TPSA, the remaining three physicochemical parameters (MW, HBD, and p<i>K</i><sub>a</sub>) exhibited no apparent trends upon similar analysis (data not shown). On the basis of the ClogD and ClogP ranges associated with the set of successful and failed PET ligands, and the inflection points and corresponding scores associated with the CNS MPO tools (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), the CNS PET MPO tool is able to better capture differences in the overall desirability scores for the two groups of ligands.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Distribution of calculated physicochemical properties, ClogD, ClogP, and TPSA, for validated PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next examined the in vitro ADME parameters RRCK and MDR1 BA/AB, which are related to brain permeability (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). With regard to passive permeability, a total of 92% of the ligands in the âYesâ category had RRCK <i>P</i><sub>app</sub> AB values >5 Ã 10<sup>â6</sup> cm/s, consistent with moderate to high passive permeability [RRCK <i>P</i><sub>app</sub> AB > 10, high permeability, 68%; 5 < RRCK <i>P</i><sub>app</sub> AB â¤ 10, moderate permeability, 24%]. In terms of P-gp liability, 87% of the ligands in the âYesâ category had MDR1 BA/AB ratios â¤2.5, consistent with low P-gp liability or efflux. These observations confirmed that a favorable combination of passive permeability and P-gp liability determined by RRCK <i>P</i><sub>app</sub> AB values and MDR1 BA/AB ratios, respectively, could indeed serve as a reasonable predictor for brain permeability of PET ligands. Compounds in the âNoâ category exhibited similar values (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>): 73% of the ligands in the âNoâ category had RRCK <i>P</i><sub>app</sub> AB values of >5 Ã 10<sup>â6</sup> cm/s and 80% had MDR1 BA/AB ratios â¤2.5. These results were not surprising, as the set of ligands in the negative control group failed primarily due to high NSB rather than poor brain permeability.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of RRCK <i>P</i><sub>app</sub> AB and MDR1 BA/AB properties of validated CNS PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, when we compared properties across ligands in the âYesâ and âNoâ categories, the fraction unbound in brain (Fu_b) emerged as the most pronounced differentiator. As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, an overwhelming majority (87%) of the ligands in the âNoâ category had Fu_b â¤ 0.05, while only 33% of the ligands in the âYesâ category were in this range. This result suggests that unbound brain fraction could be used as a potential predictor of NSB, with values >0.05 preferred. Because unbound brain fraction could be a reflection of a compoundâs tendency to bind brain proteins and tissues, it is not entirely surprising that this parameter appears to predict risk of NSB.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> To a lesser extent, a similar trend was observed in the analysis of unbound plasma fractions (Fu_p). The majority of the ligands (60%) in the âYesâ category had Fu_p > 0.15, while only a small fraction (20%) of the ligands in the âNoâ category resided in this space. Taken together, these observations suggest that compounds with Fu_b > 0.05 and Fu_p > 0.05, preferably Fu_p > 0.15, should be targeted whenever possible, as such compounds would be at lower risk of NSB (60% of the ligands in the âYesâ category fulfill these criteria in contrast to 20% in the âNoâ category). Compounds with Fu_b â¤ 0.05, especially if Fu_p is also â¤0.05 (only 16% of the âYesâ category), should be avoided as they would be at risk of high levels of NSB.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis of fractions unbound in brain (Fu_b) and fractions unbound in plasma of validated PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Prompted by the larger CNS PET MPO scores associated with the successful CNS PET ligand set and our understanding of the preferred in vitro ADME properties (Fu_b, RRCK and MDR), we investigated whether higher CNS PET MPO scores (>3) would lead to an increased probability of aligning all three preferred ADME attributes in one molecule. Each PET ligand was assessed for the following desirable criteria: Fu_b > 0.05 for lower risk of NSB, RRCK <i>P</i><sub>app</sub> AB > 5 Ã 10<sup>â6</sup> cm/s for moderate to high permeability, and MDR1 BA/AB < 2.5 for low P-gp liability. An alignment count of 3 was assigned to the ligand if all three criteria were met, 2 was assigned if only two out of three criteria were met, and so on. As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A, within the set of 77 PET ligands, CNS PET MPO scores >3 clearly increased the probability of aligning the three key ADME attributes in one molecule. For the ligands with CNS PET MPO scores >3, 62% showed alignment of all three desired ADME attributes, compared to only 19% of the ligands with CNS PET MPO scores â¤3. Expansion of the analysis to a broader data set consisting of all Pfizer compounds with experimental data available for the three ADME parameters (Fu_b, RRCK, and MDR) revealed a similar trend (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). For compounds with CNS PET MPO scores >3, 49% showed an alignment score of 3 compared to only 19% for compounds with CNS PET MPO scores â¤3. This analysis indicates that CNS PET MPO scores >3 indeed would facilitate alignment of in vitro ADME attributes that are key to the success of a given CNS PET ligand and should therefore be monitored appropriately in PET ligand design.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. CNS PET MPO scores versus alignment of in vitro ADME properties for CNS PET ligands and a broader compound set. (A) PET ligand set. (B) Broad Pfizer compound set.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In summary, we have identified a set of preferred physicochemical and ADME profiles to inform the design and selection of novel PET ligand candidates (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). In addition to the existing knowledge of in vitro binding potential (<i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> > 10) and selectivity (>30- to 100-fold) criteria, one would ideally target CNS PET MPO scores >3 to optimize physicochemical properties, RRCK <i>P</i><sub>app</sub> AB > 5 Ã 10<sup>â6</sup>cm/s to ensure good passive permeability, MDR1 BA/AB < 2.5 to minimize P-gp liability, and Fu_b and Fu_p > 0.05, preferably Fu_p > 0.15, to minimize risk of NSB. In addition, CNS PET MPO scores >3 were found to increase the probability of aligning all three key ADME parameters, thereby increasing the overall probability of success for CNS PET ligand development.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Preferred design and selection parameters for novel CNS PET ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As an additional test, we further examined this set of desired design parameters against the profiles of 10 high-performing CNS PET ligands,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> which were a subset of the broader database of 77 PET ligands. Selection of these 10 ligands was based on their frequency of use, acceptance in the field, robust test-retest reliability results, and good properties for quantification. Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> highlights the alignment of the proposed set of criteria with the properties of these high-performing CNS PET ligands: all 10 met criteria for RRCK values, and 9 out of 10 compounds met the criteria of MDR1 BA/AB â¤ 2.5, Fu_b > 0.05, and CNS PET MPO > 3. Importantly, none of these 10 ligands fell within the defined high risk space for NSB (Fu_b â¤ 0.05 and Fu_p â¤ 0.05). These results suggest that the proposed design parameters have the potential to guide and accelerate novel CNS PET ligand development efforts toward higher performing ligands rather than marginal ones.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Alignment of the proposed set of criteria with 10 high-performing CNS PET ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Utilization of the Proposed PET Design Parameters in the Development of a Novel PDE2A PET Ligand</h3><div class="NLM_p">To further evaluate whether the aforementioned PET design parameters (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) would be applicable in a prospective manner for novel PET ligand development, we applied them to the design and prioritization process for a selective phosphodiesterase 2A (PDE2A) PET ligand. PDE2A is a dual-substrate PDE that hydrolyzes two key secondary messenger molecules, cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP). The highest levels of PDE2A expression are found within the limbic and basal ganglia brain circuitry;<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> inhibitors of PDE2A increase cyclic nucleotide levels in these key brain regions and could thus potentially improve cognitive processes.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We therefore sought to develop a highly selective PDE2A PET ligand to serve as a translational tool that would enable both preclinical pharmacology studies as well as clinical evaluation, including target occupancy measurements, of novel PDE2A inhibitors.</div><div class="NLM_p">Toward this end, we applied the CNS PET design and selection parameters to the prioritization of a Pfizer collection of PDE2A inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, a collection of over a thousand compounds was quickly narrowed down to â¼150 using filters of MDR1 BA/AB â¤ 2.5, RRCK <i>P</i><sub>app</sub> AB > 5, followed by cFu_b > 0.05 and cFu_p > 0.05, and CNS PET MPO > 3. A potency cutoff of 10 nM further reduced the field to â¼20 compounds, eight of which contained structural moieties that were amenable to either [<sup>11</sup>C] or [<sup>18</sup>F] radiolabeling. Potency ranking of these eight compounds yielded compound <b>1</b> as a promising lead that possessed a number of desirable characteristics for a PET tracer: reasonable potency (IC<sub>50</sub> = 2.30 nM), exquisite PDE selectivity (>500-fold over all other PDEs), excellent physicochemical properties (CNS PET MPO = 4.94), good brain permeability (RRCK <i>P</i><sub>app</sub> AB = 21.5 Ã 10<sup>â6</sup> cm/s, MDR1 BA/AB ratio = 1.46), and low risk of NSB based on experimentally obtained unbound fractions (rat brain fraction unbound, rFu_b = 9.5%; rat plasma fraction unbound, rFu_p = 32%; human plasma fraction unbound, hFu_p = 23%).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Data mining process for the identification of PDE2A PET leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using compound <b>1</b> as a lead, we carried out a focused PET-specific structureâactivity relationship (SAR) effort targeting a small set of analogues, with the main goal of increasing potency to maximize in vivo binding potential while maintaining the desirable PET design attributes around physicochemical, ADME, and NSB properties. This effort (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) consisted of: (a) designing compounds within the proposed preferred PET property space, guided by in silico models (CNS PET MPO, cRRCK, cMDR, cFu_b, and cFu_p; see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), (b) incorporating structural moieties that have been shown to be beneficial to PDE2A inhibition activity in a related system,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and (c) introducing functional groups such as methoxy (<b>2</b>â<b>4</b>, <b>6</b>) and fluoroazetidine (<b>5</b>â<b>7</b>) as structural handles for [<sup>11</sup>C] and [<sup>18</sup>F] radiolabeling. A total of six analogues (<b>2</b>â<b>7</b>) with suitable overall properties were targeted, and the syntheses of which were achieved from a common intermediate <b>8</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> via a straightforward two-step sequence: Suzuki coupling was followed by conversion to triazolotriazine intermediates, which were treated in situ with azetidines <b>10</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Six PET-Specific PDE2A Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, EtOH/water, reflux; (b) 1,2,4-triazole, POCl<sub>3</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, then Et<sub>3</sub>N, <b>10</b>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. PDE2A Activities and Calculated ADME Properties of PET-Specific Analogues <b>2</b>â<b>7</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human PDE2A IC<sub>50</sub>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CNS PET MPO</th><th class="colsep0 rowsep0" align="center" char=".">cRRCK (ÃÂ 10<sup>â6</sup>cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">cMDR1 BA/AB</th><th class="colsep0 rowsep0" align="center" char=".">cFu_b</th><th class="colsep0 rowsep0" align="center" char=".">cFu_p</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">4.55</td><td class="colsep0 rowsep0" align="char" char=".">25.5</td><td class="colsep0 rowsep0" align="char" char=".">1.36</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">4.55</td><td class="colsep0 rowsep0" align="char" char=".">23.5</td><td class="colsep0 rowsep0" align="char" char=".">1.87</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">1.08</td><td class="colsep0 rowsep0" align="char" char=".">4.55</td><td class="colsep0 rowsep0" align="char" char=".">23.9</td><td class="colsep0 rowsep0" align="char" char=".">1.48</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">4.81</td><td class="colsep0 rowsep0" align="char" char=".">21.5</td><td class="colsep0 rowsep0" align="char" char=".">1.32</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">2.01</td><td class="colsep0 rowsep0" align="char" char=".">4.55</td><td class="colsep0 rowsep0" align="char" char=".">21.7</td><td class="colsep0 rowsep0" align="char" char=".">1.57</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">1.72</td><td class="colsep0 rowsep0" align="char" char=".">4.83</td><td class="colsep0 rowsep0" align="char" char=".">28.4</td><td class="colsep0 rowsep0" align="char" char=".">1.12</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values obtained from a cGMP-stimulated human recombinant full-length PDE2A enzymatic assay; Values represent the mean of at least three experiments.</p></div></div></div><div class="NLM_p">The human PDE2A potencies of analogues <b>2</b>â<b>7</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. In general, all analogues showed similar or improved potency compared to <b>1</b>. The most potent analogues, <b>3</b> and 4-(3-fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazol-4-yl}imidazo[5,1-<i>f</i>][1,2,4]triazine (PF-05270430, <b>5</b>) were selected for further in vitro ADME and in vivo PK evaluation. As predicted by in silico models, both compounds demonstrated high RRCK <i>P</i><sub>app</sub> AB(>10 Ã 10<sup>â6</sup> cm/s) and low MDR1 BA/AB ratio (â¤2.5), as well as Fu_b and Fu_p consistent with low predicted risk for NSB (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compound <b>5</b> was selected for further study based on its higher in vivo brain permeability (B/P_free of 0.5 for <b>5</b> vs B/P_free of 0.2 for <b>3</b>). Evaluation of <b>5</b> in a PDE selectivity panel<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and a broad CEREP panel<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> confirmed its exquisite selectivity against other targets (>1800-fold).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro and in Vivo PK Properties of Compounds <b>3</b> and <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK properties</th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RRCK <i>P</i><sub>app</sub>ABÂ (10<sup>â6</sup>Â cm/s)</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR1 BA/AB</td><td class="colsep0 rowsep0" align="left">1.23</td><td class="colsep0 rowsep0" align="left">1.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rFu_pÂ (rat)(%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rFu_bÂ (rat)(%)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hFu_p(%)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P_total(rat)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">1.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P_free (rat)</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Fraction unbound in rat plasma.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Fraction unbound in rat brain.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Fraction unbound in human plasma.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Ratio of total drug levels in rat brain and plasma; determined from pharmacokinetics in Wistar-Han rats 0â2 h following a single 1 mg/kg intravenous (IV) dosing.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Ratio of free drug levels in rat brain and plasma; calculated based on B/P_total and fractions unbound in rat brain and plasma.</p></div></div></div><div class="NLM_p">In light of its favorable profile, compound <b>5</b> was advanced to radiochemistry development. As illustrated in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, hydroxyazetidine <b>11</b> was synthesized following a similar two-step sequence to that described above from triazinone intermediate <b>8</b>. Subsequent tosylation yielded the tosylate precursor <b>12</b>. Nucleophilic displacement of the tosylate using [<sup>18</sup>F]tetrabutylammonium fluoride in <i>t</i>-amyl alcohol produced [<sup>18</sup>F]<b>5</b> reproducibly (7.3 Â± 1.9% radiochemical yield, decay-corrected to starting [<sup>18</sup>F]fluoride in the reactor, <i>n</i> = 8) in high specific activity (>500 GBq/Î¼mol at end of synthesis) and radiochemical purity (>99.5%).</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of [<sup>18</sup>F]<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, 4-trifluoromethylphenyl boronic acid, K<sub>3</sub>PO<sub>4</sub>, EtOH/water, reflux, 40%; (b) 1,2,4-triazole, POCl<sub>3</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, then Et<sub>3</sub>N, 4-hydroxyazetidine hydrochloride salt, CH<sub>2</sub>Cl<sub>2</sub>, 87%; (c) TsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 57%; (d) TBA[<sup>18</sup>F], <i>t</i>-amyl alcohol, 110 Â°C, 30 min, 99.5% radiochemical purity, 540 Â± 152 GBq/Î¼mol (14592 Â± 4095 Ci/mmol) specific activity.</p></p></figure><div class="NLM_p">PET ligand [<sup>18</sup>F]<b>5</b> was subsequently evaluated in cynomolgus monkeys for baseline and displacement studies. Primates were maintained under anesthesia with isoflurane and injected intravenously with an average of 215 MBq (5.8 mCi) of [<sup>18</sup>F]<b>5</b>, and dynamic brain scans were performed with a Siemens Focus220 PET scanner for 90 min. Timeâactivity curves (TACs) were generated for brain regions of interest defined in the reference PET images such as frontal cortex, putamen, caudate, and cerebellum (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>a). Reconstructed images were scaled to standardized uptake values (SUV) and coregistered to an individual reference PET image for each primate using a mutual information algorithm (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>b). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, both the TACs for brain regions of interest and the baseline SUV images, summed between 0 and 60 min, demonstrated rapid and high uptake of [<sup>18</sup>F]<b>5</b> in striatum (putamen and caudate) and low uptake in cerebellum, consistent with the distribution pattern of PDE2A enzyme.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> No skull uptake due to defluorination was observed. Employing cerebellum as a reference region for NSB, [<sup>18</sup>F]<b>5</b> was calculated to have an in vivo binding potential of 1.51 Â± 0.18 (<i>n</i> = 2) in striatum using a simplified reference tissue model. Importantly, the signal in striatum was blocked by a nonradioactive structurally related PDE2A inhibitor in a dose-responsive manner (data not shown). The blocking study in primates to measure PDE2A target occupancy, and additional data including rat dosimetry and radioactive metabolite analysis, will be reported in a future publication. Overall, these data indicate that [<sup>18</sup>F]<b>5</b> is a promising PET ligand that could be used for imaging PDE2A in vivo.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Representative baseline timeâactivity curves (TACs) from [<sup>18</sup>F]<b>5</b> in cynomolgus monkeys. (b) Representative baseline standard uptake value (SUV) images in transverse and coronal views, summed between 0 and 60 min of PET imaging.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The identification of novel PET ligands in an accelerated fashion with reduced resources is an important area of focus for CNS medicinal chemistry. Neuroimaging with PET ligands is a noninvasive clinical methodology that is frequently used to quantify the concentration of drugs reaching the pharmacological target, as it provides a direct measure of RO. In addition, PET ligands can be used to assess disease stage and progression. As part of our efforts to accelerate the identification of novel PET ligands, we undertook an analysis of validated PET ligands and negative controls to define a series of design parameters which could lead to the selection of novel ligands with higher probability of success. Physicochemical properties as summarized by a CNS PET MPO tool and ADME end points such as permeability and P-gp efflux, together with unbound fraction in brain and plasma as indirect measures of nonspecific binding, were identified as key parameters in this analysis of a set of 77 PET ligands. These properties, coupled with pharmacological parameters such as in vitro binding potential and selectivity, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, could be used to prioritize and accelerate the identification of PET ligands.</div><div class="NLM_p last">The prospective use of this approach was illustrated by efforts leading to the identification of [<sup>18</sup>F]<b>5</b> as the first highly selective PDE2A PET ligand.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Incorporation of these design parameters, aided by in silico models, enabled SAR efforts to be carried out in a highly rational and focused manner, yielding a suitable PET ligand in a single design cycle with a small number of analogues. We envision that these design parameters and overall approach for the identification of novel PET ligands may be applicable across a broad range of brain targets. Future application of this strategy will result in additional refinement of this methodology and further optimize the target range of design parameters for successful PET ligands.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> CNS MPO and CNS PET MPO</h3><div class="NLM_p last">The CNS MPO tool has been previously described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> A monotonic decreasing function was used for ClogP, ClogD, MW, HBD and p<i>K</i><sub>a</sub>, and a hump function was used for TPSA. More desirable and less desirable ranges were defined for each physicochemical property in the corresponding transformed function, which was given a desirability score ranging from 0.0 to 1.0. The transformed function definitions associated with the CNS MPO tool are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The summation of the individual transformed functions representing each of the six physicochemical properties yielded the final CNS MPO desirability score, which can range from 0 to 6. CNS PET MPO uses the same set of physicochemical properties and transformation functions but with different inflection values (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The revised inflection values were taken from the median values, the 25th percentile and the 75th percentile values exhibited by marketed CNS drugs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> A CNS PET MPO calculator in Excel format is included as part of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Silico ADME models</h3><div class="NLM_p last">RRCK passive permeability (cRRCK), MDR1 BA/AB efflux (cMDR1 BA/AB), fraction unbound in plasma (cFu_p), and fraction unbound in brain (cFu_b) in silico models were built internally at Pfizer using the Cubist algorithm from RuleQuest Research. Descriptors used include MOE and E-state descriptors, ClogP, and structural fragments. The size of the data set in these models is roughly 132000, 103000, 5200, and 2700 compounds, respectively. The performance of these in silico models was tested by an 80/20 split of the data set, where the model was trained on the 80% and validated on the 20%. Performance of the model was assessed by determining the % predicted within 2-fold of experimental values.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Measurement of Recombinant Human PDE2A Inhibition by SPA Technology</h3><div class="NLM_p last">The activities of the test substances on human full-length PDE2A3 enzyme were determined using the [<sup>3</sup>H]cGMP scintillation proximity assay (SPA) modified from the Amersham TRKQ7100 instructions (GE Healthcare, USA). PDE2A3 protein was obtained from FLAG purification of sf21 insect cells using standard affinity purification procedures for this tag (anti-FLAG M2, Sigma-Aldrich). The SPA assay was performed using PDE SPA yttrium silicate beans (Perkin-Elmer RPNQ0024), which bind preferentially to the linear nucleotide GMP, compared to the cyclic nucleotide cGMP. The [<sup>3</sup>H]GMP product was detected using a Wallac MicroBeta scintillation counter. The reaction time was chosen with respect to the amount of time in which 10â20% of substrates were hydrolyzed by the enzyme. The corresponding IC<sub>50</sub> values of the compounds for the inhibition of PDE2A activities were determined from the concentrationâeffect curves by means of nonlinear regression.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Methods</h4><div class="NLM_p last">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Concentration refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSep <i>R</i><sub>f</sub> 4 to 120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage Horizon automatic purification system. Microwave reactions were carried out in a microwave reactor manufactured by Smith Creator of Personal Chemistry. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C<sub>18</sub> columns, 5 Î¼m, 30 mm Ã 100 mm steel. Compounds were presalted as TFA salts and diluted with dimethyl sulfoxide (1 mL). Samples were purified by mass-triggered collection using mobile phases of 0.1% trifluoroacetic acid in water and acetonitrile with a gradient of 100% aqueous to 100% acetonitrile over 10 min at a 20 mL per min flow rate. Elemental analyses were performed by QTI, Whitehouse, NJ. All target compounds were analyzed using ultra high-performance liquid chromatography/ultraviolet/evaporative light scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). Unless otherwise noted, all tested compounds were found to be â¥95% pure by this method.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> UHPLC/MS Analysis</h4><div class="NLM_p last">UHPLC was performed on a Waters ACQUITY UPLC system (Waters, Milford, MA), which was equipped with a binary solvent delivery manager, column manager, and sample manager coupled to ELSD and UV detectors (Waters, Milford, MA). Detection was performed on a Waters LCT premier XE mass spectrometry (Waters, Milford, MA). The instrument was fitted with an Acquity BEH (Bridged Ethane Hybrid) C18 column (30 mm Ã 2.1 mm, 1.7 Î¼m particle size, Waters, Milford, MA) operated at 60 Â°C. Mobile phase A, 0.05% trifluoroacetic acid in water (v/v); Mobile phase B, 0.05% trifluoroacetic acid in acetonitrile (v/v). Gradient: 5.0% to 95% B, linear over 4.0 min. Flow rate: 2 mL/min.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Synthetic Procedure for PDE2 Analogues <b>2</b>â<b>7</b></h3><div class="NLM_p">A 1.0 M solution of potassium phosphate (2.5 equiv) in water was added to a suspension of <b>8</b> (1.0 equiv) and the aryl boronic acid (1.5 equiv) in ethanol (0.13 M). Nitrogen was bubbled through the mixture for 10 min, and the reaction was warmed to 70 Â°C over 10 min with consistent nitrogen flow through the solution. Tetrakis(triphenylphosphine)palladium(0) (1 mol %) was added in one portion, and the reaction was heated at 100 Â°C for 4 h, then was cooled to room temperature and filtered through Celite, eluting with dichloromethane. The filtrate was concentrated and diluted with water. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried over sodium sulfate and concentrated. The crude product was purified by flash column silica chromatography, eluting with 2â8% dichloromethane in methanol, to yield the corresponding triazinone <b>9</b>.</div><div class="NLM_p">Phosphorus oxychloride (3.0 equiv) was added to a suspension of 1,2,4-triazole (5.0 equiv) in acetonitrile (0.05 M) at 0 Â°C. Triethylamine (6.0 equiv) was added dropwise to the reaction mixture at 0 Â°C, and the mixture was allowed to stir for 5 min at room temperature. The triazinone <b>9</b> (1.0 equiv) was added to the mixture as a solid, and the reaction was heated at 80 Â°C for 12 h, then was cooled to room temperature and concentrated. After addition of water, the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated. The crude solid was diluted with dichloromethane (0.06 M), triethylamine (3.0 equiv), and the azetidine hydrochloride 10 (1.0 equiv) were added, and the mixture was stirred at room temperature for 12 h. Water was added, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated. The crude product was purified by flash column silica chromatography, eluting with 5â10% methanol in dichloromethane, and then recrystallized from ethanol to yield the desired PDE2 analogues <b>2</b>â<b>7</b> and intermediate <b>11</b>.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-(Azetidin-1-yl)-5-[5-(2-fluoro-4-methoxyphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]-7-methylimidazo[5,1-<i>f</i>][1,2,4]triazine (<b>2</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 2.22â2.31 (m, 2H), 2.56 (s, 3H), 3.6â3.9 (br m, 2H), 3.78 (s, 3H), 3.82 (br s, 3H), 4.0â4.3 (v br m, 2H), 6.71 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 6.82 (dd, <i>J</i> = 12.4, 2.4 Hz, 1H), 7.69 (s, 1H), 7.71 (s, 1H). LCMS <i>m</i>/<i>z</i> = 394, LCMS-ELSD purity = 100%. HPLC retention time = 0.47 min. HPLC method: UPLC, 0.05% TFA 95â5 to 5â95 waterâACN.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-(Azetidin-1-yl)-5-[5-(4-methoxy-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]-7-methylimidazo[5,1-<i>f</i>][1,2,4]triazine (<b>3</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.06 (s, 3H), 2.24â2.32 (m, 2H), 2.56 (s, 3H), 3.67 (s, 3H), 3.77 (s, 3H), 3.8â4.2 (br m, 4H), 6.71â6.73 (m, 2H), 7.17â7.19 (m, 1H), 7.65 (s, 1H), 7.75 (s, 1H). LCMS <i>m</i>/<i>z</i> = 390, LCMS-ELSD purity = 100%. HPLC retention time = 0.48 min. HPLC method: UPLC 0.05% TFA 95â5 to 5â95 waterâACN.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-(Azetidin-1-yl)-5-[5-(2,3-difluoro-4-methoxyphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]-7-methylimidazo[5,1-<i>f</i>][1,2,4]triazine (<b>4</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.21â2.30 (m, 2H), 2.63 (s, 3H), 3.4â4.4 (br m, 4H), 3.84 (d, <i>J</i> = 1.6 Hz, 3H), 3.89 (s, 3H), 6.68 (ddd, <i>J</i> = 8.8, 7.6, 1.8 Hz, 1H), 7.02 (ddd, <i>J</i> = 8.8, 7.6, 2.3 Hz, 1H), 7.68 (s, 1H), 7.77 (s, 1H). LCMS <i>m</i>/<i>z</i> = 412.1 LCMS-ELSD purity = 100%. HPLC retention time = 0.49 min. HPLC method: UPLC 0.05% TFA 95â5 to 5â95 waterâACN.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-(3-Fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazol-4-yl}imidazo[5,1-<i>f</i>][1,2,4]triazine (<b>5</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.71 (s, 3H), 3.8â4.0 (br m, 2H), 3.93 (s, 3H), 4.0â4.3 (br m, 2H), 5.13â5.33 (m, <i>J</i><sub>HF</sub> = 57.0 Hz, 1H), 7.62 (AB quartet, <i>J</i><sub>AB</sub> = 8.1 Hz, ÎÎ½<sub>AB</sub> = 35.7 Hz, 4H), 7.70 (s, 1H), 7.86 (s, 1H). GCMS <i>m</i>/<i>z</i> 431 (M). LCMS <i>m</i>/<i>z</i> = 432, LCMS-ELSD purity = 100%. HPLC retention time = 0.59 min. HPLC method: UPLC 0.05% TFA 95â5 to 5â95 waterâACN. Anal. Calcd for C<sub>20</sub>H<sub>17</sub>F<sub>4</sub>N<sub>7</sub>: C, 55.68%; H, 3.97%; N, 22.73%. Found: C, 55.48%; H, 3.92%; N, 22.52%.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(3-Fluoroazetidin-1-yl)-5-{5-[2-methoxy-4-(trifluoromethyl)phenyl]-1-methyl-1<i>H</i>-pyrazol-4-yl}-7-methylimidazo[5,1-<i>f</i>][1,2,4]triazine (<b>6</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.64 (s, 3H), 3.78 (s, 3H), 3.89 (br s, 3H), 3.9â4.5 (br m, 4H), 5.11â5.31 (m, <i>J</i><sub>HF</sub> = 57.3 Hz, 1H), 7.16 (br s, 1H), 7.18 (br d, <i>J</i> = 8 Hz, 1H), 7.41 (br d, <i>J</i> = 8 Hz, 1H), 7.67 (s, 1H), 7.79 (s, 1H). LCMS <i>m</i>/<i>z</i> = 462.2, LCMS-ELSD purity = 100%. HPLC retention time = 0.59 min. HPLC method: UPLC 0.05% TFA 95â5 to 5â95 waterâACN.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-[5-(4-Chloro-2-fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]-4-(3-fluoroazetidin-1-yl)-7-methylimidazo[5,1-<i>f</i>][1,2,4]triazine (<b>7</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.68 (s, 3H), 3.83 (s, 3H), 3.85â4.3 (br m, 4H), 4.95â5.30 (m, <i>J</i><sub>HF</sub> = 56 Hz, 1H), 7.14â7.19 (m, 2H), 7.43â7.47 (m, 1H), 7.69 (s, 1H), 7.84 (s, 1H). LCMS <i>m</i>/<i>z</i> = 415, LCMS-ELSD purity = 93%. HPLC retention time = 0.56 min. HPLC method: UPLC 0.05% TFA 95â5 to 5â95 waterâACN.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(7-Methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazol-4-yl}imidazo[5,1-<i>f</i>][1,2,4]triazin-4-yl)azetidin-3-ol (<b>11</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.59 (s, 3H), 3.2â3.3 (br m, 2H), 3.55â3.70 (br m, 2H), 3.88 (s, 3H), 4.50â4.56 (m, 1H), 7.49 (d, <i>J</i> = 8 Hz, 2H), 7.59 (br d, <i>J</i> = 8 Hz, 2H), 7.61 (s, 1H), 7.75 (s, 1H). LCMS <i>m</i>/<i>z</i> = 330, LCMS-ELSD purity = 100%. HPLC retention time = 2.42 min.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(7-Methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazol-4-yl}imidazo[5,1-<i>f</i>][1,2,4]triazin-4-yl)azetidin-3-yl 4-methylbenzenesulfonate (<b>12</b>)</h4><div class="NLM_p last">Triethylamine (1.29 mL, 9.0 mmol, 3 equiv) and <i>p</i>-toluenesulfonyl chloride (744 mg, 3.9 mmol, 1.3 equiv) were added to a solution of <b>11</b> (1.29 g, 3.0 mmol, 1.0 equiv) in dichloromethane (20 mL). The reaction mixture was stirred at room temperature for 12 h. The mixture was diluted with ethyl acetate and water. The layers were separated, and the organic layer was washed with brine, dried over sodium sulfate, and concentrated. The crude product was purified by flash chromatography (silica gel, 0â4% methanol in dichloromethane). The resulting off-white powder was recrystallized from dichloromethane/<i>n</i>-heptane to yield the desired tosylate intermediate <b>12</b> in 57% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) characteristic peaks: Î´ 2.45 (s, 3H), 2.63 (s, 3H), 3.75â4.15 (br m, 4H), 3.93 (s, 3H), 4.90 (m, 1H), 7.33â7.38 (m, 2H), 7.57 (d, <i>J</i> = 8.2 Hz, 2H), 7.59 (s, 1H), 7.62 (d, <i>J</i> = 8.2 Hz, 2H), 7.71â7.75 (m, 2H). LCMS <i>m</i>/<i>z</i> = 584.3, LCMS-ELSD purity = 100%. Anal. Calcd for C<sub>27</sub>H<sub>24</sub>F<sub>3</sub>N<sub>7</sub>O<sub>3</sub>S: C, 55.57%; H, 4.15%; N, 16.80%. Found: C, 55.33%; H, 4.12%; N, 16.56%.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Radiosynthesis of [<sup>18</sup>F]<b>5</b></h4><div class="NLM_p">Oxygen-18 enriched (97%) water was purchased from Huayi Isotopes (cat. no. WT-98â5), Taiyo Nippon Sanso Corp. (cat. no. F03â0027), or Sigma-Aldrich (cat. no. 329878) . All solvents were purchased from Sigma-Aldrich. Radiochemistry was performed on a GE TracerLab FX FâN synthesis module. [<sup>18</sup>F]<b>5</b> was purified by HPLC available on the GE TracerLab FX FâN module, consisting of a Sykam S-1021 pump, a Knauer K-2001 UV detector (Î» = 254 nm) in series with a Berthold Î²+-flow detector, on a Phenomenex Hydro-RP column (10 Ã 250 mm, 4 Î¼m) equipped with a Phenomenex semiprep Security Guard holder (cat. no. AJ0â7220 with cartridge AJ0â7512) at 5 mL/min with 40% v/v acetonitrile/water (modified with 0.1% formic acid) as the mobile phase. Quality control analysis of [<sup>18</sup>F]<b>5</b> for radiochemical and chemical purity was performed on an Agilent 1100 using a Phenomenex Hydro-RP column (4.6 mm Ã 150 mm, 5 Î¼m) and 40% acetonitrile/0.1% formic acid (1.0 mL/min) as the mobile phase. The identity of the labeled compound was confirmed by HPLC coinjection with authentic material. The specific activity was determined by injection of an aliquot of the final solution with known radioactivity on the analytical HPLC system described above. The area of the UV peak measured at 254 nm corresponding to the carrier product was measured and compared to a standard curve relating mass to UV absorbance. Radioactivity was measured with a Capintec CRC-15 PET dose calibrator.</div><div class="NLM_p last">No-carrier-added [<sup>18</sup>F]fluoride was prepared by proton irradiation (70 min, 60 Î¼amp beam) of a 2.4 mL tantalum target [<sup>18</sup>O(p,n)<sup>18</sup>F]. The semiprep HPLC column was equilibrated with the mobile phase 15â30 min at 3 mL/min during the beam. The radioactivity was unloaded from the target and delivered to the glass V-vial on the GE TracerLab FX FâN synthesis module. The [<sup>18</sup>F]fluoride was trapped on a Waters QMA Plus Light cartridge (cat. no. 023531; pretreated with 5 mL 0.2 M potassium phosphate, then dried under an N<sub>2</sub> stream). The [<sup>18</sup>F]fluoride was eluted with a solution of 1 mL of 0.03 M tetrabutylammonium mesylate in methanol. The methanol was evaporated at 100 Â°C in vacuo under a stream of helium until dry (about 3.5 min). The reactor was then cooled to 40 Â°C while still under vacuum. The residue from the drying step was dissolved in a solution of <b>12</b> (5 mg) in 2-methyl-2-butanol (<i>t</i>-amyl alcohol, 0.6 mL) and heated at 110 Â°C for 30 min. The reaction mixture was cooled to 90 Â°C, and the 2-methyl-2-butanol was evaporated in vacuo under helium (â¼1 min). The reaction mixture was cooled to 30 Â°C, and the residue was dissolved in a mixture of aqueous sodium hydroxide (1 M, 0.5 mL) and acetonitrile (0.5 mL) and stirred for 3 min. The mixture was diluted with aqueous formic acid (1 M, 0.5 mL) and 50% acetonitrile/0.1% formic acid (1.0 mL). This solution was passed through a Waters Alumina N Sep-Pak Light (part no. 23561) into an intermediate vial. The contents of the intermediate vial were then purified by semiprep chromatography (vide supra). The fraction containing [<sup>18</sup>F]<b>5</b> was collected between 14.7 and 16.2 min and diluted with 60 mL water, followed by trapping on a Waters 30 mg Oasis HLB vac cartridge (WAT186001879). The cartridge was washed with water (3 mL), then eluted with ethanol (0.5 mL) and pH 7.4 phosphate-buffered saline (4.5 mL). The final formulation was filtered (Millipore Durapore PVDF 13 mm, cat. no. SLGSV013SL) and collected in a sterile 10 mL HollisterâStier crimp-sealed vial, with a small aliquot (0.4 mL) set aside in a sterile 2 mL QC vial for analytical HPLC analysis on the Agilent system (vide supra). Averages over eight reactions: starting radioactivity (reactor following elution of fluoride), 75.9 Â± 10.4 GBq (2050 Â± 281 mCi); time of synthesis (from end of beam), 81 min; product radioactivity, 3.22 Â± 0.67 GBq (87 Â± 18 mCi); radiochemical yield, 7.3 Â± 1.9%, decay-corrected to starting [<sup>18</sup>F]fluoride in the reactor; specific activity, 540 Â± 152 GBq/Î¼mol (14592 Â± 4095 Ci/mmol); radiochemical purity, 99.5 Â± 0.3%; chemical purity, 93.3 Â± 6.5%.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> PET Imaging Protocol</h3><div class="NLM_p last">This study employed two male nonhuman primates (NHPs, 5- to 6-year-old cynomolgus monkeys) fasted overnight prior to PET imaging. In preparation for PET scanning, NHPs were premedicated with ketamine (10 mg/kg, IM) and glycopyrrolate (0.01 mg/kg, IM), intubated, and maintained under isoflurane anesthesia (1.5â2.0% in oxygen) for the duration of the scan procedure. An intravenous (IV) catheter was placed into the saphenous vein in the leg for tracer injection/blood sampling. Before radiotracer injection, a 515 s transmission scan was acquired for attenuation and scatter correction using a <sup>57</sup>Co point-source. Baseline PET scans were conducted with [<sup>18</sup>F]<b>5</b> administered IV as a bolus dose targeting an injected radioactivity of 37 MBq/kg (1.0 mCi/kg). Dynamic PET scans of 90 min were conducted in a Focus 220 microPET scanner (Siemens Medical Systems) and initiated on administration of the radiotracer. PET data was histogrammed into 16 image frames (five 1 min frames, five 5 min frames, six 10 min frames) over the 90 min dynamic scan duration. The Focus 220 scanner consists of 48 rings of detectors axially. 3D sinograms were created with corrections for random coincidences and global. Attenuation and scatter correction maps were created from the measured <sup>57</sup>Co transmission scan (515 s duration). PET images were reconstructed into a 256 Ã 256 Ã 95 volume with <i>x</i>, <i>y</i> pixel dimension of 0.9 mm and slice thickness of 0.8 mm with corrections for detector normalization, decay, attenuation, and scatter using OSEM3D fastMAP iterative image reconstruction using inverse Fourier rebinning for fully 3D PET (Siemens Medical Systems). Reconstructed images were scaled to standardized uptake value (SUV) and coregistered to an individual reference PET image for each NHP using a mutual information algorithm. Timeâactivity curves were generated for regions of interest defined in the reference PET images for frontal cortex, putamen, caudate, and cerebellum. PDE2A binding potential was calculated for each tissue using the simplified reference tissue model<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> implemented in PMOD software (PMOD Technologies) employing cerebellum as a reference region of nonspecific binding.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/jm400312y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The full data set of the PET ligand database, an extended version of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> with individual parameters of CNS PET MPO (ClogP, ClogD, MW, HBD, TPSA, and p<i>K</i><sub>a</sub>), and a CNS PET MPO calculator in Excel format.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400312y/suppl_file/jm400312y_si_001.pdf">jm400312y_si_001.pdf (200.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400312y/suppl_file/jm400312y_si_003.xls">jm400312y_si_003.xls (34.0 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400312y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Zhang</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#521e373b7c083a333c35611222343b2837207c313d3f"><span class="__cf_email__" data-cfemail="3f735a561165575e51580c7f4f5956455a4d115c5052">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anabella Villalobos</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth M. Beck</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Bocan</span> - <span class="hlFld-Affiliation affiliation">BioImaging Center, Precision Medicine,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas A. Chappie</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laigao Chen</span> - <span class="hlFld-Affiliation affiliation">BioImaging Center, Precision Medicine,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Grimwood</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Research Unit,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven D. Heck</span> - <span class="hlFld-Affiliation affiliation">Data Analytical Group, Groton
Center of Chemistry, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun Hou</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Humphrey</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiemin Lu</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc B. Skaddan</span> - <span class="hlFld-Affiliation affiliation">BioImaging Center, Precision Medicine,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy J. McCarthy</span> - <span class="hlFld-Affiliation affiliation">BioImaging Center, Precision Medicine,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick R. Verhoest</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis T. Wager</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry,
Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Zasadny</span> - <span class="hlFld-Affiliation affiliation">BioImaging Center, Precision Medicine,
Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2020-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Rebecca OâConnor and Mary C. MacDougall for providing the PDE2A activity and PDE selectivity data and the Pfizer ADME technology group for generating the in vitro pharmacokinetic data and developing the in silico RRCK passive permeability, MDR efflux, and plasma and brain fractions unbound models. We also thank Laura Blumberg, Brian S. Bronk, and Clive Brown-Proctor for helpful discussions and suggestions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> Abbreviations Used</h2><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine monophosphate</p></td></tr><tr><td class="NLM_term">ClogD</td><td class="NLM_def"><p class="first last">calculated distribution coefficient</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">MardinâDarby canine kidney</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">NSB</td><td class="NLM_def"><p class="first last">nonspecific binding</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">RR canine kidney</p></td></tr><tr><td class="NLM_term">RO</td><td class="NLM_def"><p class="first last">receptor occupancy</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standard uptake value</p></td></tr><tr><td class="NLM_term">TAC</td><td class="NLM_def"><p class="first last">timeâactivity curve</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Phelps, M. E.</span><span> </span><span class="NLM_article-title">PET: The Merging of Biology and Imaging into Molecular Imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=10768568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ivFSmtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=661-681&author=M.+E.+Phelps&title=PET%3A+The+Merging+of+Biology+and+Imaging+into+Molecular+Imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">PET: the merging of biology and imaging into molecular imaging</span></div><div class="casAuthors">Phelps M E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">661-81</span>
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    </div><div class="casAbstract">PET and SPECT are molecular imaging techniques that use radiolabeled molecules to image molecular interactions of biological processes in vivo.  PET imaging technologies have been developed to provide a pathway to the patient from the experimental paradigms of biological and pharmaceutical sciences in genetically engineered and tissue transplanted mouse models of disease.  PET provides a novel way for molecular therapies and molecular diagnostics to come together in the discovery of molecules that can be used in low mass amounts to image the function of a target and, by elevating the mass, to pharmacologically modify the function of the target.  In both cases, the molecules are the same or analogs of each other.  PET can be used to titrate drugs to their sites of action within organ systems in vivo and to assay biological outcomes of the processes being modified in the mouse and the patient.  The goal is to provide a novel way to improve the rates of discovery and approval of radiopharmaceuticals and pharmaceuticals.  Extending this relationship into clinical practice can improve drug use by providing molecular diagnostics in concert with molecular therapeutics.  Diseases are biological processes, and molecular imaging with PET is sensitive and informative to these processes.  This sensitivity is exemplified by the detection of disease with PET without evidence of anatomic changes on CT and MRI.  These biological changes are seen early in the course of disease, even in asymptomatic stages, as illustrated by the metabolic abnormalities detected with PET and FDG in Huntington's and familial Alzheimer's diseases 7 and 5 y, respectively, before symptoms appear.  Differentiation of viable from nonviable tissue is fundamentally a metabolic question, as shown by the use of PET to differentiate patients with coronary artery disease who will benefit from revascularization from those who will not.  Although beginning within a specific organ, cancer is a systemic disease the most devastating consequences of which result from metastases.  Whole-body PET imaging with FDG enables inspection of glucose metabolism in all organ systems in a single examination to improve the detection and staging of cancer, selection of therapy, and assessment of therapeutic response.  In lung and colorectal cancers, melanoma, and lymphoma, PET FDG improves the accuracy of detection and staging from 8% to 43% over conventional work-ups and results in treatment changes in 20%-40% of the patients, depending on the clinical question.  Approximately 65% are upstaged because unsuspected metastases are detected, and 35% are downstaged because a structural diagnosis of lesions is changed from malignant to benign.  Similar results are now being shown for other cancers.  The main difference between CT, sonography, MRI, and PET or SPECT is not technologic but, rather, a difference between detecting and characterizing a disease by its anatomic features as opposed to its biology.  The importance and success of developing new molecular imaging probes is increasing as PET becomes integral to the study of the integrative mammalian biology of disease and as molecular therapies targeting the biological processes of disease are developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTWLVzWjiD60loaUqgkFHkfW6udTcc2eZzDy3H3YPI3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ivFSmtw%253D%253D&md5=6fb5310a58e1432756db8fa0a37546ed</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26atitle%3DPET%253A%2520The%2520Merging%2520of%2520Biology%2520and%2520Imaging%2520into%2520Molecular%2520Imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D41%26spage%3D661%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Molecular Imaging with PET</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">â</span> <span class="NLM_lpage">1516</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0782426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFShtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1501-1516&author=S.+M.+Ametameyauthor=M.+Honerauthor=P.+A.+Schubiger&title=Molecular+Imaging+with+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Imaging with PET</span></div><div class="casAuthors">Ametamey, Simon M.; Honer, Michael; Schubiger, Pius August</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1501-1516</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgtMhO_aTjrVg90H21EOLACvtfcHk0lgWrFFPuErk5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFShtL0%253D&md5=513a2a8c8779c207122a8c23586fd016</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Fcr0782426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0782426%26sid%3Dliteratum%253Aachs%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DMolecular%2520Imaging%2520with%2520PET%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1501%26epage%3D1516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morgan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Graaf, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltner, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, S. D. A.</span><span> </span><span class="NLM_article-title">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">â</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2Fj.drudis.2011.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=22227532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=419-424&author=P.+Morganauthor=P.+H.+Van+Der+Graafauthor=J.+Arrowsmithauthor=D.+E.+Feltnerauthor=K.+S.+Drummondauthor=C.+D.+Wegnerauthor=S.+D.+A.+Street&title=Can+the+flow+of+medicines+be+improved%3F+Fundamental+pharmacokinetic+and+pharmacological+principles+toward+improving+phase+II+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival</span></div><div class="casAuthors">Morgan, Paul; Van Der Graaf, Piet H.; Arrowsmith, John; Feltner, Doug E.; Drummond, Kira S.; Wegner, Craig D.; Street, Steve D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">419-424</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In an effort to uncover systematic learnings that can be applied to improve compd. survival, an anal. was performed on data from Phase II decisions for 44 programs at Pfizer.  It was found that not only were the majority of failures caused by lack of efficacy but also that, in a large no. of cases (43%), it was not possible to conclude whether the mechanism had been tested adequately.  A key finding was that an integrated understanding of the fundamental pharmacokinetic/pharmacodynamic principles of exposure at the site of action, target binding and expression of functional pharmacol. activity (termed together as the three Pillars of survival') all det. the likelihood of candidate survival in Phase II trials and improve the chance of progression to Phase III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFyWWmU_ARMLVg90H21EOLACvtfcHk0lgqovzB3QlWoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D&md5=18816036124edb3d50c4e063fdc40614</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DVan%2BDer%2BGraaf%26aufirst%3DP.%2BH.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DFeltner%26aufirst%3DD.%2BE.%26aulast%3DDrummond%26aufirst%3DK.%2BS.%26aulast%3DWegner%26aufirst%3DC.%2BD.%26aulast%3DStreet%26aufirst%3DS.%2BD.%2BA.%26atitle%3DCan%2520the%2520flow%2520of%2520medicines%2520be%2520improved%253F%2520Fundamental%2520pharmacokinetic%2520and%2520pharmacological%2520principles%2520toward%2520improving%2520phase%2520II%2520survival%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D419%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Frank, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LÃ¥ngstrÃ¶m, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agdeppa, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendizabal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderheyden, J.-L.</span><span> </span><span class="NLM_article-title">The imaging continuum: bench to biomarkers to diagnostics</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">â</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1002%2Fjlcr.1444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jsL%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=746-769&author=R.+A.+Frankauthor=B.+L%C3%A5ngstr%C3%B6mauthor=G.+Antoniauthor=M.+C.+Montaltoauthor=E.+D.+Agdeppaauthor=M.+Mendizabalauthor=I.+A.+Wilsonauthor=J.-L.+Vanderheyden&title=The+imaging+continuum%3A+bench+to+biomarkers+to+diagnostics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The imaging continuum: bench to biomarkers to diagnostics</span></div><div class="casAuthors">Frank, Richard A.; Longstrom, Bengt; Antoni, Gunnar; Montalto, Michael C.; Agdeppa, Eric D.; Mendizabal, Marivi; Wilson, Ian A.; Vanderheyden, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">746-769</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Innovation in basic and applied science has brought radiotracers to fruition as diagnostics.  Non-invasive, longitudinal, and quantifiable mol. imaging is the key to diagnosing and monitoring numerous illnesses, with more to come from characterization of the clin. relevance of findings from genomics research.  Radiotracers enable real-time in vivo studies of the effects of drug candidates on receptors, pathways, pharmacodynamics, and clin. relevant endpoints, thereby providing both early detection of pathophysiol. to enable early intervention, and then monitoring of treatment responses to enable individualization of treatment regimens.  We review developments which have translated imaging from 'bench to bedside', or 'biomarkers to diagnostics'.  Notable developments include (1) synthesis methods for rapid 11C labeling of biomols. to high specific radioactivity; (2) ligand-binding assays for screening mol. imaging agents rather than drugs; (3) in vivo imaging of radiotracers in animals; (4) discovering the imaging advantages of 99mTc, 11C, and 18F; (5) co-registration and automated quant. assessment of high spatial resoln. CT and MR images with mol. images from PET for longitudinal studies of treatment effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpX1uF1bzrvbVg90H21EOLACvtfcHk0lgqovzB3QlWoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jsL%252FM&md5=e867959e4c1b01b60d78adc0f551c30d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1444%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DR.%2BA.%26aulast%3DL%25C3%25A5ngstr%25C3%25B6m%26aufirst%3DB.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DMontalto%26aufirst%3DM.%2BC.%26aulast%3DAgdeppa%26aufirst%3DE.%2BD.%26aulast%3DMendizabal%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DVanderheyden%26aufirst%3DJ.-L.%26atitle%3DThe%2520imaging%2520continuum%253A%2520bench%2520to%2520biomarkers%2520to%2520diagnostics%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2007%26volume%3D50%26spage%3D746%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a mini-review</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">â</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+mini-review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0liFaSzbkMgW9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520mini-review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. Y.</span><span> </span><span class="NLM_article-title">Positron emission tomography: imaging and quantification of neurotransporter availability</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2FS1046-2023%2802%2900085-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=12183117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtFWhs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=287-299&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Y.+Huang&title=Positron+emission+tomography%3A+imaging+and+quantification+of+neurotransporter+availability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography: imaging and quantification of neurotransporter availability</span></div><div class="casAuthors">Laruelle, Marc; Slifstein, Mark; Huang, Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">287-299</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review.  Over the last decade, a large no. of radiotracers have been developed to image and quantify transporter availability with positron emission tomog. (PET) or single-photon emission computed tomog. (SPECT).  Radiotracers suitable to image dopamine transporters (DATs) and serotonin transporters (SERTs) have been the object of most efforts.  Following a brief overview of DAT and SERT radiotracers that have been demonstrated to be suitable for quant. anal. in vivo, this article describes the principal methods that have been used for the anal. of these data.  Kinetic modeling is the most direct implementation of the compartment models, but with some tracers accurate input function measurement and good compartment configuration identification can be difficult to obtain.  Other methods were designed to overcome some particular vulnerability to error of classic kinetic modeling, but introduced new vulnerabilities in the process.  Ref. region methods obviate the need for arterial plasma measurement, but are not as robust to violations of the underlying modeling assumptions as methods using the arterial input function.  Graphical methods give ests. of distribution vols. without the requirement of compartment model specification, but provide a biased estimator in the presence of statistical noise.  True equil. methods are quite robust, but their use is limited to expts. with tracers that are suitable for const. infusion.  In conclusion, no universally "best" method is applicable to all neurotransporter imaging studies, and careful evaluation of model-based methods is required for each radiotracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3jdsXbliaMLVg90H21EOLACvtfcHk0liFaSzbkMgW9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtFWhs74%253D&md5=1ec923e982f1769d80fd74b68d7b05ed</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1046-2023%2802%2900085-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-2023%252802%252900085-3%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%2BY.%26atitle%3DPositron%2520emission%2520tomography%253A%2520imaging%2520and%2520quantification%2520of%2520neurotransporter%2520availability%26jtitle%3DMethods%26date%3D2002%26volume%3D27%26spage%3D287%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">â</span> <span class="NLM_lpage">572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2FS0969-8051%2801%2900211-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=11516700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVGrtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=561-572&author=J.+S.+Fowlerauthor=N.+D.+Volkowauthor=G.-J.+Wangauthor=S.+J.+Gatleyauthor=J.+Logan&title=%5B11C%5DCocaine%3A+PET+studies+of+cocaine+pharmacokinetics%2C+dopamine+transporter+availability+and+dopamine+transporter+occupancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">[11C]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy</span></div><div class="casAuthors">Fowler, J. S.; Volkow, N. D.; Wang, G.-J.; Gatley, S. J.; Logan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-572</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Cocaine was initially labeled with carbon-11 in order to track the distribution and pharmacokinetics of this powerful stimulant and drug of abuse in the human brain and body.  It was soon discovered that [11C]cocaine was not only useful for measuring cocaine pharmacokinetics and its relationship to behavior but that it is also a sensitive radiotracer for dopamine transporter (DAT) availability.  Measures of DAT availability were facilitated by the development of a graphical anal. method (Logan Plot) for reversible systems which streamlined kinetic anal.  This expanded the applications of [11C]cocaine to studies of DAT availability in the human brain and allowed the first comparative measures of the degree of DAT occupancy by cocaine and another stimulant drug methylphenidate.  This article will summarize preclin. and clin. research with [11C]cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQaCi9sqkBwrVg90H21EOLACvtfcHk0liFaSzbkMgW9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVGrtrw%253D&md5=a8fcb29ec74058ddf5dfa72a8395c8a2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900211-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900211-6%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.-J.%26aulast%3DGatley%26aufirst%3DS.%2BJ.%26aulast%3DLogan%26aufirst%3DJ.%26atitle%3D%255B11C%255DCocaine%253A%2520PET%2520studies%2520of%2520cocaine%2520pharmacokinetics%252C%2520dopamine%2520transporter%2520availability%2520and%2520dopamine%2520transporter%2520occupancy%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D561%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the bloodâbrain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood%E2%80%93brain+barrier+and+surviving+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">â</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+to+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score â¥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liFaSzbkMgW9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cunningham, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">PET studies in drug development: methodological considerations</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=311-315&author=V.+J.+Cunninghamauthor=C.+A.+Parkerauthor=E.+A.+Rabinerauthor=A.+D.+Geeauthor=R.+N.+Gunn&title=PET+studies+in+drug+development%3A+methodological+considerations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DV.%2BJ.%26aulast%3DParker%26aufirst%3DC.%2BA.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGee%26aufirst%3DA.%2BD.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DPET%2520studies%2520in%2520drug%2520development%253A%2520methodological%2520considerations%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2005%26volume%3D2%26spage%3D311%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camenisch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chretien, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raevsky, O. A.</span><span> </span><span class="NLM_article-title">Estimation of BloodâBrain Barrier Crossing of Drugs Using Molecular Size and Shape, and H-Bonding Descriptors</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">â</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.3109%2F10611869808997889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=9886238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=151-165&author=H.+Van+de+Waterbeemdauthor=G.+Camenischauthor=G.+Folkersauthor=J.+R.+Chretienauthor=O.+A.+Raevsky&title=Estimation+of+Blood%E2%80%93Brain+Barrier+Crossing+of+Drugs+Using+Molecular+Size+and+Shape%2C+and+H-Bonding+Descriptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span></div><div class="casAuthors">Van de Waterbeemd, Han; Camenisch, Gian; Folkers, Gerd; Chretien, Jacques R.; Raevsky, Oleg A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-165</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The influence of physicochem. properties, including lipophilicity, H-bonding capacity and mol. size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs.  It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential.  A combination of a H-bonding and a mol. size descriptor, i.e., the major components of lipophilicity and permeability, avoiding knowledge of distribution coeffs., is proposed to est. brain penetration potential of new drug candidates.  Previously reported exptl. surface activity data appear to be strongly correlated to mol. size of the drug compds.  Present anal. offers a modern basis for property-based design and targeting of CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0yCKmlzsa37Vg90H21EOLACvtfcHk0ljFN2xKLC7bEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D&md5=9106ff6aa0755ff76fd0634822857d4a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3109%2F10611869808997889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611869808997889%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DChretien%26aufirst%3DJ.%2BR.%26aulast%3DRaevsky%26aufirst%3DO.%2BA.%26atitle%3DEstimation%2520of%2520Blood%25E2%2580%2593Brain%2520Barrier%2520Crossing%2520of%2520Drugs%2520Using%2520Molecular%2520Size%2520and%2520Shape%252C%2520and%2520H-Bonding%2520Descriptors%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D1998%26volume%3D6%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briard, E.</span><span> </span><span class="NLM_article-title">A rapid vesicle electrokinetic chromatography method for the in vitro prediction of non-specific binding for potential PET ligands</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">â</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2Fj.jpba.2010.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=21126842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2mtrrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=722-729&author=Z.+Jiangauthor=J.+Reillyauthor=B.+Everattauthor=E.+Briard&title=A+rapid+vesicle+electrokinetic+chromatography+method+for+the+in+vitro+prediction+of+non-specific+binding+for+potential+PET+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid vesicle electrokinetic chromatography method for the in vitro prediction of non-specific binding for potential PET ligands</span></div><div class="casAuthors">Jiang, Zhengjin; Reilly, John; Everatt, Brian; Briard, Emmanuelle</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">722-729</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High non-specific binding (NSB) is one of the most common reasons for candidate failure in potential positron emission tomog. (PET) radiotracer development.  It is of interest to develop high throughput in vitro methods for predicting non-specific binding prior to radiolabeling, which would help guide radiotracer candidate selection and assist decision making in new radiotracer discovery.  We evaluated several electrokinetic chromatog. (EKC) systems to help identify PET ligands with low non-specific binding characteristics by mimicking the ligand-brain tissue interaction.  The measured retention factors of tracers in clin. use or terminated candidates within AOT vesicle EKC systems were compared with literature in vitro or in vivo NSB data.  We conclude that there is a statistical correlation between the chromatog. retention parameters of tested drugs and their NSB.  The AOT vesicle EKC method can provide NSB in vitro trend anal. for a large no. of drug candidates early in the novel radiotracer discovery process with minimal resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphoegUxlpyHrVg90H21EOLACvtfcHk0ljFN2xKLC7bEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2mtrrO&md5=dd95312fc52995ed2233f2d9ccf7012a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2010.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2010.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DEveratt%26aufirst%3DB.%26aulast%3DBriard%26aufirst%3DE.%26atitle%3DA%2520rapid%2520vesicle%2520electrokinetic%2520chromatography%2520method%2520for%2520the%2520in%2520vitro%2520prediction%2520of%2520non-specific%2520binding%2520for%2520potential%2520PET%2520ligands%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2011%26volume%3D54%26spage%3D722%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R. E.</span><span> </span><span class="NLM_article-title">An In Vitro Assay for Predicting Successful Imaging Radiotracers</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2FS1536-1632%2803%2900041-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=14499146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A280%3ADC%252BD3svktFGmsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=65-71&author=S.+Patelauthor=T.+Hamillauthor=E.+Hostetlerauthor=H.+D.+Burnsauthor=R.+E.+Gibson&title=An+In+Vitro+Assay+for+Predicting+Successful+Imaging+Radiotracers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro assay for predicting successful imaging radiotracers</span></div><div class="casAuthors">Patel Shil; Hamill Terence; Hostetler Eric; Burns H Donald; Gibson Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">PURPOSE:  To develop an in vitro binding assay able to predict whether a radiolabel is likely to be a useful clinical tracer for positron emission tomography (PET).  PROCEDURES:  Rodent and rhesus brain sections were incubated with radioligands, most of which are tritiated or iodinated versions of known clinical PET radiotracers, and assayed for binding to brain receptors for a 20-minute period using a no-wash protocol (n=>/=3).  RESULTS:  Radiolabeled flumazenil (RO-151788), WAY100635, N-methylscopolamine, N-methylspiperone, raclopride, citalopram, (1-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI), paroxetine, and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-flurobenzamido]ethyl]piperazine (MPPF) were assessed for binding to either rhesus caudate putamen, and/or frontal cortex, or rat whole brain sections.  Specific binding for these compounds ranged from 0 to 94% by 20 minutes.  Those with %-specific binding less than 10% have also been shown to not be effective as in vivo PET radiotracers.  In addition, successful PET radiotracers incubated in tissue sections with target receptor either absent or present in low density behaved poorly in this assay, as expected, as did radiolabels previously shown to possess high non-specific binding.  CONCLUSIONS:  An in vitro binding assay using rodent and rhesus brain sections has been developed that, within the currently assayed radiotracers, is able to rapidly predict whether a radiolabeled compound is a useful clinical PET radiotracer.  This method suggests significant potential for the rapid in vitro evaluation of potential in vivo PET radiotracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxu1swsKtr4AMthz5_Rx5rfW6udTcc2eaTQv0g7moT1rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svktFGmsQ%253D%253D&md5=4fe5e7e7ebdd730cad9a149782f7b0eb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1536-1632%2803%2900041-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1536-1632%252803%252900041-6%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DHamill%26aufirst%3DT.%26aulast%3DHostetler%26aufirst%3DE.%26aulast%3DBurns%26aufirst%3DH.%2BD.%26aulast%3DGibson%26aufirst%3DR.%2BE.%26atitle%3DAn%2520In%2520Vitro%2520Assay%2520for%2520Predicting%2520Successful%2520Imaging%2520Radiotracers%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosso, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, I. R.</span><span> </span><span class="NLM_article-title">Ab initio Computational Study of Positron Emission Tomography Ligands Interacting with Lipid Molecule for the Prediction of Nonspecific Binding</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">â</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=2397-2405&author=L.+Rossoauthor=A.+D.+Geeauthor=I.+R.+Gould&title=Ab+initio+Computational+Study+of+Positron+Emission+Tomography+Ligands+Interacting+with+Lipid+Molecule+for+the+Prediction+of+Nonspecific+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosso%26aufirst%3DL.%26aulast%3DGee%26aufirst%3DA.%2BD.%26aulast%3DGould%26aufirst%3DI.%2BR.%26atitle%3DAb%2520initio%2520Computational%2520Study%2520of%2520Positron%2520Emission%2520Tomography%2520Ligands%2520Interacting%2520with%2520Lipid%2520Molecule%2520for%2520the%2520Prediction%2520of%2520Nonspecific%2520Binding%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2008%26volume%3D29%26spage%3D2397%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1715</span><span class="NLM_x">â</span> <span class="NLM_lpage">1723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1715-1723&author=Q.+Guoauthor=M.+Bradyauthor=R.+N.+Gunn&title=A+Biomathematical+Modeling+Approach+to+Central+Nervous+System+Radioligand+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DBrady%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DA%2520Biomathematical%2520Modeling%2520Approach%2520to%2520Central%2520Nervous%2520System%2520Radioligand%2520Discovery%2520and%2520Development%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D1715%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">For selection of the negative control compounds and their references, please see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Applications to the Prediction of Drug Transport Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">â</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+Calculation+of+Molecular+Polar+Surface+Area+as+a+Sum+of+Fragment-Based+Contributions+and+Its+Applications+to+the+Prediction+of+Drug+Transport+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520Calculation%2520of%2520Molecular%2520Polar%2520Surface%2520Area%2520as%2520a%2520Sum%2520of%2520Fragment-Based%2520Contributions%2520and%2520Its%2520Applications%2520to%2520the%2520Prediction%2520of%2520Drug%2520Transport%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">This modified version of the CNS MPO tool, derived from analysis of marketed CNS drugs, was named as CNS PET MPO to reflect its utility in PET ligand design and prioritization. A CNS PET MPO calculator is included as part of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">â</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lj5tRNZfzP7uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Whalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J.</span><span> </span><span class="NLM_article-title">A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">â</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1002%2Frcm.2469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=16628559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1497-1503&author=K.+Whalenauthor=J.+Gobeyauthor=J.+Janiszewski&title=A+centralized+approach+to+tandem+mass+spectrometry+method+development+for+high-throughput+ADME+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening</span></div><div class="casAuthors">Whalen, Kevin; Gobey, Jason; Janiszewski, John</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1497-1503</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A centralized approach to acquisition and dissemination of tandem mass spectrometry (MS/MS) conditions within an ADME-screening bioanal. mass spectrometry group was developed.  The method development process uses 2 automated software products (Autoscan and Automaton) specifically designed for mass spectrometers manufd. by MDS Sciex.  Both provide the ability to quickly det. selected reaction monitoring (SRM) transitions for hundreds of compds. per day.  Autoscan dets. optimal polarity and collision energy (CE).  Automaton also dets. the optimal declustering potential (DP) as well as the CE.  The resulting optimized conditions are loaded into a central database for access by LC/MS/MS bioanal. workstations in the group.  The effect of DP and CE on the sensitivity was studied.  Optimization of DP improved signal response â¼27% on av.  For â¼10% of compds., signal enhancement was >50% compared to the generic setting.  A generic setting of DP = 25 V can be used for the majority of ADME-screening applications.  Optimization of CE can have a much larger impact on signal intensity and a min. of 3 CE settings should be tested.  CE values of 1, 30 and 45 V provide adequate coverage for most small mol. drug discovery analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYhEOAvOWB7Vg90H21EOLACvtfcHk0lj5tRNZfzP7uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D&md5=6e57b4b490527b98931bc58aa871d48c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Frcm.2469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.2469%26sid%3Dliteratum%253Aachs%26aulast%3DWhalen%26aufirst%3DK.%26aulast%3DGobey%26aufirst%3DJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%26atitle%3DA%2520centralized%2520approach%2520to%2520tandem%2520mass%2520spectrometry%2520method%2520development%2520for%2520high-throughput%2520ADME%2520screening%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2006%26volume%3D20%26spage%3D1497%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">RRCK cells were generated in-house (Pfizer Inc., Groton, CT, USA) as a subclone of MardinâDarby canine kidney wild-type (MDCK-WT) cells that displayed low expression of endogenous P-gp (approximately 1â2% of MDCK-WT cells, based on mRNA level). For detailed information, see:</p></div><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPerle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, G. G.</span><span> </span><span class="NLM_article-title">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1111%2Fj.1365-2125.2011.03961.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=21392072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2011&pages=235-246&author=E.+Callegariauthor=B.+Malhotraauthor=P.+J.+Bungayauthor=R.+Websterauthor=K.+S.+Fennerauthor=S.+Kempshallauthor=J.+L.+LaPerleauthor=M.+C.+Michelauthor=G.+G.+Kay&title=A+comprehensive+non-clinical+evaluation+of+the+CNS+penetration+potential+of+antimuscarinic+agents+for+the+treatment+of+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span></div><div class="casAuthors">Callegari, Ernesto; Malhotra, Bimal; Bungay, Peter J.; Webster, Rob; Fenner, Katherine S.; Kempshall, Sarah; LaPerle, Jennifer L.; Michel, Martin C.; Kay, Gary G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-246</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS: To assess and compare the mechanisms of central nervous system (CNS) penetration of antimuscarinic overactive bladder (OAB) agents.  METHODS: Phys. properties were computed or compiled from the literature.  Rats were administered 5-hydroxymethyl tolterodine (HMT), darifenacin, oxybutynin, solifenacin, tolterodine or trospium s.c.  At 1 h postdose, plasma, brain and cerebrospinal fluid (CSF) concns. were detd. using LC-MS/MS assays.  Brain and plasma protein binding were detd. in vitro.  Permeability in the presence and absence of the efflux transporter P-glycoprotein (P-gp) was assessed in RRCK and MDCK-MDR1 transwell assays.  RESULTS: Oxybutynin displayed extensive CNS penetration, with brain: plasma ratios (B:P), unbound brain:unbound plasma ratios (Kp,free) and CSF:free plasma ratios each >1.  Tolterodine (B:P = 2.95, Kp,free = 0.23 and CSF:free plasma = 0.16) and solifenacin (B:P = 3.04, Kp,free = 0.28 and CSF:free plasma = 1.41) showed significant CNS penetration but with some restriction from CNS as indicated by Kp,free values significantly <1.5-HMT, darifenacin and trospium displayed much lower B:P (0.03-0.16), Kp,free (0.01-0.04) and CSF:free plasma (0.004-0.06), consistent with poor CNS penetration.  Permeability in RRCK cells was low for trospium (0.63 Ã 10-6 cm s-1), moderate for 5-HMT (11.7 Ã 10-6 cm s-1) and high for darifenacin, solifenacin, tolterodine and oxybutynin (21.5-38.2 Ã 10-6 cm s-1).  In MDCK-MDR1 cells 5-HMT, darifenacin and trospium, were P-gp substrates, whereas oxybutynin, solifenacin and tolterodine were not P-gp substrates.  CONCLUSIONS: Brain penetration was low for antimuscarinics that are P-gp substrates (5-HMT, darifenacin and trospium), and significant for those that are not P-gp substrates (oxybutynin, solifenacin and tolterodine).  CNS adverse events reported in randomized controlled clin. trials show general alignment with the preclin. data described in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9FelRyq-h7Vg90H21EOLACvtfcHk0ljs1EOnnPjIbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM&md5=dbd56eb7943853a1f58f9d56d92316bb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.03961.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.03961.x%26sid%3Dliteratum%253Aachs%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DMalhotra%26aufirst%3DB.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DFenner%26aufirst%3DK.%2BS.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DLaPerle%26aufirst%3DJ.%2BL.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DKay%26aufirst%3DG.%2BG.%26atitle%3DA%2520comprehensive%2520non-clinical%2520evaluation%2520of%2520the%2520CNS%2520penetration%2520potential%2520of%2520antimuscarinic%2520agents%2520for%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D72%26spage%3D235%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+Vitro+P-glycoprotein+Assays+to+Predict+the+in+Vivo+Interactions+of+P-glycoprotein+with+Drugs+in+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljs1EOnnPjIbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520Vitro%2520P-glycoprotein%2520Assays%2520to%2520Predict%2520the%2520in%2520Vivo%2520Interactions%2520of%2520P-glycoprotein%2520with%2520Drugs%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species Independence in Brain Tissue Binding Using Brain Homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">â</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+Independence+in+Brain+Tissue+Binding+Using+Brain+Homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0ljs1EOnnPjIbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520Independence%2520in%2520Brain%2520Tissue%2520Binding%2520Using%2520Brain%2520Homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Keefer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span> </span><span class="NLM_article-title">An interpretable probability-based confidence metric for continuous QSAR models</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">â</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci300554t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=368-383&author=C.+E.+Keeferauthor=G.+W.+Kauffmanauthor=R.+Gupta&title=An+interpretable+probability-based+confidence+metric+for+continuous+QSAR+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Interpretable, Probability-Based Confidence Metric for Continuous Quantitative Structure-Activity Relationship Models</span></div><div class="casAuthors">Keefer, Christopher E.; Kauffman, Gregory W.; Gupta, Rishi Raj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A great deal of research has gone into the development of robust confidence in prediction and applicability domain (AD) measures for quant. structure-activity relationship (QSAR) models in recent years.  Much of the attention has historically focused on structural similarity, which can be defined in many forms and flavors.  A concept that is frequently overlooked in the realm of the QSAR applicability domain is how the local activity landscape plays a role in how accurate a prediction is or is not.  In this work, we describe an approach that pairs information about both the chem. similarity and activity landscape of a test compd.'s neighborhood into a single calcd. confidence value.  We also present an approach for converting this value into an interpretable confidence metric that has a simple and informative meaning across data sets.  The approach will be introduced to the reader in the context of models built upon four diverse literature data sets.  The steps we will outline include the definition of similarity used to det. nearest neighbors (NN), how we incorporate the NN activity landscape with a similarity-weighted root-mean-square distance (wRMSD) value, and how that value is then calibrated to generate an intuitive confidence metric for prospective application.  Finally, we will illustrate the prospective performance of the approach on five proprietary models whose predictions and confidence metrics have been tracked for more than a year.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqvcorWVQ5O7Vg90H21EOLACvtfcHk0ljmOUBoVcVK6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D&md5=14d2b7d42f91b5e4e90fa53b6266a178</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fci300554t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300554t%26sid%3Dliteratum%253Aachs%26aulast%3DKeefer%26aufirst%3DC.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DGupta%26aufirst%3DR.%26atitle%3DAn%2520interpretable%2520probability-based%2520confidence%2520metric%2520for%2520continuous%2520QSAR%2520models%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D368%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">In silico model-derived ADME values were employed in the analysis, except for compounds that were part of the Pfizer compound collection (21 of the 62 ligands in the âYesâ category and 5 of the 15 ligands in the âNoâ category), in which case experimentally measured values were used. Information on the origin of data for specific compounds can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cella, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhouse, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fray, A. E.</span><span> </span><span class="NLM_article-title">A novel method for the assessment of potential PET ligands using an in vitro assay of non-specific binding</span> <span class="citation_source-journal">FENS Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">A059.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=A059.4&author=C.+V.+Cellaauthor=S.+M.+Woodhouseauthor=R.+A.+Lewisauthor=A.+E.+Fray&title=A+novel+method+for+the+assessment+of+potential+PET+ligands+using+an+in+vitro+assay+of+non-specific+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCella%26aufirst%3DC.%2BV.%26aulast%3DWoodhouse%26aufirst%3DS.%2BM.%26aulast%3DLewis%26aufirst%3DR.%2BA.%26aulast%3DFray%26aufirst%3DA.%2BE.%26atitle%3DA%2520novel%2520method%2520for%2520the%2520assessment%2520of%2520potential%2520PET%2520ligands%2520using%2520an%2520in%2520vitro%2520assay%2520of%2520non-specific%2520binding%26jtitle%3DFENS%2520Abstr.%26date%3D2004%26volume%3D2%26spage%3DA059.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">The top 10 performing PET ligands were selected by Pfizerâs PET imaging group, who was blinded to our analysis, based on their experience and literature understanding of PET ligands frequency of use, acceptance in the field, robust test-retest reliability results, and good properties for quantification. Representative references for the 10 high performing CNS PET ligands include:</p></div><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">[<sup>11</sup>C]Raclopride:</p></div><span class="NLM_contrib-group">Ribeiro, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LiÃ¨vre, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottlaender, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gervais, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DollÃ©, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syrota, A.</span><span> </span><span class="NLM_article-title">Biodistribution and radiation dosimetry of [<sup>11</sup>C]raclopride in healthy volunteers</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">â</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1007%2Fs00259-005-1783-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=15841376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A280%3ADC%252BD2MrnslWquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=952-958&author=M.-J.+Ribeiroauthor=M.+Ricardauthor=S.+Bourgeoisauthor=M.-A.+Li%C3%A8vreauthor=M.+Bottlaenderauthor=P.+Gervaisauthor=F.+Doll%C3%A9author=A.+Syrota&title=Biodistribution+and+radiation+dosimetry+of+%5B11C%5Draclopride+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers</span></div><div class="casAuthors">Ribeiro Maria-Joao; Ricard Marcel; Bourgeois Sandrine; Lievre Marie-Angele; Bottlaender Michel; Gervais Philippe; Dolle Frederic; Syrota Andre</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">952-8</span>
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    </div><div class="casAbstract">PURPOSE:  This study reports on the whole-body biodistribution and radiation dosimetry of [11C]raclopride, a dopamine D2 receptor antagonist.  METHODS:  In three healthy male volunteers, whole-body scans were performed up to 2 h following i.v. injection of 320+/-65 MBq [11C]raclopride.  Transmission scans (3 min per step, eight or nine steps according to the height of the subject) in 2D mode were used for subsequent attenuation correction of emission scans.  Emission scans (1 min per step, eight or nine steps) were acquired over 2 h.  Venous blood samples and urine were collected up to 2 h after injection of the radiotracer.  For each subject, the percentage of injected activity measured in regions of interest over brain, intestine, lungs, kidneys and liver was fitted to a mono-exponential model, as an uptake phase followed by a mono-exponential washout, for urinary bladder to generate time-activity curves.  Using the MIRD method, several source organs were considered in estimating residence time and mean effective radiation absorbed doses.  RESULTS:  Blood pressure and ECG findings remained unchanged after tracer injection.  The analysed blood and urine pharmacological parameters did not change significantly after [(11)C]raclopride injection.  The primary routes of clearance were renal and intestinal.  Ten minutes after injection, high activities were observed in the gall-bladder, kidneys and liver.  High activity was observed in the gall-bladder during the whole study.  The kidneys, urinary bladder wall, liver and gall-bladder received the highest absorbed doses.  The average effective dose of [11C]raclopride was estimated to be 6.7+/-0.4 microSv/MBq.  CONCLUSION:  The amount of [11C]raclopride required for adequate dopamine D2 receptor imaging results in an acceptable effective dose equivalent, permitting two or three repeated clinical PET imaging studies, with the injection of 222 MBq for each study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzsc65JCF81L5XHngOXiV_fW6udTcc2ebEC8-7p4JTdbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrnslWquw%253D%253D&md5=428b9fffb57ee9de0c5c1c34519dd429</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1007%2Fs00259-005-1783-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-005-1783-2%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DM.-J.%26aulast%3DRicard%26aufirst%3DM.%26aulast%3DBourgeois%26aufirst%3DS.%26aulast%3DLi%25C3%25A8vre%26aufirst%3DM.-A.%26aulast%3DBottlaender%26aufirst%3DM.%26aulast%3DGervais%26aufirst%3DP.%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26aulast%3DSyrota%26aufirst%3DA.%26atitle%3DBiodistribution%2520and%2520radiation%2520dosimetry%2520of%2520%255B11C%255Draclopride%2520in%2520healthy%2520volunteers%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2005%26volume%3D32%26spage%3D952%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">[<sup>18</sup>F]Fallypride:</p></div><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvogt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¶sch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreckenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ¼nder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span> </span><span class="NLM_article-title">Parametric Mapping of Binding in Human Brain of D<sub>2</sub> Receptor Ligands of Different Affinities</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">964</span><span class="NLM_x">â</span> <span class="NLM_lpage">972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=964-972&author=T.+Siessmeierauthor=Y.+Zhouauthor=H.-G.+Buchholzauthor=C.+Landvogtauthor=I.+Vernalekenauthor=M.+Peilauthor=R.+Schirrmacherauthor=F.+R%C3%B6schauthor=M.+Schreckenbergerauthor=D.+F.+Wongauthor=P.+Cummingauthor=G.+Gr%C3%BCnderauthor=P.+Bartenstein&title=Parametric+Mapping+of+Binding+in+Human+Brain+of+D2+Receptor+Ligands+of+Different+Affinities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DBuchholz%26aufirst%3DH.-G.%26aulast%3DLandvogt%26aufirst%3DC.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DPeil%26aufirst%3DM.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26aulast%3DSchreckenberger%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DBartenstein%26aufirst%3DP.%26atitle%3DParametric%2520Mapping%2520of%2520Binding%2520in%2520Human%2520Brain%2520of%2520D2%2520Receptor%2520Ligands%2520of%2520Different%2520Affinities%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D964%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">[<sup>11</sup>C]Flumazenil:</p></div><span class="NLM_contrib-group">Lassen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevett, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patsalos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. V.</span><span> </span><span class="NLM_article-title">Benzodiazepine receptor quantification in vivo in humans using [<sup>11</sup>C]Flumazenil and PET: application of the steady-state principle</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">â</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1038%2Fjcbfm.1995.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=7798333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVWlsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=152-165&author=N.+A.+Lassenauthor=P.+A.+Bartensteinauthor=A.+A.+Lammertsmaauthor=M.+C.+Prevettauthor=D.+R.+Turtonauthor=S.+K.+Luthraauthor=S.+Osmanauthor=P.+M.+Bloomfieldauthor=T.+Jonesauthor=P.+N.+Patsalosauthor=M.+T.+O%E2%80%99Connellauthor=J.+S.+Duncanauthor=J.+V.+Andersen&title=Benzodiazepine+receptor+quantification+in+vivo+in+humans+using+%5B11C%5DFlumazenil+and+PET%3A+application+of+the+steady-state+principle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle</span></div><div class="casAuthors">Lassen, N. A.; Bartenstein, P. A.; Lammertsma, A. A.; Prevett, M. C.; Turton, D. R.; Luthra, S. K.; Osman, S.; Bloomfield, P. M.; Jones, T.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-65</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">Carbon-11-labeled flumazenil combined with positron emission tomog. (PET) was used to measure the concn. (Bmax) of the benzodiazepine (Bz) receptor in the brain and its equil. dissocn. const. (KD) for flumazenil in five normal subjects.  The steady-state approach was used injecting the tracer as a bolus of high specific activity.  In each subject two studies were carried out.  The first study was performed at essentially zero receptor occupancy, the tracer alone study.  The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged const. infusion of nonlabeled ("cold") flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period.  In this second study the free concn. of unmetabolized flumazenil in plasma water was measured in multiple blood samples.  The obsd. tissue and plasma tracer curves, calibrated in the same units of radioactivity per mm, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding no. of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments.  The noncompartmental and the compartmental analyses gave essentially the same values for the distribution vol. of the tracer, the parameter used for quantitation of the Bz receptor.  As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred.  The five subjects had a mean KD value of 12 nM/L of water and Bmax values of the gray matter ranging from 39 in thalamus to 120 nM/L of brain in occipital cortex.  Most previous studies have been based on the pseudoequil. approach using the brain stem as a receptor-free ref. region.  This yields practically the same KD but lower Bmax values than the steady-state approach presented here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjfURC4GZXWbVg90H21EOLACvtfcHk0lgdfJTs8crjlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVWlsro%253D&md5=09a333bb64f38f2812e353f9dcb589c8</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1995.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1995.17%26sid%3Dliteratum%253Aachs%26aulast%3DLassen%26aufirst%3DN.%2BA.%26aulast%3DBartenstein%26aufirst%3DP.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DPrevett%26aufirst%3DM.%2BC.%26aulast%3DTurton%26aufirst%3DD.%2BR.%26aulast%3DLuthra%26aufirst%3DS.%2BK.%26aulast%3DOsman%26aufirst%3DS.%26aulast%3DBloomfield%26aufirst%3DP.%2BM.%26aulast%3DJones%26aufirst%3DT.%26aulast%3DPatsalos%26aufirst%3DP.%2BN.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DM.%2BT.%26aulast%3DDuncan%26aufirst%3DJ.%2BS.%26aulast%3DAndersen%26aufirst%3DJ.%2BV.%26atitle%3DBenzodiazepine%2520receptor%2520quantification%2520in%2520vivo%2520in%2520humans%2520using%2520%255B11C%255DFlumazenil%2520and%2520PET%253A%2520application%2520of%2520the%2520steady-state%2520principle%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1995%26volume%3D15%26spage%3D152%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">[<sup>11</sup>C]DASB:</p></div><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span> </span><span class="NLM_article-title">Imaging the serotonin transporter with positron emission tomography: initial human studies with [<sup>11</sup>C]DAPP and [<sup>11</sup>C]DASB</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">â</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1007%2Fs002590000365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=11105830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVWls7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=1719-1722&author=S.+Houleauthor=N.+Ginovartauthor=D.+Husseyauthor=J.+H.+Meyerauthor=A.+A.+Wilson&title=Imaging+the+serotonin+transporter+with+positron+emission+tomography%3A+initial+human+studies+with+%5B11C%5DDAPP+and+%5B11C%5DDASB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB</span></div><div class="casAuthors">Houle, S.; Ginovart, N.; Hussey, D.; Meyer, J. H.; Wilson, A. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-1722</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Two novel radioligands, N,N-dimethyl-2-(2-amino-4-methoxyphenylthio)benzylamine (DAPP) and N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine (DASB), were radiolabeled with carbon-11 and evaluated as in vivo probes of the serotonin transporter (SERT) using positron emission tomog. (PET).  Both compds. are highly selective, with nanomolar affinity for the serotonin transporter and micromolar affinity for the dopamine and norepinephrine transporters.  Six volunteers were imaged twice, once with each of the two radioligands.  Both ligands displayed very good brain penetration and selective retention in regions rich in serotonin reuptake sites.  Both had similar brain uptake and kinetics, but the cyano analog, [11C]DASB, had a slightly higher brain penetration in all subjects.  Plasma anal. revealed that both radiotracers were rapidly metabolized to give mainly hydrophilic species as detd. by reverse-phase HPLC.  Inhibition of specific binding to the SERT was demonstrated in three addnl. subjects imaged with [11C]DASB following an oral dose of the selective serotonin reuptake blocker citalopram.  These preliminary studies indicate that both these substituted phenylthiobenzylamines have highly suitable characteristics for probing the serotonin reuptake system with PET in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGPfVBkfUIjLVg90H21EOLACvtfcHk0lgdfJTs8crjlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVWls7s%253D&md5=1dae55a52038299f45152063a26e17a3</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1007%2Fs002590000365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590000365%26sid%3Dliteratum%253Aachs%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DHussey%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26atitle%3DImaging%2520the%2520serotonin%2520transporter%2520with%2520positron%2520emission%2520tomography%253A%2520initial%2520human%2520studies%2520with%2520%255B11C%255DDAPP%2520and%2520%255B11C%255DDASB%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D27%26spage%3D1719%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25e"><span><span class="NLM_label">(e) </span><div class="note"><p class="first last">[<sup>11</sup>C]Î²-CFT:</p></div><span class="NLM_contrib-group">Rinne, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laihinen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NÃ¥gren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruottinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruotsalainen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, U. K.</span><span> </span><span class="NLM_article-title">PET examination of the monoamine transporter with [<sup>11</sup>C]Î²-CIT and [<sup>11</sup>C]Î²-CFT in early Parkinsonâs disease</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1995&pages=97-103&author=J.+O.+Rinneauthor=A.+Laihinenauthor=K.+N%C3%A5grenauthor=H.+Ruottinenauthor=U.+Ruotsalainenauthor=U.+K.+Rinne&title=PET+examination+of+the+monoamine+transporter+with+%5B11C%5D%CE%B2-CIT+and+%5B11C%5D%CE%B2-CFT+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DLaihinen%26aufirst%3DA.%26aulast%3DN%25C3%25A5gren%26aufirst%3DK.%26aulast%3DRuottinen%26aufirst%3DH.%26aulast%3DRuotsalainen%26aufirst%3DU.%26aulast%3DRinne%26aufirst%3DU.%2BK.%26atitle%3DPET%2520examination%2520of%2520the%2520monoamine%2520transporter%2520with%2520%255B11C%255D%25CE%25B2-CIT%2520and%2520%255B11C%255D%25CE%25B2-CFT%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSynapse%26date%3D1995%26volume%3D21%26spage%3D97%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25f"><span><span class="NLM_label">(f) </span><div class="note"><p class="first last">[<sup>11</sup>C]MDL100907:</p></div><span class="NLM_contrib-group">Andree, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaquet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Positron Emission Tomographic Analysis of Dose-Dependent MDL 100,907 Binding to 5-Hydroxytryptamine-2A Receptors in the Human Brain</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1097%2F00004714-199808000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=9690698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaK1cXltFSms7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=317-323&author=B.+Andreeauthor=S.+Nybergauthor=H.+Itoauthor=N.+Ginovartauthor=F.+Brunnerauthor=F.+Jaquetauthor=C.+Halldinauthor=L.+Farde&title=Positron+Emission+Tomographic+Analysis+of+Dose-Dependent+MDL+100%2C907+Binding+to+5-Hydroxytryptamine-2A+Receptors+in+the+Human+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25fR"><div class="casContent"><span class="casTitleNuber">25f</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain</span></div><div class="casAuthors">Andree, Bengt; Nyberg, Svante; Ito, Hiroshi; Ginovart, Nathalie; Brunner, Francoise; Jaquet, Francoise; Halldin, Christer; Farde, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Selective 5-hydroxytryptamine-2A (5-HT2A) antagonism has been proposed as a mechanism of atypical antipsychotic drug action.  MDL 100,907, a new selective 5-HT2A receptor antagonist, has high affinity in vitro for 5-HT2A receptors and is being developed as a potential antipsychotic drug.  In this study, neocortical 5-HT2A receptor occupancy was measured in six healthy male volunteers after placebo and escalating single doses (1-72 mg) of MDL 100,907 using positron emission tomog. and the nonspecific radioligand [11C]N-methyl-spiperone ([11C]NMSP).  Receptor occupancy was calcd. using a ratio-equil. anal., assuming that maximal radioligand binding inhibition represents 100% 5-HT2A receptor occupancy.  Plasma concns. of MDL 100,907 were measured with high-pressure liq. chromatog.  The pharmacokinetic parameters area under the curve and peak plasma concn. increased linearly with dose, with rapid absorption and a 6-to 9-h elimination half-life.  The neocortical binding of [11C]NMSP was inhibited dose-dependently.  After administration of 6 mg of MDL 100,907 the inhibition was 70%, corresponding to a 5-HT2A receptor occupancy of 90%.  The calcd. maximal inhibition was 77%.  These observations indicate that MDL 100,907 passes the blood-brain barrier and binds to 5-HT2A receptors in a saturable manner in the living human brain.  Repeated doses of MDL 100,907, 10 mg/day or more, should induce a sustained 5-HT2A receptor occupancy in most patients.  Thus, MDL 100,907 provides a suitable tool to evaluate the potential of selective 5-HT2A receptor antagonism in the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECc-40bFOPbVg90H21EOLACvtfcHk0lgdfJTs8crjlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFSms7c%253D&md5=8f62fb7f2b597693cb3c19a051caf64a</span></div><a href="/servlet/linkout?suffix=cit25f&amp;dbid=16384&amp;doi=10.1097%2F00004714-199808000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199808000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DAndree%26aufirst%3DB.%26aulast%3DNyberg%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DBrunner%26aufirst%3DF.%26aulast%3DJaquet%26aufirst%3DF.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DPositron%2520Emission%2520Tomographic%2520Analysis%2520of%2520Dose-Dependent%2520MDL%2520100%252C907%2520Binding%2520to%25205-Hydroxytryptamine-2A%2520Receptors%2520in%2520the%2520Human%2520Brain%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1998%26volume%3D18%26spage%3D317%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25g"><span><span class="NLM_label">(g) </span><div class="note"><p class="first last">[<sup>11</sup>C]WAY100635:</p></div><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span> </span><span class="NLM_article-title">Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">â</span> <span class="NLM_lpage">1971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=1965-1971&author=L.+Fardeauthor=H.+Itoauthor=C.+G.+Swahnauthor=V.+W.+Pikeauthor=C.+Halldin&title=Quantitative+analyses+of+carbonyl-carbon-11-WAY-100635+binding+to+central+5-hydroxytryptamine-1A+receptors+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSwahn%26aufirst%3DC.%2BG.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DQuantitative%2520analyses%2520of%2520carbonyl-carbon-11-WAY-100635%2520binding%2520to%2520central%25205-hydroxytryptamine-1A%2520receptors%2520in%2520man%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1998%26volume%3D39%26spage%3D1965%26epage%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25h"><span><span class="NLM_label">(h) </span><div class="note"><p class="first last">[<sup>11</sup>C]Carfentanil:</p></div><span class="NLM_contrib-group">Frost, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglass, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayberg, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Links, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crozier, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, H. N.</span><span> </span><span class="NLM_article-title">Multicompartmental analysis of [<sup>11</sup>C]carfentanil binding to opiate receptors in humans measured by positron emission tomography</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">â</span> <span class="NLM_lpage">409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25h&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1038%2Fjcbfm.1989.59" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25h&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=2541148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25h&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaL1MXltFWlurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=398-409&author=J.+J.+Frostauthor=K.+H.+Douglassauthor=H.+S.+Maybergauthor=R.+F.+Dannalsauthor=J.+M.+Linksauthor=A.+A.+Wilsonauthor=H.+T.+Ravertauthor=W.+C.+Crozierauthor=H.+N.+Wagner&title=Multicompartmental+analysis+of+%5B11C%5Dcarfentanil+binding+to+opiate+receptors+in+humans+measured+by+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25hR"><div class="casContent"><span class="casTitleNuber">25h</span><div class="casTitle"><span class="NLM_cas:atitle">Multicompartmental analysis of [11C]carfentanil binding to opiate receptors in humans measured by positron emission tomography</span></div><div class="casAuthors">Frost, J. J.; Douglass, K. H.; Mayberg, H. S.; Dannals, R. F.; Links, J. M.; Wilson, A. A.; Ravert, H. T.; Crozier, William C.; Wagner, H. N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">398-409</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">[11C]carfentanil is a high-affinity opiate agonist that can be used to localize mu opiate receptors in humans by positron emission tomog. (PET).  A 4-compartment model was used to obtain quant. ests. of rate consts. for receptor assocn. and dissocn.  PET studies were performed in 5 normal subjects in the absence and presence of 1 mg/kg naloxone.  Arterial plasma concn. of [11C]carfentanil and its labeled metabolites were detd. during each PET study.  The value of k3/k4 = Bmax/kD was detd. for each subject in the presence and absence of naloxone.  There was a significant redn. in the value of k3/k4 from 3.4 to 0.26 in the thalamus and from 1.8 to 0.16 in the frontal cortex.  Mean values of frontal cortex/occipital cortex and thalamus/occipital cortex ratios were detd. for the interval 35-70 min after injection when receptor binding is high relative to nonspecific binding.  The relationship between the measured region/occipital cortex values and the corresponding values of k3/k4 in the presence and absence of naloxone was: regions/occipital cortex = 0.95 (k3/k4) with r = 0.98.  Simulation studies also demonstrated a linear relationship between the thalamus/occipital cortex or frontal cortex/occipital cortex ratio and k3/k4 for <2-fold increases or decreases in k3/k4.  Simulation studies in which thalamic blood flow was varied demonstrated no significant effect on the region/occipital cortex ratio at 35-70 min for a 2-fold increase or 4-fold decrease in blood flow.  Therefore, the region/occipital cortex ratio can be used to quantitate changes in k3/k[4 when tracer kinetic modeling is not feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonFV6GQkCusrVg90H21EOLACvtfcHk0liQHcpMV76nWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltFWlurw%253D&md5=e23946c3ac098ea3364cac665395fbd5</span></div><a href="/servlet/linkout?suffix=cit25h&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1989.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1989.59%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BJ.%26aulast%3DDouglass%26aufirst%3DK.%2BH.%26aulast%3DMayberg%26aufirst%3DH.%2BS.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DLinks%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DCrozier%26aufirst%3DW.%2BC.%26aulast%3DWagner%26aufirst%3DH.%2BN.%26atitle%3DMulticompartmental%2520analysis%2520of%2520%255B11C%255Dcarfentanil%2520binding%2520to%2520opiate%2520receptors%2520in%2520humans%2520measured%2520by%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1989%26volume%3D9%26spage%3D398%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25i"><span><span class="NLM_label">(i) </span><div class="note"><p class="first last">[<sup>11</sup>C]PHNO:</p></div><span class="NLM_contrib-group">Gurevich, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span> </span><span class="NLM_article-title">Distribution of Dopamine D<sub>3</sub> Receptor Expressing Neurons in the Human Forebrain: Comparison with D<sub>2</sub> Receptor Expressing Neurons</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=60-80&author=E.+V.+Gurevichauthor=J.+N.+Joyce&title=Distribution+of+Dopamine+D3+Receptor+Expressing+Neurons+in+the+Human+Forebrain%3A+Comparison+with+D2+Receptor+Expressing+Neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurevich%26aufirst%3DE.%2BV.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DDistribution%2520of%2520Dopamine%2520D3%2520Receptor%2520Expressing%2520Neurons%2520in%2520the%2520Human%2520Forebrain%253A%2520Comparison%2520with%2520D2%2520Receptor%2520Expressing%2520Neurons%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D60%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25j"><span><span class="NLM_label">(j) </span><div class="note"><p class="first last">[<sup>11</sup>C]ABP688:</p></div><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streffer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagoev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hintermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A.</span><span> </span><span class="NLM_article-title">Human PET Studies of Metabotropic Glutamate Receptor Subtype 5 with <sup>11</sup>C-ABP688</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25j&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=17268022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25j&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVKmsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=247-252&author=S.+M.+Ametameyauthor=V.+Treyerauthor=J.+Strefferauthor=M.+T.+Wyssauthor=M.+Schmidtauthor=M.+Blagoevauthor=S.+Hintermannauthor=Y.+Aubersonauthor=F.+Gaspariniauthor=U.+C.+Fischerauthor=A.+Buck&title=Human+PET+Studies+of+Metabotropic+Glutamate+Receptor+Subtype+5+with+11C-ABP688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25jR"><div class="casContent"><span class="casTitleNuber">25j</span><div class="casTitle"><span class="NLM_cas:atitle">Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688</span></div><div class="casAuthors">Ametamey, Simon M.; Treyer, Valerie; Streffer, Johannes; Wyss, Matthias T.; Schmidt, Mark; Blagoev, Milen; Hintermann, Samuel; Auberson, Yves; Gasparini, Fabrizio; Fischer, Uta C.; Buck, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-252</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime (11C-ABP688), a noncompetitive and highly selective antagonist for the metabotropic glutamate receptor subtype 5 (mGluR5), was evaluated for its potential as a PET agent.  Methods: Six healthy male volunteers (mean age, 25 y; range, 21-33 y) were studied.  Brain perfusion (15O-H2O) was measured immediately before each 11C-ABP688 PET scan.  For anat. coregistration, T1-weighted MRI was performed on each subject.  Arterial blood samples for the detn. of the arterial input curve were obtained at predefined time points, and 11C-ABP688 uptake was assessed quant. using a 2-tissue-compartment model.  Results: An initial rapid uptake of radioactivity followed by a gradual clearance from all examd. brain regions was obsd.  Relatively high radioactivity concns. were obsd. in mGluR5-rich brain regions such as the anterior cingulate, medial temporal lobe, amygdala, caudate, and putamen, whereas radioactivity uptake in the cerebellum and white matter, regions known to contain low densities of mGluR5, was low.  Specific distribution vol. as an outcome measure of mGluR5 d. in the various brain regions ranged from 5.45 Â± 1.47 (anterior cingulate) to 1.91 Â± 0.32 (cerebellum), and the rank order of the corresponding specific distribution vols. of 11C-ABP688 in cortical regions was temporal > frontal > occipital > parietal.  The metab. of 11C-ABP688 in plasma was rapid; at 60 min after injection, 25% Â± 0.03% of radioactivity measured in the plasma of healthy volunteers was intact parent compd.  Conclusion: The results of these studies indicate that 11C-ABP688 has suitable characteristics and is a promising PET ligand for imaging mGluR5 distribution in humans.  Furthermore, it could be of great value for the selection of appropriate doses of clin. relevant candidate drugs that bind to mGluR5 and for PET studies of patients with psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQUZCrGnQChLVg90H21EOLACvtfcHk0linWrA6Q6RN-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVKmsb0%253D&md5=be3ec54c117f3789e4482b1e138568b3</span></div><a href="/servlet/linkout?suffix=cit25j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DTreyer%26aufirst%3DV.%26aulast%3DStreffer%26aufirst%3DJ.%26aulast%3DWyss%26aufirst%3DM.%2BT.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBlagoev%26aufirst%3DM.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DAuberson%26aufirst%3DY.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DFischer%26aufirst%3DU.%2BC.%26aulast%3DBuck%26aufirst%3DA.%26atitle%3DHuman%2520PET%2520Studies%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520with%252011C-ABP688%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Repaske, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goy, M. F.</span><span> </span><span class="NLM_article-title">A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">â</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=673-686&author=D.+R.+Repaskeauthor=J.+G.+Corbinauthor=M.+Contiauthor=M.+F.+Goy&title=A+cyclic+GMP-stimulated+cyclic+nucleotide+phosphodiesterase+gene+is+highly+expressed+in+the+limbic+system+of+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRepaske%26aufirst%3DD.%2BR.%26aulast%3DCorbin%26aufirst%3DJ.%2BG.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DGoy%26aufirst%3DM.%2BF.%26atitle%3DA%2520cyclic%2520GMP-stimulated%2520cyclic%2520nucleotide%2520phosphodiesterase%2520gene%2520is%2520highly%2520expressed%2520in%2520the%2520limbic%2520system%2520of%2520the%2520rat%2520brain%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D56%26spage%3D673%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Boess, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Staay, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staveren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">â</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.-J.+van+der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+van+Staverenauthor=J.+de+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+phosphodiesterase+2+increases+neuronal+cGMP%2C+synaptic+plasticity+and+memory+performance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.-J.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3Dvan%2BStaveren%26aufirst%3DW.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520increases%2520neuronal%2520cGMP%252C%2520synaptic%2520plasticity%2520and%2520memory%2520performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D1081%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Helal, C. J.; Chappie, T. A.; Humphrey, J. M.; Verhoest, P. R.; Yang, E.</span><span> </span><span class="NLM_article-title">Preparation of imidazo[5,1-<i>f</i>][1,2,4]triazines for the treatment of neurological disorders</span>. U.S. Patent 20120214791 A1, <span class="NLM_month">Aug</span><span class="NLM_day">23</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Helal&author=T.+A.+Chappie&author=J.+M.+Humphrey&author=P.+R.+Verhoest&author=E.+Yang&title=Preparation+of+imidazo%5B5%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+for+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520of%2520imidazo%255B5%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520for%2520the%2520treatment%2520of%2520neurological%2520disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">The synthesis of intermediate <b>8</b> has been previously disclosed. For detailed synthetic information, please see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Compound <b>5</b> was screened in a PDE selectivity panel consisting of 10 PDE subtypes and exhibited the following activity values: PDE1b (IC<sub>50</sub> > 30 Î¼M), PDE3a (IC<sub>50</sub> > 30 Î¼M), PDE4d (IC<sub>50</sub> > 30 Î¼M), PDE5a (IC<sub>50</sub> = 26 Î¼M), PDE6a (IC<sub>50</sub> > 10 Î¼M), PDE7b (IC<sub>50</sub> = 12 Î¼M), PDE8b (IC<sub>50</sub> > 10 Î¼M), PDE9a (IC<sub>50</sub> > 10 Î¼M), PDE10a (IC<sub>50</sub> = 3.9 Î¼M), and PDE11 (IC<sub>50</sub> > 10 Î¼M).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">Compound <b>5</b> was screened in a CEREP broad selectivity panel of 79 targets and exhibited <30% inhibition at 1 Î¼M for all targets. This corresponds to >1800-fold selectivity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterases in the CNS: targets for drug development</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">660</span><span class="NLM_x">â</span> <span class="NLM_lpage">670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=660-670&author=F.+S.+Mennitiauthor=W.+S.+Faraciauthor=C.+J.+Schmidt&title=Phosphodiesterases+in+the+CNS%3A+targets+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DFaraci%26aufirst%3DW.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterases%2520in%2520the%2520CNS%253A%2520targets%2520for%2520drug%2520development%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D660%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><div class="note"><p class="first last">During the preparation of this manuscript, a PET ligand with a mixed PDE2/PDE10 pharmacology (PDE2 pIC<sub>50</sub> = 8.86, PDE10 pIC<sub>50</sub> = 7.96) was reported in the patent literature.</p></div><span class="NLM_contrib-group">AndrÃ©s-Gil, J. I.; Rombouts, F. J. R.; Trabanco-SuÃ¡rez, A. A.; Vanhoof, G. C. P.; De Angelis, M.; Buijnsters, P. J. J. A.; Guillemont, J. E. G.; Bormans, G. M. R.; Celen, S. J. L.; Vliegen, M.</span><span> </span><span class="NLM_article-title">1-Aryl-4-methyl-[1,2,4]triazolo[4,3-<i>a</i>]quinoxaline derivatives</span>. WO 2013/000924, <span class="NLM_month">January</span><span class="NLM_day">3</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+I.+Andr%C3%A9s-Gil&author=F.+J.+R.+Rombouts&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+C.+P.+Vanhoof&author=M.+De+Angelis&author=P.+J.+J.+A.+Buijnsters&author=J.+E.+G.+Guillemont&author=G.+M.+R.+Bormans&author=S.+J.+L.+Celen&author=M.+Vliegen&title=1-Aryl-4-methyl-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dquinoxaline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s-Gil%26aufirst%3DJ.%2BI.%26atitle%3D1-Aryl-4-methyl-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dquinoxaline%2520derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span> </span><span class="NLM_article-title">Simplified Reference Tissue Model for PET Receptor Studies</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=153-158&author=A.+A.+Lammertsmaauthor=S.+P.+Hume&title=Simplified+Reference+Tissue+Model+for+PET+Receptor+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DHume%26aufirst%3DS.%2BP.%26atitle%3DSimplified%2520Reference%2520Tissue%2520Model%2520for%2520PET%2520Receptor%2520Studies%26jtitle%3DNeuroImage%26date%3D1996%26volume%3D4%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':[],'ref15':['cit15'],'ref16':[],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':[],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c','cit25d','cit25e','cit25f','cit25g','cit25h','cit25i','cit25j'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':[],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 111 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiyun Sun, Zhiwei Xiao, Ahmed Haider, Catherine Gebhard, Hao Xu, Hai-Bin Luo, Han-Ting Zhang, Lee Josephson, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7083-7109. <a href="https://doi.org/10.1021/acs.jmedchem.1c00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252BCyclic%252BNucleotide%252BPhosphodiesterase-Targeted%252BPET%252BImaging%252Band%252BDrug%252BDiscovery%26aulast%3DSun%26aufirst%3DJiyun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7083%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuta Takamura, <span class="NLM_string-name hlFld-ContribAuthor">Hiroki Kakuta</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5226-5251. <a href="https://doi.org/10.1021/acs.jmedchem.0c01714" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01714%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVivo%252BReceptor%252BVisualization%252Band%252BEvaluation%252Bof%252BReceptor%252BOccupancy%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DTakamura%26aufirst%3DYuta%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30092020%26date%3D27042021%26volume%3D64%26issue%3D9%26spage%3D5226%26epage%3D5251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yasushi Hattori, Satoru Matsuda, Rina Baba, Kouta Matsumiya, Shinji Iwasaki, Cristian C. Constantinescu, Thomas J. Morley, Vincent M. Carroll, Caroline Papin, Alexandra Gouasmat, David Alagille, Gilles Tamagnan, <span class="NLM_string-name hlFld-ContribAuthor">Tatsuki Koike</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of (2-Aminocyclopropyl)phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3780-3793. <a href="https://doi.org/10.1021/acs.jmedchem.0c01937" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01937%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252B%2525282-Aminocyclopropyl%252529phenyl%252BDerivatives%252Bas%252BNovel%252BPositron%252BEmission%252BTomography%252BImaging%252BAgents%252Bfor%252BLysine-Specific%252BDemethylase%252B1%252Bin%252Bthe%252BBrain%26aulast%3DHattori%26aufirst%3DYasushi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09112020%26date%3D17032021%26volume%3D64%26issue%3D7%26spage%3D3780%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Longbin Liu, Michael E. Prime, Matt R. Lee, Vinod Khetarpal, Christopher J. Brown, Peter D. Johnson, Patricia Miranda-Azpiazu, Xuemei Chen, Daniel Clark-Frew, Samuel Coe, Randall Davis, Anthony Dickie, Andreas Ebneth, Simone Esposito, Elise Gadouleau, Xinjie Gai, Sebastien Galan, Samantha Green, Catherine Greenaway, Paul Giles, Christer Halldin, Sarah Hayes, Todd Herbst, Frank Herrmann, Manuela HeÃmann, Zhisheng Jia, Alexander Kiselyov, Adrian Kotey, Thomas Krulle, John E. Mangette, Richard W. Marston, Sergio Menta, Matthew R. Mills, Edith Monteagudo, Sangram Nag, Martina Nibbio, Laura Orsatti, Sabine Schaertl, Christoph Scheich, Joanne Sproston, Vladimir Stepanov, Marie Svedberg, Akihiro Takano, Malcolm Taylor, Wayne Thomas, MiklÃ³s Toth, Darshan Vaidya, Katarina VanrÃ¤s, Derek Weddell, Ian Wigginton, John Wityak, Ladislav Mrzljak, Ignacio Munoz-Sanjuan, Jonathan A. Bard, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8608-8633. <a href="https://doi.org/10.1021/acs.jmedchem.0c00955" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImaging%252BMutant%252BHuntingtin%252BAggregates%25253A%252BDevelopment%252Bof%252Ba%252BPotential%252BPET%252BLigand%26aulast%3DLiu%26aufirst%3DLongbin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11062020%26date%3D30072020%26date%3D14072020%26volume%3D63%26issue%3D15%26spage%3D8608%26epage%3D8633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuichi Wakabayashi, Sanjay Telu, Rachel M. Dick, Masahiro Fujita, Maarten Ooms, Cheryl L. Morse, Jeih-San Liow, Jinsoo S. Hong, Robert L. Gladding, Lester S. Manly, Sami S. Zoghbi, Xuesheng Mo, Emily C. DâAmato, Janice A. Sindac, Richard A. Nugent, Brian E. Marron, Mark E. Gurney, Robert B. Innis, <span class="NLM_string-name hlFld-ContribAuthor">Victor W. Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1311-1323. <a href="https://doi.org/10.1021/acschemneuro.0c00077" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00077%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%25252C%252BRadiolabeling%25252C%252Band%252BEvaluation%252Bof%252BSubtype-Selective%252BInhibitors%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Bof%252BBrain%252BPhosphodiesterase-4D%26aulast%3DWakabayashi%26aufirst%3DYuichi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D26032020%26date%3D08042020%26date%3D26032020%26volume%3D11%26issue%3D9%26spage%3D1311%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ling Tong, Wenping Li, Michael Man-Chu Lo, Xiaolei Gao, Jenny Miu-Chen Wai, Michael Rudd, David Tellers, Aniket Joshi, Zhizhen Zeng, Patricia Miller, Cristian Salinas, Kerry Riffel, Hyking Haley, Mona Purcell, Marie Holahan, Liza Gantert, Jeffrey W. Schubert, Kristen Jones, James Mulhearn, Melissa Egbertson, Zhaoyang Meng, Barbara Hanney, Robert Gomez, Scott T. Harrison, Paul McQuade, Tjerk Bueters, Jason Uslaner, John Morrow, Fiona Thomson, Jongrock Kong, Jing Liao, Oleg Selyutin, Jianming Bao, Nicholas B. Hastings, Sony Agrawal, Brian C. Magliaro, Frederick J. Monsma, Jr., Michelle D. Smith, Stefania Risso, David Hesk, Eric Hostetler, <span class="NLM_string-name hlFld-ContribAuthor">Robert Mazzola</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2411-2425. <a href="https://doi.org/10.1021/acs.jmedchem.9b01406" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01406%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25255B11C%25255DMK-6884%25253A%252BA%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%252BAgent%252Bfor%252Bthe%252BStudy%252Bof%252BM4Muscarinic%252BReceptor%252BPositive%252BAllosteric%252BModulators%252B%252528PAMs%252529%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DTong%26aufirst%3DLing%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D25082019%26date%3D03032020%26date%3D26022020%26volume%3D63%26issue%3D5%26spage%3D2411%26epage%3D2425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Takeshi Fuchigami, Masao Kawasaki, Ryusuke Koyama, Mari Nakaie, Takehiro Nakagaki, Kazunori Sano, Ryuichiro Atarashi, Sakura Yoshida, Mamoru Haratake, Masahiro Ono, Noriyuki Nishida, <span class="NLM_string-name hlFld-ContribAuthor">Morio Nakayama</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Radioiodinated Benzofuran Derivatives for in Vivo Imaging of Prion Deposits in the Brain. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (12)
                                     , 2003-2013. <a href="https://doi.org/10.1021/acsinfecdis.8b00184" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00184%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDevelopment%252Bof%252BRadioiodinated%252BBenzofuran%252BDerivatives%252Bfor%252Bin%252BVivo%252BImaging%252Bof%252BPrion%252BDeposits%252Bin%252Bthe%252BBrain%26aulast%3DFuchigami%26aufirst%3DTakeshi%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27072018%26date%3D27032019%26date%3D15032019%26volume%3D5%26issue%3D12%26spage%3D2003%26epage%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vadim Bernard-Gauthier, Andrew V. Mossine, Ashley Knight, Debasis Patnaik, Wen-Ning Zhao, Chialin Cheng, Hema S. Krishnan, Lucius L. Xuan, Peter S. Chindavong, Surya A. Reis, Jinshan Michael Chen, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Nicolas Salem, David Bonsall, Brenda Amaral, Cassis Varlow, Lisa Wells, Laurent Martarello, Shil Patel, Steven H. Liang, Ravi G. Kurumbail, Stephen J. Haggarty, Peter J. H. Scott, <span class="NLM_string-name hlFld-ContribAuthor">Neil Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Achieving GSK-3Î² Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9600-9617. <a href="https://doi.org/10.1021/acs.jmedchem.9b01030" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BBasis%252Bfor%252BAchieving%252BGSK-3%2525CE%2525B2%252BInhibition%252Bwith%252BHigh%252BPotency%25252C%252BSelectivity%25252C%252Band%252BBrain%252BExposure%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Band%252BDrug%252BDiscovery%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28062019%26date%3D21102019%26date%3D19092019%26volume%3D62%26issue%3D21%26spage%3D9600%26epage%3D9617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Zhang, Christopher R. Butler, Kevin P. Maresca, Akihiro Takano, Sangram Nag, Zhisheng Jia, Ryosuke Arakawa, Justin R. Piro, Tarek Samad, Deborah L. Smith, Deane M. Nason, Steven OâNeil, Laura McAllister, Klaas Schildknegt, Patrick Trapa, Timothy J. McCarthy, Anabella Villalobos, <span class="NLM_string-name hlFld-ContribAuthor">Christer Halldin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8532-8543. <a href="https://doi.org/10.1021/acs.jmedchem.9b00847" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00847%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BDevelopment%252Bof%252Ban%252BIrreversible%252BMonoacylglycerol%252BLipase%252B%252528MAGL%252529%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BRadioligand%252Bwith%252BHigh%252BSpecificity%26aulast%3DZhang%26aufirst%3DLei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D16092019%26date%3D04092019%26volume%3D62%26issue%3D18%26spage%3D8532%26epage%3D8543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elina Tampio LâEstrade, Mengfei Xiong, Vladimir Shalgunov, Fraser G. Edgar, BalÃ¡zs Volk, Simone L. Baerentzen, Mikael Palner, Maria Erlandsson, Tomas Ohlsson, Gitte M. Knudsen, <span class="NLM_string-name hlFld-ContribAuthor">Matthias M. Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Evaluation of Two Potential 5-HT7 Receptor PET Tracers: [18F]ENL09 and [18F]ENL10. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 3961-3968. <a href="https://doi.org/10.1021/acschemneuro.9b00132" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00132%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDevelopment%252Band%252BEvaluation%252Bof%252BTwo%252BPotential%252B5-HT7%252BReceptor%252BPET%252BTracers%25253A%252B%25255B18F%25255DENL09%252Band%252B%25255B18F%25255DENL10%26aulast%3DTampio%2BL%25E2%2580%2599Estrade%26aufirst%3DElina%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06032019%26date%3D11042019%26date%3D22042019%26date%3D11042019%26volume%3D10%26issue%3D9%26spage%3D3961%26epage%3D3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hualong Fu, Weiting Tang, Zhen Chen, Vasily V. Belov, Genwei Zhang, Tuo Shao, Xiaofei Zhang, Qingzhen Yu, Jian Rong, Xiaoyun Deng, Wei Han, Scott J. Myers, Pilar Giffenig, Lu Wang, Lee Josephson, Yihan Shao, April T. Davenport, James B. Daunais, Mikhail Papisov, Hongjie Yuan, Zijing Li, Stephen F. Traynelis, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([18F]N2B-0518) for GluN2B Subunit in the Brain. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 2263-2275. <a href="https://doi.org/10.1021/acschemneuro.8b00591" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00591%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%252Band%252BPreliminary%252BEvaluations%252Bof%252Ba%252BTriazole-Cored%252BAntagonist%252Bas%252Ba%252BPET%252BImaging%252BProbe%252B%252528%25255B18F%25255DN2B-0518%252529%252Bfor%252BGluN2B%252BSubunit%252Bin%252Bthe%252BBrain%26aulast%3DFu%26aufirst%3DHualong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D31102018%26date%3D30012019%26date%3D27022019%26date%3D30012019%26volume%3D10%26issue%3D5%26spage%3D2263%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ethan L. Fisher, Christopher W. am Ende, <span class="NLM_string-name hlFld-ContribAuthor">John M. Humphrey</span>. </span><span class="cited-content_cbyCitation_article-title">2,2,2-Trifluoroethoxy Aromatic Heterocycles: Hydrolytically Stable Alternatives to Heteroaryl Chlorides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4904-4909. <a href="https://doi.org/10.1021/acs.joc.8b02453" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02453%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D2%25252C2%25252C2-Trifluoroethoxy%252BAromatic%252BHeterocycles%25253A%252BHydrolytically%252BStable%252BAlternatives%252Bto%252BHeteroaryl%252BChlorides%26aulast%3DFisher%26aufirst%3DEthan%2BL.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D21092018%26date%3D29102018%26date%3D19102018%26volume%3D84%26issue%3D8%26spage%3D4904%26epage%3D4909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhen Chen, Wakana Mori, Xiaoyun Deng, Ran Cheng, Daisuke Ogasawara, Genwei Zhang, Michael A. Schafroth, Kenneth Dahl, Hualong Fu, Akiko Hatori, Tuo Shao, Yiding Zhang, Tomoteru Yamasaki, Xiaofei Zhang, Jian Rong, Qingzhen Yu, Kuan Hu, Masayuki Fujinaga, Lin Xie, Katsushi Kumata, Yuancheng Gou, Jingjin Chen, Shuyin Gu, Liang Bao, Lu Wang, Thomas Lee Collier, Neil Vasdev, Yihan Shao, Jun-An Ma, Benjamin F. Cravatt, Christopher Fowler, Lee Josephson, Ming-Rong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a âTail Switchingâ Strategy on a Piperazinyl Azetidine Skeleton. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3336-3353. <a href="https://doi.org/10.1021/acs.jmedchem.8b01778" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01778%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BReversible%252Band%252BIrreversible%252BMonoacylglycerol%252BLipase%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BTracers%252BUsing%252Ba%252B%2525E2%252580%25259CTail%252BSwitching%2525E2%252580%25259D%252BStrategy%252Bon%252Ba%252BPiperazinyl%252BAzetidine%252BSkeleton%26aulast%3DChen%26aufirst%3DZhen%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D14112018%26date%3D21032019%26date%3D04032019%26volume%3D62%26issue%3D7%26spage%3D3336%26epage%3D3353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yasushi Hattori, Kazunobu Aoyama, Jun Maeda, Naoto Arimura, Yasuko Takahashi, Masako Sasaki, Masayuki Fujinaga, Chie Seki, Yuji Nagai, Kazunori Kawamura, Tomoteru Yamasaki, Ming-Rong Zhang, Makoto Higuchi, <span class="NLM_string-name hlFld-ContribAuthor">Tatsuki Koike</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2362-2375. <a href="https://doi.org/10.1021/acs.jmedchem.8b01576" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01576%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252B%2525284R%252529-1-%25257B3-%25255B2-%25252818F%252529Fluoro-4-methylpyridin-3-yl%25255Dphenyl%25257D-4-%25255B4-%2525281%25252C3-thiazol-2-ylcarbonyl%252529piperazin-1-yl%25255Dpyrrolidin-2-one%252B%252528%25255B18F%25255DT-401%252529%252Bas%252Ba%252BNovel%252BPositron-Emission%252BTomography%252BImaging%252BAgent%252Bfor%252BMonoacylglycerol%252BLipase%26aulast%3DHattori%26aufirst%3DYasushi%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D10102018%26date%3D26022019%26date%3D12022019%26volume%3D62%26issue%3D5%26spage%3D2362%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aleksandra PekoÅ¡ak, Janez Å½. Bulc, Å pela Korat, Robert C. Schuit, Esther Kooijman, Ricardo Vos, Marissa Rongen, Mariska Verlaan, Kevin Takkenkamp, Wissam Beaino, Alex J. Poot, <span class="NLM_string-name hlFld-ContribAuthor">Albert D. Windhorst</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P1â7. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (11)
                                     , 4872-4883. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00518" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00518%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Band%252BPreclinical%252BEvaluation%252Bof%252Bthe%252BFirst%252BCarbon-11%252BLabeled%252BPET%252BTracers%252BTargeting%252BSubstance%252BP1%2525E2%252580%2525937%26aulast%3DPeko%25C5%25A1ak%26aufirst%3DAleksandra%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16052018%26date%3D18102018%26date%3D20082018%26date%3D25102018%26date%3D18102018%26volume%3D15%26issue%3D11%26spage%3D4872%26epage%3D4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Zhang, Laigao Chen, Jason K. Dutra, Elizabeth M. Beck, Sangram Nag, Akihiro Takano, Nahid Amini, Ryosuke Arakawa, Michael A. Brodney, Leanne M. Buzon, Shawn D. Doran, Lorraine F. Lanyon, Timothy J. McCarthy, Kelly R. Bales, Charles E. Nolan, Brian T. OâNeill, Klaas Schildknegt, Christer Halldin, <span class="NLM_string-name hlFld-ContribAuthor">Anabella Villalobos</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging Î²-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3296-3308. <a href="https://doi.org/10.1021/acs.jmedchem.7b01769" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01769%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BNovel%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BLigand%252Bfor%252BImaging%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE-1%252529%252Bin%252BBrain%26aulast%3DZhang%26aufirst%3DLei%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30112017%26date%3D02022018%26date%3D22012018%26volume%3D61%26issue%3D8%26spage%3D3296%26epage%3D3308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Salvatore Bongarzone, <span class="NLM_string-name hlFld-ContribAuthor">Antony D. Gee</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1: Now We Can See You. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3293-3295. <a href="https://doi.org/10.1021/acs.jmedchem.8b00474" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00474%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE1%25253A%252BNow%252BWe%252BCan%252BSee%252BYou%26aulast%3DBongarzone%26aufirst%3DSalvatore%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26032018%26date%3D04042018%26volume%3D61%26issue%3D8%26spage%3D3293%26epage%3D3295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Laigao  Chen</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Chappie</span>, <span class="hlFld-ContribAuthor ">Richard V.  Coelho</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsien  Fan</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Zoe  Hughes</span>, <span class="hlFld-ContribAuthor ">Kyle  Kuszpit</span>, <span class="hlFld-ContribAuthor ">Erik A.  Lachapelle</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Chewah  Lee</span>, <span class="hlFld-ContribAuthor ">Robert J.  Mather</span>, <span class="hlFld-ContribAuthor ">Nandini C.  Patel</span>, <span class="hlFld-ContribAuthor ">Marc B.  Skaddan</span>, <span class="hlFld-ContribAuthor ">Simone  Sciabola</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Young</span>, <span class="hlFld-ContribAuthor ">Kenneth  Zasadny</span>, and <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8538-8551. <a href="https://doi.org/10.1021/acs.jmedchem.7b01050" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252Ba%252BNovel%252BPhosphodiesterase%252B%252528PDE%252529%252B4B-Preferring%252BRadioligand%252Bfor%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%26aulast%3DZhang%26aufirst%3DLei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19072017%26date%3D09102017%26date%3D26102017%26date%3D28092017%26volume%3D60%26issue%3D20%26spage%3D8538%26epage%3D8551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Ramalakshmi Y.  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Todd W.  Butler</span>, <span class="hlFld-ContribAuthor ">Jianke  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Shenping  Liu</span>, <span class="hlFld-ContribAuthor ">Angela C.  Doran</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Katherine  Fisher</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>, <span class="hlFld-ContribAuthor ">Joseph R.  Hedde</span>, <span class="hlFld-ContribAuthor ">Michael  Marconi</span>, and <span class="hlFld-ContribAuthor ">Klaas  Schildknegt</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1995-2004. <a href="https://doi.org/10.1021/acschemneuro.7b00155" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00155%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Band%252BProfiling%252Bof%252Ba%252BSelective%252Band%252BBrain%252BPenetrant%252BRadioligand%252Bfor%252Bin%252BVivo%252BTarget%252BOccupancy%252BMeasurement%252Bof%252BCasein%252BKinase%252B1%252B%252528CK1%252529%252BInhibitors%26aulast%3DWager%26aufirst%3DTravis%2BT.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D13062017%26date%3D30062017%26date%3D20092017%26date%3D13062017%26volume%3D8%26issue%3D9%26spage%3D1995%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca C.  Gobbi</span>, <span class="hlFld-ContribAuthor ">Henner  Knust</span>, <span class="hlFld-ContribAuthor ">Matthias  KÃ¶rner</span>, <span class="hlFld-ContribAuthor ">Michael  Honer</span>, <span class="hlFld-ContribAuthor ">Christian  Czech</span>, <span class="hlFld-ContribAuthor ">Sara  Belli</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Martin R.  Edelmann</span>, <span class="hlFld-ContribAuthor ">Thomas  Hartung</span>, <span class="hlFld-ContribAuthor ">Isabella  Erbsmehl</span>, <span class="hlFld-ContribAuthor ">Sandra  Grall-Ulsemer</span>, <span class="hlFld-ContribAuthor ">Andreas  Koblet</span>, <span class="hlFld-ContribAuthor ">Marianne  Rueher</span>, <span class="hlFld-ContribAuthor ">Sandra  Steiner</span>, <span class="hlFld-ContribAuthor ">Hayden T.  Ravert</span>, <span class="hlFld-ContribAuthor ">William B.  Mathews</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Heather  Valentine</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, and <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimerâs Disease with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7350-7370. <a href="https://doi.org/10.1021/acs.jmedchem.7b00632" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00632%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BThree%252BNovel%252BRadiotracers%252Bfor%252BImaging%252BAggregated%252BTau%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DGobbi%26aufirst%3DLuca%2BC.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D12072017%26date%3D14092017%26date%3D27062017%26volume%3D60%26issue%3D17%26spage%3D7350%26epage%3D7370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Simon  Lindner</span>, <span class="hlFld-ContribAuthor ">Lena  Vomacka</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Xia  Shao</span>, <span class="hlFld-ContribAuthor ">Carole A.  Quesada</span>, <span class="hlFld-ContribAuthor ">Phillip  Sherman</span>, <span class="hlFld-ContribAuthor ">Anne  Mahringer</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Marilyn  GrandâMaison</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Soucy</span>, <span class="hlFld-ContribAuthor ">Alexander  Thiel</span>, <span class="hlFld-ContribAuthor ">David R.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Gert  Fricker</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  WÃ¤ngler</span>, <span class="hlFld-ContribAuthor ">Peter  Bartenstein</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, and <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>  . </span><span class="cited-content_cbyCitation_article-title">A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (16)
                                     , 6897-6910. <a href="https://doi.org/10.1021/acs.jmedchem.7b00396" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BKinome-Wide%252BSelective%252BRadiolabeled%252BTrkB%25252FC%252BInhibitor%252Bfor%252Bin%252BVitro%252Band%252Bin%252BVivo%252BNeuroimaging%25253A%252BSynthesis%25252C%252BPreclinical%252BEvaluation%25252C%252Band%252BFirst-in-Human%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15032017%26date%3D21072017%26date%3D24082017%26date%3D11072017%26volume%3D60%26issue%3D16%26spage%3D6897%26epage%3D6910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Eric P.  Arnold</span>, <span class="hlFld-ContribAuthor ">Tracey L.  Boyden</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Chappie</span>, <span class="hlFld-ContribAuthor ">Kimberly F.  Fennell</span>, <span class="hlFld-ContribAuthor ">Michael D.  Forman</span>, <span class="hlFld-ContribAuthor ">Mihaly  Hajos</span>, <span class="hlFld-ContribAuthor ">John F.  Harms</span>, <span class="hlFld-ContribAuthor ">William E.  Hoffman</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Zhijun  Kang</span>, <span class="hlFld-ContribAuthor ">Robin J.  Kleiman</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Jiemin  Lu</span>, <span class="hlFld-ContribAuthor ">Noha  Maklad</span>, <span class="hlFld-ContribAuthor ">Laura  McDowell</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  OâConnor</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Mary  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Anne W.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Ueno</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Edward X.  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5673-5698. <a href="https://doi.org/10.1021/acs.jmedchem.7b00397" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00397%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BStructure-Based%252BDesign%252Band%252BParallel%252BChemistry%252Bto%252BIdentify%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain%252BPenetrant%252BPhosphodiesterase%252B2A%252BInhibitor%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14032017%26date%3D16062017%26date%3D13072017%26date%3D02062017%26volume%3D60%26issue%3D13%26spage%3D5673%26epage%3D5698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guy A.  Higgins</span>  . </span><span class="cited-content_cbyCitation_article-title">18F-FPP: A PET Ligand for the 5-HT2C Receptor?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 904-907. <a href="https://doi.org/10.1021/acschemneuro.7b00133" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00133%26sid%3Dliteratum%253Aachs%26date%3D2017%26jtitle%3DACS%2520Chem.%2520Neurosci.%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D18F-FPP%25253A%252BA%252BPET%252BLigand%252Bfor%252Bthe%252B5-HT2C%252BReceptor%25253F%26aulast%3DHiggins%26aufirst%3DGuy%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12042017%26date%3D26042017%26date%3D01052017%26date%3D17052017%26volume%3D8%26issue%3D5%26spage%3D904%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Cummins</span> and <span class="hlFld-ContribAuthor ">Michael A.  Bell</span>  . </span><span class="cited-content_cbyCitation_article-title">Integrating Everything: The Molecule Selection Toolkit, a System for Compound Prioritization in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 6999-7010. <a href="https://doi.org/10.1021/acs.jmedchem.5b01338" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01338%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrating%252BEverything%25253A%252BThe%252BMolecule%252BSelection%252BToolkit%25252C%252Ba%252BSystem%252Bfor%252BCompound%252BPrioritization%252Bin%252BDrug%252BDiscovery%26aulast%3DCummins%26aufirst%3DDavid%2BJ.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D28082015%26date%3D22032016%26date%3D11082016%26date%3D07032016%26volume%3D59%26issue%3D15%26spage%3D6999%26epage%3D7010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norihito  Oi</span>, <span class="hlFld-ContribAuthor ">Masaki  Tokunaga</span>, <span class="hlFld-ContribAuthor ">Michiyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Yuji  Nagai</span>, <span class="hlFld-ContribAuthor ">Yosuke  Nakatani</span>, <span class="hlFld-ContribAuthor ">Noboru  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Jun  Maeda</span>, <span class="hlFld-ContribAuthor ">Takafumi  Minamimoto</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Suhara</span>, and <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Novel PET Probes for Central 2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8444-8462. <a href="https://doi.org/10.1021/acs.jmedchem.5b00712" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00712%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%252BPET%252BProbes%252Bfor%252BCentral%252B2-Amino-3-%2525283-hydroxy-5-methyl-4-isoxazolyl%252529propionic%252BAcid%252BReceptors%26aulast%3DOi%26aufirst%3DNorihito%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08052015%26date%3D02112015%26date%3D12112015%26date%3D15102015%26volume%3D58%26issue%3D21%26spage%3D8444%26epage%3D8462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, and <span class="hlFld-ContribAuthor ">JosÃ© Ignacio  AndrÃ©s</span>  . </span><span class="cited-content_cbyCitation_article-title">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4365-4382. <a href="https://doi.org/10.1021/jm5017544" title="DOI URL">https://doi.org/10.1021/jm5017544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5017544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%25253A%252BPast%25252C%252BPresent%25252C%252Band%252BFuture%26aulast%3DAriza%26aufirst%3DManuela%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D12112014%26date%3D25022015%26date%3D11062015%26date%3D11022015%26volume%3D58%26issue%3D11%26spage%3D4365%26epage%3D4382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Antonio  Aliaga</span>, <span class="hlFld-ContribAuthor ">Mehdi  Boudjemeline</span>, <span class="hlFld-ContribAuthor ">Robert  Hopewell</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Alexander  Thiel</span>, and <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>  . </span><span class="cited-content_cbyCitation_article-title">Syntheses and Evaluation of Carbon-11- and Fluorine-18-Radiolabeled pan-Tropomyosin Receptor Kinase (Trk) Inhibitors: Exploration of the 4-Aza-2-oxindole Scaffold as Trk PET Imaging Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (2)
                                     , 260-276. <a href="https://doi.org/10.1021/cn500193f" title="DOI URL">https://doi.org/10.1021/cn500193f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500193f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500193f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSyntheses%252Band%252BEvaluation%252Bof%252BCarbon-11-%252Band%252BFluorine-18-Radiolabeled%252Bpan-Tropomyosin%252BReceptor%252BKinase%252B%252528Trk%252529%252BInhibitors%25253A%252BExploration%252Bof%252Bthe%252B4-Aza-2-oxindole%252BScaffold%252Bas%252BTrk%252BPET%252BImaging%252BAgents%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25082014%26date%3D28102014%26date%3D10112014%26date%3D18022015%26date%3D28102014%26volume%3D6%26issue%3D2%26spage%3D260%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa  Barth</span> and <span class="hlFld-ContribAuthor ">Anne  Need</span>  . </span><span class="cited-content_cbyCitation_article-title">Identifying Novel Radiotracers for PET Imaging of the Brain: Application of LC-MS/MS to Tracer Identification. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1148-1153. <a href="https://doi.org/10.1021/cn500072r" title="DOI URL">https://doi.org/10.1021/cn500072r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500072r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500072r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentifying%252BNovel%252BRadiotracers%252Bfor%252BPET%252BImaging%252Bof%252Bthe%252BBrain%25253A%252BApplication%252Bof%252BLC-MS%25252FMS%252Bto%252BTracer%252BIdentification%26aulast%3DBarth%26aufirst%3DVanessa%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07042014%26date%3D13052014%26date%3D28052014%26date%3D17122014%26date%3D14052014%26volume%3D5%26issue%3D12%26spage%3D1148%26epage%3D1153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth M.  Joshi</span>, <span class="hlFld-ContribAuthor ">Anne  Need</span>, <span class="hlFld-ContribAuthor ">John  Schaus</span>, <span class="hlFld-ContribAuthor ">Zhaogen  Chen</span>, <span class="hlFld-ContribAuthor ">Dana  Benesh</span>, <span class="hlFld-ContribAuthor ">Charles  Mitch</span>, <span class="hlFld-ContribAuthor ">Stuart  Morton</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Raub</span>, <span class="hlFld-ContribAuthor ">Lee  Phebus</span>, and <span class="hlFld-ContribAuthor ">Vanessa  Barth</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficiency Gains in Tracer Identification for Nuclear Imaging: Can In Vivo LC-MS/MS Evaluation of Small Molecules Screen for Successful PET Tracers?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1154-1163. <a href="https://doi.org/10.1021/cn500073j" title="DOI URL">https://doi.org/10.1021/cn500073j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500073j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500073j%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DEfficiency%252BGains%252Bin%252BTracer%252BIdentification%252Bfor%252BNuclear%252BImaging%25253A%252BCan%252BIn%252BVivo%252BLC-MS%25252FMS%252BEvaluation%252Bof%252BSmall%252BMolecules%252BScreen%252Bfor%252BSuccessful%252BPET%252BTracers%25253F%26aulast%3DJoshi%26aufirst%3DElizabeth%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07042014%26date%3D22092014%26date%3D13102014%26date%3D17122014%26date%3D23092014%26volume%3D5%26issue%3D12%26spage%3D1154%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus  Piel</span>, <span class="hlFld-ContribAuthor ">Ingo  Vernaleken</span>, and <span class="hlFld-ContribAuthor ">Frank  RÃ¶sch</span>  . </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (22)
                                     , 9232-9258. <a href="https://doi.org/10.1021/jm5001858" title="DOI URL">https://doi.org/10.1021/jm5001858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5001858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5001858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositron%252BEmission%252BTomography%252Bin%252BCNS%252BDrug%252BDiscovery%252Band%252BDrug%252BMonitoring%26aulast%3DPiel%26aufirst%3DMarkus%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03022014%26date%3D10092014%26date%3D26112014%26date%3D21082014%26volume%3D57%26issue%3D22%26spage%3D9232%26epage%3D9258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Genevieve C.  Van de Bittner</span>, <span class="hlFld-ContribAuthor ">Emily L.  Ricq</span>, and <span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>  . </span><span class="cited-content_cbyCitation_article-title">A Philosophy for CNS Radiotracer Design. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2014,</strong> <em>47 </em>
                                    (10)
                                     , 3127-3134. <a href="https://doi.org/10.1021/ar500233s" title="DOI URL">https://doi.org/10.1021/ar500233s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ar500233s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Far500233s%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DA%252BPhilosophy%252Bfor%252BCNS%252BRadiotracer%252BDesign%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DGenevieve%2BC.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24062014%26date%3D01102014%26date%3D21102014%26volume%3D47%26issue%3D10%26spage%3D3127%26epage%3D3134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjun  Gao</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Kellar</span>, <span class="hlFld-ContribAuthor ">Robert P.  Yasuda</span>, <span class="hlFld-ContribAuthor ">Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Yingxian  Xiao</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, and <span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>  . </span><span class="cited-content_cbyCitation_article-title">Derivatives of Dibenzothiophene for Positron Emission Tomography Imaging of Î±7-Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (19)
                                     , 7574-7589. <a href="https://doi.org/10.1021/jm401184f" title="DOI URL">https://doi.org/10.1021/jm401184f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401184f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401184f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDerivatives%252Bof%252BDibenzothiophene%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Bof%252B%2525CE%2525B17-Nicotinic%252BAcetylcholine%252BReceptors%26aulast%3DGao%26aufirst%3DYongjun%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03052013%26date%3D19092013%26date%3D10102013%26volume%3D56%26issue%3D19%26spage%3D7574%26epage%3D7589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Kuebler</span>, <span class="hlFld-ContribAuthor ">Sabrina  Buss</span>, <span class="hlFld-ContribAuthor ">Andrei  Leonov</span>, <span class="hlFld-ContribAuthor ">Sergey  Ryazanov</span>, <span class="hlFld-ContribAuthor ">Felix  Schmidt</span>, <span class="hlFld-ContribAuthor ">Andreas  Maurer</span>, <span class="hlFld-ContribAuthor ">Daniel  Weckbecker</span>, <span class="hlFld-ContribAuthor ">Anne M.  Landau</span>, <span class="hlFld-ContribAuthor ">Thea P.  Lillethorup</span>, <span class="hlFld-ContribAuthor ">Daniel  Bleher</span>, <span class="hlFld-ContribAuthor ">Ran Sing  Saw</span>, <span class="hlFld-ContribAuthor ">Bernd J.  Pichler</span>, <span class="hlFld-ContribAuthor ">Christian  Griesinger</span>, <span class="hlFld-ContribAuthor ">Armin  Giese</span>, <span class="hlFld-ContribAuthor ">Kristina  Herfert</span>. </span><span class="cited-content_cbyCitation_article-title">[11C]MODAG-001âtowards a PET tracer targeting Î±-synuclein aggregates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>48 </em>
                                    (6)
                                     , 1759-1772. <a href="https://doi.org/10.1007/s00259-020-05133-x" title="DOI URL">https://doi.org/10.1007/s00259-020-05133-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-05133-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-05133-x%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3D%25255B11C%25255DMODAG-001%2525E2%252580%252594towards%252Ba%252BPET%252Btracer%252Btargeting%252B%2525CE%2525B1-synuclein%252Baggregates%26aulast%3DKuebler%26aufirst%3DLaura%26date%3D2021%26date%3D2020%26volume%3D48%26issue%3D6%26spage%3D1759%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susann  SchrÃ¶der</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheunemann</span>, <span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 3832. <a href="https://doi.org/10.3390/ijms22083832" title="DOI URL">https://doi.org/10.3390/ijms22083832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22083832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22083832%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DChallenges%252Bon%252BCyclic%252BNucleotide%252BPhosphodiesterases%252BImaging%252Bwith%252BPositron%252BEmission%252BTomography%25253A%252BNovel%252BRadioligands%252Band%252B%252528Pre-%252529Clinical%252BInsights%252Bsince%252B2016%26aulast%3DSchr%25C3%25B6der%26aufirst%3DSusann%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D3832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linjing  Mu</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 427-481. <a href="https://doi.org/10.1007/978-3-030-53176-8_13" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BRadioligands%252Bfor%252Bthe%252BPET%252BImaging%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DMu%26aufirst%3DLinjing%26date%3D2021%26date%3D2020%26spage%3D427%26epage%3D481%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Fuchigami</span>, <span class="hlFld-ContribAuthor ">Morio  Nakayama</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Magata</span>. </span><span class="cited-content_cbyCitation_article-title">Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 661-711. <a href="https://doi.org/10.1007/978-3-030-53176-8_19" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_19%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BPET%252Band%252BSPECT%252BRadioligands%252Bfor%252BIn%252BVivo%252BImaging%252Bof%252BNMDA%252BReceptors%26aulast%3DFuchigami%26aufirst%3DTakeshi%26date%3D2021%26date%3D2020%26spage%3D661%26epage%3D711%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Carolin  Jaworski</span>, <span class="hlFld-ContribAuthor ">Carmen  WÃ¤ngler</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  WÃ¤ngler</span>, <span class="hlFld-ContribAuthor ">Justin  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Toward Imaging Tropomyosin Receptor Kinase (Trk) with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1041-1059. <a href="https://doi.org/10.1007/978-3-030-53176-8_31" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_31</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_31%26sid%3Dliteratum%253Aachs%26atitle%3DToward%252BImaging%252BTropomyosin%252BReceptor%252BKinase%252B%252528Trk%252529%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DSchirrmacher%26aufirst%3DRalf%26date%3D2021%26date%3D2020%26spage%3D1041%26epage%3D1059%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric E.  Abrahamson</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Stehouwer</span>, <span class="hlFld-ContribAuthor ">Alberto L.  Vazquez</span>, <span class="hlFld-ContribAuthor ">Guo-Feng  Huang</span>, <span class="hlFld-ContribAuthor ">N. Scott  Mason</span>, <span class="hlFld-ContribAuthor ">Brian J.  Lopresti</span>, <span class="hlFld-ContribAuthor ">William E.  Klunk</span>, <span class="hlFld-ContribAuthor ">Chester A.  Mathis</span>, <span class="hlFld-ContribAuthor ">Milos D.  Ikonomovic</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a PET radioligand selective for cerebral amyloid angiopathy. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>92 </em>, 85-96. <a href="https://doi.org/10.1016/j.nucmedbio.2020.05.001" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DDevelopment%252Bof%252Ba%252BPET%252Bradioligand%252Bselective%252Bfor%252Bcerebral%252Bamyloid%252Bangiopathy%26aulast%3DAbrahamson%26aufirst%3DEric%2BE.%26date%3D2021%26volume%3D92%26spage%3D85%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Donnelly,</span>. </span><span class="cited-content_cbyCitation_article-title">PET
              Imaging in Drug Discovery and Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 703-725. <a href="https://doi.org/10.1002/9781119500575.ch22" title="DOI URL">https://doi.org/10.1002/9781119500575.ch22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119500575.ch22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119500575.ch22%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BImaging%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DDonnelly%252C%26aufirst%3DDavid%2BJ.%26date%3D2020%26date%3D2021%26spage%3D703%26epage%3D725%26pub%3DWiley%26atitle%3DHandbook%252Bof%252BRadiopharmaceuticals%26aulast%3DScott%26aufirst%3DPeter%26date%3D2020%26date%3D2021%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina  Tampio LâEstrade</span>, <span class="hlFld-ContribAuthor ">Vladimir  Shalgunov</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Ida  Nymann Petersen</span>, <span class="hlFld-ContribAuthor ">Christian Bernard Matthijs  Poulie</span>, <span class="hlFld-ContribAuthor ">Fraser G.  Edgar</span>, <span class="hlFld-ContribAuthor ">BalÃ¡zs  Volk</span>, <span class="hlFld-ContribAuthor ">Tomas  Ohlsson</span>, <span class="hlFld-ContribAuthor ">Maria  Erlandsson</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based labeling using condensation reactions of six potential 5-HT7R PET tracers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Radioanalytical and Nuclear Chemistry</span><span> <strong>2020,</strong> <em>326 </em>
                                    (3)
                                     , 1749-1762. <a href="https://doi.org/10.1007/s10967-020-07475-0" title="DOI URL">https://doi.org/10.1007/s10967-020-07475-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10967-020-07475-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10967-020-07475-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Radioanalytical%2520and%2520Nuclear%2520Chemistry%26atitle%3DFragment-based%252Blabeling%252Busing%252Bcondensation%252Breactions%252Bof%252Bsix%252Bpotential%252B5-HT7R%252BPET%252Btracers%26aulast%3DTampio%2BL%25E2%2580%2599Estrade%26aufirst%3DElina%26date%3D2020%26date%3D2020%26volume%3D326%26issue%3D3%26spage%3D1749%26epage%3D1762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Lu  Hou</span>, <span class="hlFld-ContribAuthor ">Jiefeng  Gan</span>, <span class="hlFld-ContribAuthor ">Qijun  Cai</span>, <span class="hlFld-ContribAuthor ">Weijian  Ye</span>, <span class="hlFld-ContribAuthor ">Jiahui  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Tan</span>, <span class="hlFld-ContribAuthor ">Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">Guocong  Li</span>, <span class="hlFld-ContribAuthor ">Hao  Xu</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127513. <a href="https://doi.org/10.1016/j.bmcl.2020.127513" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127513%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bpreliminary%252Bevaluation%252Bof%252Ba%252Bnovel%252Bpositron%252Bemission%252Btomography%252B%252528PET%252529%252Bligand%252Bfor%252Bimaging%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252B%252528FAAH%252529%26aulast%3DChen%26aufirst%3DZhen%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Fuchigami</span>, <span class="hlFld-ContribAuthor ">Masao  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Takehiro  Nakagaki</span>, <span class="hlFld-ContribAuthor ">Kodai  Nishi</span>, <span class="hlFld-ContribAuthor ">Kazunori  Sano</span>, <span class="hlFld-ContribAuthor ">Ryuichiro  Atarashi</span>, <span class="hlFld-ContribAuthor ">Mari  Nakaie</span>, <span class="hlFld-ContribAuthor ">Sakura  Yoshida</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Nishida</span>, <span class="hlFld-ContribAuthor ">Morio  Nakayama</span>. </span><span class="cited-content_cbyCitation_article-title">Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2020,</strong> <em>90-91 </em>, 41-48. <a href="https://doi.org/10.1016/j.nucmedbio.2020.09.003" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DFeasibility%252Bstudies%252Bof%252Bradioiodinated%252Bpyridyl%252Bbenzofuran%252Bderivatives%252Bas%252Bpotential%252BSPECT%252Bimaging%252Bagents%252Bfor%252Bprion%252Bdeposits%252Bin%252Bthe%252Bbrain%26aulast%3DFuchigami%26aufirst%3DTakeshi%26date%3D2020%26volume%3D90-91%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele  Gabellieri</span>, <span class="hlFld-ContribAuthor ">Francesca  Capotosti</span>, <span class="hlFld-ContribAuthor ">Jerome  Molette</span>, <span class="hlFld-ContribAuthor ">Nampally  Sreenivasachary</span>, <span class="hlFld-ContribAuthor ">Andre  Mueller</span>, <span class="hlFld-ContribAuthor ">Mathias  Berndt</span>, <span class="hlFld-ContribAuthor ">Hanno  Schieferstein</span>, <span class="hlFld-ContribAuthor ">Tanja  Juergens</span>, <span class="hlFld-ContribAuthor ">Yvan  Varisco</span>, <span class="hlFld-ContribAuthor ">Felix  Oden</span>, <span class="hlFld-ContribAuthor ">Heribert  Schmitt-Willich</span>, <span class="hlFld-ContribAuthor ">David  Hickman</span>, <span class="hlFld-ContribAuthor ">Ludger  Dinkelborg</span>, <span class="hlFld-ContribAuthor ">Andrew  Stephens</span>, <span class="hlFld-ContribAuthor ">Andrea  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Heiko  Kroth</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-câ]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimerâs disease and other tauopathies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112615. <a href="https://doi.org/10.1016/j.ejmech.2020.112615" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112615%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%2525284-%2525282-fluoroethoxy%252529piperidin-1-yl%252529-9-methyl-9H-pyrrolo%25255B2%25252C3-b%25253A4%25252C5-c%2525E2%252580%252599%25255Ddipyridine%252B%252528%25255B18F%25255DPI-2014%252529%252Bas%252BPET%252Btracer%252Bfor%252Bthe%252Bdetection%252Bof%252Bpathological%252Baggregated%252Btau%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bother%252Btauopathies%26aulast%3DGabellieri%26aufirst%3DEmanuele%26date%3D2020%26volume%3D204%26spage%3D112615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Fuchigami</span>, <span class="hlFld-ContribAuthor ">Tom  Haywood</span>, <span class="hlFld-ContribAuthor ">Gayatri  Gowrishankar</span>, <span class="hlFld-ContribAuthor ">David  Anders</span>, <span class="hlFld-ContribAuthor ">Mohammad  Namavari</span>, <span class="hlFld-ContribAuthor ">Mirwais  Wardak</span>, <span class="hlFld-ContribAuthor ">Sanjiv Sam  Gambhir</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of 9-(4-[18F]Fluoro-3-(hydroxymethyl)butyl)-2-(phenylthio)-6-oxopurine as a Novel PET Agent for Mutant Herpes Simplex Virus Type 1 Thymidine Kinase Reporter Gene Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     , 1151-1160. <a href="https://doi.org/10.1007/s11307-020-01517-5" title="DOI URL">https://doi.org/10.1007/s11307-020-01517-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-020-01517-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-020-01517-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252B9-%2525284-%25255B18F%25255DFluoro-3-%252528hydroxymethyl%252529butyl%252529-2-%252528phenylthio%252529-6-oxopurine%252Bas%252Ba%252BNovel%252BPET%252BAgent%252Bfor%252BMutant%252BHerpes%252BSimplex%252BVirus%252BType%252B1%252BThymidine%252BKinase%252BReporter%252BGene%252BImaging%26aulast%3DFuchigami%26aufirst%3DTakeshi%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D5%26spage%3D1151%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina T.  L'Estrade</span>, <span class="hlFld-ContribAuthor ">Maria  Erlandsson</span>, <span class="hlFld-ContribAuthor ">Fraser G.  Edgar</span>, <span class="hlFld-ContribAuthor ">Tomas  Ohlsson</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>172 </em>, 107830. <a href="https://doi.org/10.1016/j.neuropharm.2019.107830" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.107830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.107830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.107830%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DTowards%252Bselective%252BCNS%252BPET%252Bimaging%252Bof%252Bthe%252B5-HT7%252Breceptor%252Bsystem%25253A%252BPast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DL%2527Estrade%26aufirst%3DElina%2BT.%26date%3D2020%26volume%3D172%26spage%3D107830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Stephanie  Fiedler</span>, <span class="hlFld-ContribAuthor ">Robin  Striar</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2020,</strong> <em>84-85 </em>, 96-101. <a href="https://doi.org/10.1016/j.nucmedbio.2020.04.003" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DRadiosynthesis%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Ba%252Bnew%252Bpositron%252Bemission%252Btomography%252Bradiotracer%252Btargeting%252Bbromodomain%252Band%252Bextra-terminal%252Bdomain%252B%252528BET%252529%252Bfamily%252Bproteins%26aulast%3DBai%26aufirst%3DPing%26date%3D2020%26volume%3D84-85%26spage%3D96%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Becker</span>, <span class="hlFld-ContribAuthor ">Sylvestre  Dammicco</span>, <span class="hlFld-ContribAuthor ">Mohamed Ali  Bahri</span>, <span class="hlFld-ContribAuthor ">Eric  Salmon</span>. </span><span class="cited-content_cbyCitation_article-title">The Rise of Synaptic Density PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (10)
                                     , 2303. <a href="https://doi.org/10.3390/molecules25102303" title="DOI URL">https://doi.org/10.3390/molecules25102303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25102303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25102303%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BRise%252Bof%252BSynaptic%252BDensity%252BPET%252BImaging%26aulast%3DBecker%26aufirst%3DGuillaume%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D10%26spage%3D2303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Sha  Bai</span>, <span class="hlFld-ContribAuthor ">Michael S.  Placzek</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Fiedler</span>, <span class="hlFld-ContribAuthor ">Brenda  Ntaganda</span>, <span class="hlFld-ContribAuthor ">Hsiao-Ying  Wey</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1018. <a href="https://doi.org/10.3390/molecules25051018" title="DOI URL">https://doi.org/10.3390/molecules25051018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051018%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BNew%252BPositron%252BEmission%252BTomography%252BProbe%252Bfor%252BOrexin%252BReceptors%252BNeuroimaging%26aulast%3DBai%26aufirst%3DPing%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiwei  Zhu</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Fiedler</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Hibert</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a carbon-11 radiolabeled BACE1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (2)
                                     , 262-267. <a href="https://doi.org/10.1007/s00044-019-02480-9" title="DOI URL">https://doi.org/10.1007/s00044-019-02480-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02480-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02480-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Bof%252Ba%252Bcarbon-11%252Bradiolabeled%252BBACE1%252Binhibitor%26aulast%3DZhu%26aufirst%3DYiwei%26date%3D2020%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D262%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Fabrice G.  SimÃ©on</span>, <span class="hlFld-ContribAuthor ">Sanjay  Telu</span>, <span class="hlFld-ContribAuthor ">Lisheng  Cai</span>, <span class="hlFld-ContribAuthor ">Victor W.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry of labeling heterocycles with carbon-11 or fluorine-18 for biomedical imaging. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 241-384. <a href="https://doi.org/10.1016/bs.aihch.2019.11.005" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.11.005%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bchemistry%252Bof%252Blabeling%252Bheterocycles%252Bwith%252Bcarbon-11%252Bor%252Bfluorine-18%252Bfor%252Bbiomedical%252Bimaging%26aulast%3DLu%26aufirst%3DShuiyu%26date%3D2020%26spage%3D241%26epage%3D384%26pub%3DElsevier%26date%3D2020%26volume%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritawidya</span>, <span class="hlFld-ContribAuthor ">Wenzel</span>, <span class="hlFld-ContribAuthor ">Teodoro</span>, <span class="hlFld-ContribAuthor ">Toussaint</span>, <span class="hlFld-ContribAuthor ">Kranz</span>, <span class="hlFld-ContribAuthor ">Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Ludwig</span>, <span class="hlFld-ContribAuthor ">Scheunemann</span>, <span class="hlFld-ContribAuthor ">Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4149. <a href="https://doi.org/10.3390/molecules24224149" title="DOI URL">https://doi.org/10.3390/molecules24224149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224149%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRadiosynthesis%252Band%252BBiological%252BInvestigation%252Bof%252Ba%252BNovel%252BFluorine-18%252BLabeled%252BBenzoimidazotriazine-%252BBased%252BRadioligand%252Bfor%252Bthe%252BImaging%252Bof%252BPhosphodiesterase%252B2A%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DRitawidya%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koen  Vermeulen</span>, <span class="hlFld-ContribAuthor ">Mathilde  Vandamme</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Frederik  Cleeren</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Challenges of Radiopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2019,</strong> <em>49 </em>
                                    (5)
                                     , 339-356. <a href="https://doi.org/10.1053/j.semnuclmed.2019.07.001" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2019.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2019.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2019.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DDesign%252Band%252BChallenges%252Bof%252BRadiopharmaceuticals%26aulast%3DVermeulen%26aufirst%3DKoen%26date%3D2019%26volume%3D49%26issue%3D5%26spage%3D339%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guibao  Gu</span>, <span class="hlFld-ContribAuthor ">Trevor  Scott</span>, <span class="hlFld-ContribAuthor ">Yingzhuo  Yan</span>, <span class="hlFld-ContribAuthor ">Noelle  Warren</span>, <span class="hlFld-ContribAuthor ">Adia  Zhang</span>, <span class="hlFld-ContribAuthor ">Ali  Tabatabaei</span>, <span class="hlFld-ContribAuthor ">Hao  Xu</span>, <span class="hlFld-ContribAuthor ">Kathleen  Aertgeerts</span>, <span class="hlFld-ContribAuthor ">Laurent  Gomez</span>, <span class="hlFld-ContribAuthor ">Andrew  Morse</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Li</span>, <span class="hlFld-ContribAuthor ">J. Guy  Breitenbucher</span>, <span class="hlFld-ContribAuthor ">Eben  Massari</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Vivian</span>, <span class="hlFld-ContribAuthor ">Anne  Danks</span>. </span><span class="cited-content_cbyCitation_article-title">Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>370 </em>
                                    (3)
                                     , 399-407. <a href="https://doi.org/10.1124/jpet.118.255851" title="DOI URL">https://doi.org/10.1124/jpet.118.255851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.118.255851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.118.255851%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DTarget%252BEngagement%252Bof%252Ba%252BPhosphodiesterase%252B2A%252BInhibitor%252BAffecting%252BLong-Term%252BMemory%252Bin%252Bthe%252BRat%26aulast%3DGu%26aufirst%3DGuibao%26date%3D2019%26date%3D2019%26volume%3D370%26issue%3D3%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Cristian  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Michael  Letavic</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">Chunfang A.  Xia</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Anna Katrin  Szardenings</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
              18
              F-JNJ-64413739, a PET Radioligand for P2X7 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (8)
                                     , 1154-1159. <a href="https://doi.org/10.2967/jnumed.118.212696" title="DOI URL">https://doi.org/10.2967/jnumed.118.212696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.212696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.212696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BEvaluation%252Band%252BNonhuman%252BPrimate%252BReceptor%252BOccupancy%252BStudy%252Bof%252B18%252BF-JNJ-64413739%25252C%252Ba%252BPET%252BRadioligand%252Bfor%252BP2X7%252BReceptors%26aulast%3DKolb%26aufirst%3DHartmuth%2BC.%26date%3D2019%26date%3D2019%26volume%3D60%26issue%3D8%26spage%3D1154%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Jianrong  Liu</span>, <span class="hlFld-ContribAuthor ">Sladjana  Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Friedrich-Alexander  Ludwig</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Chezal</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Moreau</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Aurelie  Maisonial-Besset</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 346-362. <a href="https://doi.org/10.1016/j.bioorg.2019.01.037" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DTargeting%252Bcyclic%252Bnucleotide%252Bphosphodiesterase%252B5%252B%252528PDE5%252529%252Bin%252Bbrain%25253A%252BToward%252Bthe%252Bdevelopment%252Bof%252Ba%252BPET%252Bradioligand%252Blabeled%252Bwith%252Bfluorine-18%26aulast%3DWenzel%26aufirst%3DBarbara%26date%3D2019%26volume%3D86%26spage%3D346%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>, <span class="hlFld-ContribAuthor ">Lena  Kaiser</span>, <span class="hlFld-ContribAuthor ">Peter  Bartenstein</span>, <span class="hlFld-ContribAuthor ">Simon  Lindner</span>, <span class="hlFld-ContribAuthor ">David R.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Gert  Fricker</span>, <span class="hlFld-ContribAuthor ">Anne  Mahringer</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Esther  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Carmen  WÃ¤ngler</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  WÃ¤ngler</span>, <span class="hlFld-ContribAuthor ">Alexander  Thiel</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Soucy</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 7. <a href="https://doi.org/10.3390/ph12010007" title="DOI URL">https://doi.org/10.3390/ph12010007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DRadioligands%252Bfor%252BTropomyosin%252BReceptor%252BKinase%252B%252528Trk%252529%252BPositron%252BEmission%252BTomography%252BImaging%26aulast%3DSchirrmacher%26aufirst%3DRalf%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Chemie der Positronenemissionstomographie: Aktuelle Fortschritte bei
              11
              Câ,
              18
              Fâ,
              13
              Nâ und
              15
              OâMarkierungsreaktionen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (9)
                                     , 2604-2631. <a href="https://doi.org/10.1002/ange.201805501" title="DOI URL">https://doi.org/10.1002/ange.201805501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201805501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201805501%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DChemie%252Bder%252BPositronenemissionstomographie%25253A%252BAktuelle%252BFortschritte%252Bbei%252B11%252BC%2525E2%252580%252590%25252C%252B18%252BF%2525E2%252580%252590%25252C%252B13%252BN%2525E2%252580%252590%252Bund%252B15%252BO%2525E2%252580%252590Markierungsreaktionen%26aulast%3DDeng%26aufirst%3DXiaoyun%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D9%26spage%3D2604%26epage%3D2631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry for Positron Emission Tomography: Recent Advances in
              11
              Câ,
              18
              Fâ,
              13
              Nâ, and
              15
              OâLabeling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (9)
                                     , 2580-2605. <a href="https://doi.org/10.1002/anie.201805501" title="DOI URL">https://doi.org/10.1002/anie.201805501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201805501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201805501%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DChemistry%252Bfor%252BPositron%252BEmission%252BTomography%25253A%252BRecent%252BAdvances%252Bin%252B11%252BC%2525E2%252580%252590%25252C%252B18%252BF%2525E2%252580%252590%25252C%252B13%252BN%2525E2%252580%252590%25252C%252Band%252B15%252BO%2525E2%252580%252590Labeling%252BReactions%26aulast%3DDeng%26aufirst%3DXiaoyun%26date%3D2019%26volume%3D58%26issue%3D9%26spage%3D2580%26epage%3D2605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Doller</span>, <span class="hlFld-ContribAuthor ">Paul  Wes</span>. </span><span class="cited-content_cbyCitation_article-title">Quality of Research Tools. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 119-145. <a href="https://doi.org/10.1007/164_2019_281" title="DOI URL">https://doi.org/10.1007/164_2019_281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2019_281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2019_281%26sid%3Dliteratum%253Aachs%26atitle%3DQuality%252Bof%252BResearch%252BTools%26aulast%3DDoller%26aufirst%3DDario%26date%3D2019%26date%3D2019%26spage%3D119%26epage%3D145%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DGood%252BResearch%252BPractice%252Bin%252BNon-Clinical%252BPharmacology%252Band%252BBiomedicine%26aulast%3DBespalov%26aufirst%3DAnton%26date%3D2020%26volume%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristina  Herfert</span>, <span class="hlFld-ContribAuthor ">Sabina  Marciano</span>, <span class="hlFld-ContribAuthor ">Laura  Kuebler</span>, <span class="hlFld-ContribAuthor ">Sabrina  Buss</span>, <span class="hlFld-ContribAuthor ">Natalie  Landeck</span>, <span class="hlFld-ContribAuthor ">Julia G.  Mannheim</span>, <span class="hlFld-ContribAuthor ">Hanna  Napieczynska</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Experimentation in Neurology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 583-606. <a href="https://doi.org/10.1007/978-3-319-98947-1_34" title="DOI URL">https://doi.org/10.1007/978-3-319-98947-1_34</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-98947-1_34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-98947-1_34%26sid%3Dliteratum%253Aachs%26atitle%3DPreclinical%252BExperimentation%252Bin%252BNeurology%26aulast%3DHerfert%26aufirst%3DKristina%26date%3D2019%26date%3D2019%26spage%3D583%26epage%3D606%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DRadiopharmaceutical%252BChemistry%26aulast%3DLewis%26aufirst%3DJason%2BS.%26date%3D2019%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan D.  Andersson</span>, <span class="hlFld-ContribAuthor ">David  Matuskey</span>, <span class="hlFld-ContribAuthor ">Sjoerd J.  Finnema</span>. </span><span class="cited-content_cbyCitation_article-title">Positron emission tomography imaging of the Î³-aminobutyric acid system. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2019,</strong> <em>691 </em>, 35-43. <a href="https://doi.org/10.1016/j.neulet.2018.08.010" title="DOI URL">https://doi.org/10.1016/j.neulet.2018.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2018.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2018.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DPositron%252Bemission%252Btomography%252Bimaging%252Bof%252Bthe%252B%2525CE%2525B3-aminobutyric%252Bacid%252Bsystem%26aulast%3DAndersson%26aufirst%3DJan%2BD.%26date%3D2019%26volume%3D691%26spage%3D35%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Zhang</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Dunn</span>, <span class="hlFld-ContribAuthor ">Genwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hualong  Fu</span>, <span class="hlFld-ContribAuthor ">Tuo  Shao</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Longle  Ma</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Qingzhen  Yu</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Jun-An  Ma</span>, <span class="hlFld-ContribAuthor ">Yihan  Shao</span>, <span class="hlFld-ContribAuthor ">Susumu  Tomita</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, pharmacology and preclinical evaluation of 11C-labeled 1,3-dihydro-2H-benzo[d]imidazole-2-ones for imaging Î³8-dependent transmembrane AMPA receptor regulatory protein. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 898-908. <a href="https://doi.org/10.1016/j.ejmech.2018.08.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bpharmacology%252Band%252Bpreclinical%252Bevaluation%252Bof%252B11C-labeled%252B1%25252C3-dihydro-2H-benzo%25255Bd%25255Dimidazole-2-ones%252Bfor%252Bimaging%252B%2525CE%2525B38-dependent%252Btransmembrane%252BAMPA%252Breceptor%252Bregulatory%252Bprotein%26aulast%3DChen%26aufirst%3DZhen%26date%3D2018%26volume%3D157%26spage%3D898%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yves P.  Auberson</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Briard</span>, <span class="hlFld-ContribAuthor ">Bettina  Rudolph</span>, <span class="hlFld-ContribAuthor ">Klemens  Kaupmann</span>, <span class="hlFld-ContribAuthor ">Paul  Smith</span>, <span class="hlFld-ContribAuthor ">Berndt  Oberhauser</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of T Cells: Target Identification and Feasibility Assessment. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1566-1579. <a href="https://doi.org/10.1002/cmdc.201800241" title="DOI URL">https://doi.org/10.1002/cmdc.201800241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800241%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPET%252BImaging%252Bof%252BT%252BCells%25253A%252BTarget%252BIdentification%252Band%252BFeasibility%252BAssessment%26aulast%3DAuberson%26aufirst%3DYves%2BP.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1566%26epage%3D1579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susann  SchrÃ¶der</span>, <span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Mathias  Kranz</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheunemann</span>, <span class="hlFld-ContribAuthor ">Ute  Egerland</span>, <span class="hlFld-ContribAuthor ">Norbert  HÃ¶fgen</span>, <span class="hlFld-ContribAuthor ">Detlef  Briel</span>, <span class="hlFld-ContribAuthor ">JÃ¶rg  Steinbach</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (3)
                                     , 556. <a href="https://doi.org/10.3390/molecules23030556" title="DOI URL">https://doi.org/10.3390/molecules23030556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23030556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23030556%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInvestigation%252Bof%252Ban%252B18F-labelled%252BImidazopyridotriazine%252Bfor%252BMolecular%252BImaging%252Bof%252BCyclic%252BNucleotide%252BPhosphodiesterase%252B2A%26aulast%3DSchr%25C3%25B6der%26aufirst%3DSusann%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip S.  Murphy</span>, <span class="hlFld-ContribAuthor ">Neel  Patel</span>, <span class="hlFld-ContribAuthor ">Timothy J.  McCarthy</span>. </span><span class="cited-content_cbyCitation_article-title">Has molecular imaging delivered to drug development?. </span><span class="cited-content_cbyCitation_journal-name">Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences</span><span> <strong>2017,</strong> <em>375 </em>
                                    (2107)
                                     , 20170112. <a href="https://doi.org/10.1098/rsta.2017.0112" title="DOI URL">https://doi.org/10.1098/rsta.2017.0112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsta.2017.0112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsta.2017.0112%26sid%3Dliteratum%253Aachs%26jtitle%3DPhilosophical%2520Transactions%2520of%2520the%2520Royal%2520Society%2520A%253A%2520Mathematical%252C%2520Physical%2520and%2520Engineering%2520Sciences%26atitle%3DHas%252Bmolecular%252Bimaging%252Bdelivered%252Bto%252Bdrug%252Bdevelopment%25253F%26aulast%3DMurphy%26aufirst%3DPhilip%2BS.%26date%3D2017%26date%3D2017%26volume%3D375%26issue%3D2107%26spage%3D20170112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Collier</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of PET radiopharmaceuticals at the academia-industry interface. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 19-26. <a href="https://doi.org/10.1016/j.ddtec.2017.09.001" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DDiscovery%252Bof%252BPET%252Bradiopharmaceuticals%252Bat%252Bthe%252Bacademia-industry%252Binterface%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2017%26volume%3D25%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JosÃ© Ignacio  AndrÃ©s</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry strategies for PET tracer discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 11-17. <a href="https://doi.org/10.1016/j.ddtec.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DMedicinal%252BChemistry%252Bstrategies%252Bfor%252BPET%252Btracer%252Bdiscovery%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BIgnacio%26date%3D2017%26volume%3D25%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joel  Mercier</span>, <span class="hlFld-ContribAuthor ">Laurent  Provins</span>, <span class="hlFld-ContribAuthor ">Anne  Valade</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of SV2A PET tracers: Potential for imaging synaptic density and clinical applications. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 45-52. <a href="https://doi.org/10.1016/j.ddtec.2017.11.003" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252BSV2A%252BPET%252Btracers%25253A%252BPotential%252Bfor%252Bimaging%252Bsynaptic%252Bdensity%252Band%252Bclinical%252Bapplications%26aulast%3DMercier%26aufirst%3DJoel%26date%3D2017%26volume%3D25%26spage%3D45%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Kilbourn</span>, <span class="hlFld-ContribAuthor ">Peter J.H.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Is logP truly dead?. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2017,</strong> <em>54 </em>, 41-42. <a href="https://doi.org/10.1016/j.nucmedbio.2017.08.006" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2017.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2017.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DIs%252BlogP%252Btruly%252Bdead%25253F%26aulast%3DKilbourn%26aufirst%3DMichael%2BR.%26date%3D2017%26volume%3D54%26spage%3D41%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Need</span>, <span class="hlFld-ContribAuthor ">Nancy  Kant</span>, <span class="hlFld-ContribAuthor ">Cynthia  Jesudason</span>, <span class="hlFld-ContribAuthor ">Vanessa  Barth</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches for the discovery of novel positron emission tomography radiotracers for brain imaging. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Imaging</span><span> <strong>2017,</strong> <em>5 </em>
                                    (3)
                                     , 265-274. <a href="https://doi.org/10.1007/s40336-017-0221-3" title="DOI URL">https://doi.org/10.1007/s40336-017-0221-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40336-017-0221-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40336-017-0221-3%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Imaging%26atitle%3DApproaches%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bpositron%252Bemission%252Btomography%252Bradiotracers%252Bfor%252Bbrain%252Bimaging%26aulast%3DNeed%26aufirst%3DAnne%26date%3D2017%26date%3D2017%26volume%3D5%26issue%3D3%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E  Schmidt</span>, <span class="hlFld-ContribAuthor ">JosÃ© Ignacio  AndrÃ©s</span>. </span><span class="cited-content_cbyCitation_article-title">The value of PET ligand discovery to CNS drug development. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (4)
                                     , 351-356. <a href="https://doi.org/10.4155/fmc-2017-0018" title="DOI URL">https://doi.org/10.4155/fmc-2017-0018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0018%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bvalue%252Bof%252BPET%252Bligand%252Bdiscovery%252Bto%252BCNS%252Bdrug%252Bdevelopment%26aulast%3DSchmidt%26aufirst%3DMark%2BE%26date%3D2017%26volume%3D9%26issue%3D4%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy B.  Durham</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wiley</span>. </span><span class="cited-content_cbyCitation_article-title">Target Engagement Measures in Preclinical Drug Discovery: Theory, Methods, and Case Studies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 41-80. <a href="https://doi.org/10.1007/978-3-319-50042-3_3" title="DOI URL">https://doi.org/10.1007/978-3-319-50042-3_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-50042-3_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-50042-3_3%26sid%3Dliteratum%253Aachs%26atitle%3DTarget%252BEngagement%252BMeasures%252Bin%252BPreclinical%252BDrug%252BDiscovery%25253A%252BTheory%25252C%252BMethods%25252C%252Band%252BCase%252BStudies%26aulast%3DDurham%26aufirst%3DTimothy%2BB.%26date%3D2017%26date%3D2017%26spage%3D41%26epage%3D80%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTranslating%252BMolecules%252Binto%252BMedicines%26aulast%3DBhattachar%26aufirst%3DShobha%2BN.%26date%3D2017%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From Imaging Agents to Theranostic Drugs in Alzheimerâs Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 74-106. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12285-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12285-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12285-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12285-1%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BImaging%252BAgents%252Bto%252BTheranostic%252BDrugs%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBolognesi%26aufirst%3DM.L.%26date%3D2017%26spage%3D74%26epage%3D106%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Mercier</span>, <span class="hlFld-ContribAuthor ">L.  Provins</span>, <span class="hlFld-ContribAuthor ">J.  Hannestad</span>. </span><span class="cited-content_cbyCitation_article-title">Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 20-64. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12437-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12437-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12437-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12437-0%26sid%3Dliteratum%253Aachs%26atitle%3DProgress%252Band%252BChallenges%252Bin%252Bthe%252BDevelopment%252Bof%252BPET%252BLigands%252Bto%252BAid%252BCNS%252BDrug%252BDiscovery%26aulast%3DMercier%26aufirst%3DJ.%26date%3D2017%26spage%3D20%26epage%3D64%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Kehler</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Phosphodiesterases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 384-407. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12445-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12445-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12445-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12445-X%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BPhosphodiesterases%252Bin%252Bthe%252BCNS%26aulast%3DKehler%26aufirst%3DJ.%26date%3D2017%26spage%3D384%26epage%3D407%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger N.  Gunn</span>, <span class="hlFld-ContribAuthor ">Eugenii A.  Rabiner</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging in Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2017,</strong> <em>47 </em>
                                    (1)
                                     , 89-98. <a href="https://doi.org/10.1053/j.semnuclmed.2016.09.001" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2016.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2016.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2016.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DImaging%252Bin%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DGunn%26aufirst%3DRoger%2BN.%26date%3D2017%26volume%3D47%26issue%3D1%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to facilitate the discovery of novel CNS PET ligands. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2017,</strong> <em>1 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-016-0016-2" title="DOI URL">https://doi.org/10.1186/s41181-016-0016-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-016-0016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-016-0016-2%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DStrategies%252Bto%252Bfacilitate%252Bthe%252Bdiscovery%252Bof%252Bnovel%252BCNS%252BPET%252Bligands%26aulast%3DZhang%26aufirst%3DLei%26date%3D2017%26date%3D2016%26volume%3D1%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Mikami</span>, <span class="hlFld-ContribAuthor ">Masanori  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Shuhei  Ikeda</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Negoro</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakamura</span>, <span class="hlFld-ContribAuthor ">Izumi  Nomura</span>, <span class="hlFld-ContribAuthor ">Tomoko  Ashizawa</span>, <span class="hlFld-ContribAuthor ">Hironori  Kokubo</span>, <span class="hlFld-ContribAuthor ">Isaac Dylan  Hoffman</span>, <span class="hlFld-ContribAuthor ">Hua  Zou</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Oki</span>, <span class="hlFld-ContribAuthor ">Noriko  Uchiyama</span>, <span class="hlFld-ContribAuthor ">Yuuto  Hiura</span>, <span class="hlFld-ContribAuthor ">Maki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Yuuki  Itou</span>, <span class="hlFld-ContribAuthor ">Masato  Nakashima</span>, <span class="hlFld-ContribAuthor ">Hiroki  Iwashita</span>, <span class="hlFld-ContribAuthor ">Takahiko  Taniguchi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of Pyrazolo[1,5-a]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2017,</strong> <em>65 </em>
                                    (11)
                                     , 1058-1077. <a href="https://doi.org/10.1248/cpb.c17-00564" title="DOI URL">https://doi.org/10.1248/cpb.c17-00564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c17-00564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c17-00564%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BPyrazolo%25255B1%25252C5-a%25255Dpyrimidine-Based%252BPhosphodiesterase%252B2A%252BInhibitors%252BStructurally%252BDifferent%252Bfrom%252BN-%252528%2525281S%252529-1-%2525283-Fluoro-4-%252528trifluoromethoxy%252529phenyl%252529-2-methoxyethyl%252529-7-methoxy-2-oxo-2%25252C3-dihydropyrido%25255B2%25252C3-b%25255Dpyrazine-4%2525281H%252529-carboxamide%252B%252528TAK-915%252529%25252C%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDisorders%26aulast%3DMikami%26aufirst%3DSatoshi%26date%3D2017%26volume%3D65%26issue%3D11%26spage%3D1058%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah L.  Smith</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Davoren</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Sarah  Neal</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of a Novel M
              1
              Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [
              3
              H]PT-1284. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2016,</strong> <em>90 </em>
                                    (3)
                                     , 177-187. <a href="https://doi.org/10.1124/mol.116.104737" title="DOI URL">https://doi.org/10.1124/mol.116.104737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.116.104737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.116.104737%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DCharacterization%252Bof%252Ba%252BNovel%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptor%252BPositive%252BAllosteric%252BModulator%252BRadioligand%25252C%252B%25255B%252B3%252BH%25255DPT-1284%26aulast%3DSmith%26aufirst%3DDeborah%2BL.%26date%3D2016%26date%3D2016%26volume%3D90%26issue%3D3%26spage%3D177%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laigao  Chen</span>, <span class="hlFld-ContribAuthor ">Nabeel  Nabulsi</span>, <span class="hlFld-ContribAuthor ">Mika  Naganawa</span>, <span class="hlFld-ContribAuthor ">Kenneth  Zasadny</span>, <span class="hlFld-ContribAuthor ">Marc B.  Skaddan</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Soheila  Najafzadeh</span>, <span class="hlFld-ContribAuthor ">Shu-fei  Lin</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Tracey L.  Boyden</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Jim  Ropchan</span>, <span class="hlFld-ContribAuthor ">Richard E.  Carson</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>, <span class="hlFld-ContribAuthor ">Yiyun  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of
              18
              F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2016,</strong> <em>57 </em>
                                    (9)
                                     , 1448-1453. <a href="https://doi.org/10.2967/jnumed.115.171454" title="DOI URL">https://doi.org/10.2967/jnumed.115.171454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.115.171454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.115.171454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BEvaluation%252Bof%252B18%252BF-PF-05270430%25252C%252Ba%252BNovel%252BPET%252BRadioligand%252Bfor%252Bthe%252BPhosphodiesterase%252B2A%252BEnzyme%26aulast%3DChen%26aufirst%3DLaigao%26date%3D2016%26date%3D2016%26volume%3D57%26issue%3D9%26spage%3D1448%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mika  Naganawa</span>, <span class="hlFld-ContribAuthor ">Rikki N.  Waterhouse</span>, <span class="hlFld-ContribAuthor ">Nabeel  Nabulsi</span>, <span class="hlFld-ContribAuthor ">Shu-Fei  Lin</span>, <span class="hlFld-ContribAuthor ">David  Labaree</span>, <span class="hlFld-ContribAuthor ">Jim  Ropchan</span>, <span class="hlFld-ContribAuthor ">Sanela  Tarabar</span>, <span class="hlFld-ContribAuthor ">Nicholas  DeMartinis</span>, <span class="hlFld-ContribAuthor ">Adam  Ogden</span>, <span class="hlFld-ContribAuthor ">Anindita  Banerjee</span>, <span class="hlFld-ContribAuthor ">Yiyun  Huang</span>, <span class="hlFld-ContribAuthor ">Richard E.  Carson</span>. </span><span class="cited-content_cbyCitation_article-title">First-in-Human Assessment of the Novel PDE2A PET Radiotracer
              18
              F-PF-05270430. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2016,</strong> <em>57 </em>
                                    (9)
                                     , 1388-1395. <a href="https://doi.org/10.2967/jnumed.115.166850" title="DOI URL">https://doi.org/10.2967/jnumed.115.166850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.115.166850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.115.166850%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DFirst-in-Human%252BAssessment%252Bof%252Bthe%252BNovel%252BPDE2A%252BPET%252BRadiotracer%252B18%252BF-PF-05270430%26aulast%3DNaganawa%26aufirst%3DMika%26date%3D2016%26date%3D2016%26volume%3D57%26issue%3D9%26spage%3D1388%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">AndrÃ©s A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Peter  Buijnsters</span>, <span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>. </span><span class="cited-content_cbyCitation_article-title">Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (8)
                                     , 933-946. <a href="https://doi.org/10.1080/13543776.2016.1203902" title="DOI URL">https://doi.org/10.1080/13543776.2016.1203902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2016.1203902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2016.1203902%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTowards%252Bselective%252Bphosphodiesterase%252B2A%252B%252528PDE2A%252529%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B-%252Bpresent%252529%26aulast%3DTrabanco%26aufirst%3DAndr%25C3%25A9s%2BA.%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D8%26spage%3D933%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yves P.  Auberson</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Briard</span>, <span class="hlFld-ContribAuthor ">David  Sykes</span>, <span class="hlFld-ContribAuthor ">John  Reilly</span>, <span class="hlFld-ContribAuthor ">Mark  Healy</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand Specific Efficiency (LSE) Index for PET Tracer Optimization. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (13)
                                     , 1415-1427. <a href="https://doi.org/10.1002/cmdc.201600112" title="DOI URL">https://doi.org/10.1002/cmdc.201600112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600112%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DLigand%252BSpecific%252BEfficiency%252B%252528LSE%252529%252BIndex%252Bfor%252BPET%252BTracer%252BOptimization%26aulast%3DAuberson%26aufirst%3DYves%2BP.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D13%26spage%3D1415%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">D.C.  Matthews</span>, <span class="hlFld-ContribAuthor ">S.  Staelens</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging in Alzheimer Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 523-563. <a href="https://doi.org/10.1016/B978-0-12-802173-6.00020-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-802173-6.00020-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802173-6.00020-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802173-6.00020-4%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BImaging%252Bin%252BAlzheimer%252BClinical%252BTrials%26aulast%3DSchmidt%26aufirst%3DM.E.%26date%3D2016%26spage%3D523%26epage%3D563%26pub%3DElsevier%26atitle%3DDeveloping%252BTherapeutics%252Bfor%252BAlzheimer%252527s%252BDisease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Melinda  Wuest</span>, <span class="hlFld-ContribAuthor ">Garrett M.  Brodeur</span>, <span class="hlFld-ContribAuthor ">Barry J.  Bedell</span>, <span class="hlFld-ContribAuthor ">Frank  Wuest</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Development of subnanomolar radiofluorinated (2-pyrrolidin-1-yl)imidazo[1,2-
              b
              ]pyridazine pan-Trk inhibitors as candidate PET imaging probes. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (12)
                                     , 2184-2193. <a href="https://doi.org/10.1039/C5MD00388A" title="DOI URL">https://doi.org/10.1039/C5MD00388A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00388A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00388A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252Bsubnanomolar%252Bradiofluorinated%252B%2525282-pyrrolidin-1-yl%252529imidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazine%252Bpan-Trk%252Binhibitors%252Bas%252Bcandidate%252BPET%252Bimaging%252Bprobes%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D12%26spage%3D2184%26epage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin  Bailey</span>, <span class="hlFld-ContribAuthor ">Sheldon  Berke</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (12)
                                     , 22000-22027. <a href="https://doi.org/10.3390/molecules201219816" title="DOI URL">https://doi.org/10.3390/molecules201219816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201219816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201219816%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Band%252BApplication%252Bof%252BRadiolabeled%252BKinase%252BInhibitors%252Bfor%252BPET%252BImaging%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D12%26spage%3D22000%26epage%3D22027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sjoerd J.  Finnema</span>, <span class="hlFld-ContribAuthor ">Mika  Scheinin</span>, <span class="hlFld-ContribAuthor ">Mohammed  Shahid</span>, <span class="hlFld-ContribAuthor ">Jussi  Lehto</span>, <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Jukka  Sallinen</span>, <span class="hlFld-ContribAuthor ">Erik  Wong</span>, <span class="hlFld-ContribAuthor ">Lars  Farde</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>. </span><span class="cited-content_cbyCitation_article-title">Application of cross-species PET imaging to assess neurotransmitter release in brain. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2015,</strong> <em>232 </em>
                                    (21-22)
                                     , 4129-4157. <a href="https://doi.org/10.1007/s00213-015-3938-6" title="DOI URL">https://doi.org/10.1007/s00213-015-3938-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-015-3938-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-015-3938-6%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DApplication%252Bof%252Bcross-species%252BPET%252Bimaging%252Bto%252Bassess%252Bneurotransmitter%252Brelease%252Bin%252Bbrain%26aulast%3DFinnema%26aufirst%3DSjoerd%2BJ.%26date%3D2015%26date%3D2015%26volume%3D232%26issue%3D21-22%26spage%3D4129%26epage%3D4157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaoda  Zhang</span>, <span class="hlFld-ContribAuthor ">Kun-Eek  Kil</span>, <span class="hlFld-ContribAuthor ">Pekka  Poutiainen</span>, <span class="hlFld-ContribAuthor ">Ji-Kyung  Choi</span>, <span class="hlFld-ContribAuthor ">Hye-Jin  Kang</span>, <span class="hlFld-ContribAuthor ">Xi-Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Anna-Liisa  Brownell</span>. </span><span class="cited-content_cbyCitation_article-title">Re-exploring the N-phenylpicolinamide derivatives to develop mGlu4 ligands with improved affinity and in vitro microsomal stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (18)
                                     , 3956-3960. <a href="https://doi.org/10.1016/j.bmcl.2015.07.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRe-exploring%252Bthe%252BN-phenylpicolinamide%252Bderivatives%252Bto%252Bdevelop%252BmGlu4%252Bligands%252Bwith%252Bimproved%252Baffinity%252Band%252Bin%252Bvitro%252Bmicrosomal%252Bstability%26aulast%3DZhang%26aufirst%3DZhaoda%26date%3D2015%26volume%3D25%26issue%3D18%26spage%3D3956%26epage%3D3960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>. </span><span class="cited-content_cbyCitation_article-title">Current radiosynthesis strategies for 5-HT
              2A
              receptor PET tracers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 265-273. <a href="https://doi.org/10.1002/jlcr.3288" title="DOI URL">https://doi.org/10.1002/jlcr.3288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3288%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DCurrent%252Bradiosynthesis%252Bstrategies%252Bfor%252B5-HT%252B2A%252Breceptor%252BPET%252Btracers%26aulast%3DHerth%26aufirst%3DMatthias%2BM.%26date%3D2015%26date%3D2015%26volume%3D58%26issue%3D7%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susann  SchrÃ¶der</span>, <span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Ute  Egerland</span>, <span class="hlFld-ContribAuthor ">Mathias  Kranz</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheunemann</span>, <span class="hlFld-ContribAuthor ">Norbert  HÃ¶fgen</span>, <span class="hlFld-ContribAuthor ">JÃ¶rg  Steinbach</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron  Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (6)
                                     , 9591-9615. <a href="https://doi.org/10.3390/molecules20069591" title="DOI URL">https://doi.org/10.3390/molecules20069591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20069591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20069591%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252B18F-Radiolabelling%252Band%252BBiological%252BCharacterization%252Bof%252BNovel%252BFluoroalkylated%252BTriazine%252BDerivatives%252Bfor%252Bin%252BVivo%252BImaging%252Bof%252BPhosphodiesterase%252B2A%252Bin%252BBrain%252Bvia%252BPositron%252BEmission%252BTomography%26aulast%3DSchr%25C3%25B6der%26aufirst%3DSusann%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D9591%26epage%3D9615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanne D.  Hansen</span>, <span class="hlFld-ContribAuthor ">Valdemar L.  Andersen</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Janus H.  Magnussen</span>, <span class="hlFld-ContribAuthor ">Agnete  Dyssegaard</span>, <span class="hlFld-ContribAuthor ">Nikolas  Stroth</span>, <span class="hlFld-ContribAuthor ">Jesper L.  Kristensen</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Labeling and preliminary in vivo evaluation of the 5-HT7 receptor selective agonist [11C]E-55888. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (9)
                                     , 1901-1904. <a href="https://doi.org/10.1016/j.bmcl.2015.03.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLabeling%252Band%252Bpreliminary%252Bin%252Bvivo%252Bevaluation%252Bof%252Bthe%252B5-HT7%252Breceptor%252Bselective%252Bagonist%252B%25255B11C%25255DE-55888%26aulast%3DHansen%26aufirst%3DHanne%2BD.%26date%3D2015%26volume%3D25%26issue%3D9%26spage%3D1901%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy B.  Durham</span>, <span class="hlFld-ContribAuthor ">Maria-Jesus  Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Target Engagement in Lead Generation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (5)
                                     , 998-1008. <a href="https://doi.org/10.1016/j.bmcl.2014.12.076" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.076%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTarget%252BEngagement%252Bin%252BLead%252BGeneration%26aulast%3DDurham%26aufirst%3DTimothy%2BB.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D998%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Bocan</span>, <span class="hlFld-ContribAuthor ">Rekha G.  Panchal</span>, <span class="hlFld-ContribAuthor ">Sina  Bavari</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of In Vivo Imaging in the Evaluation of the Pathophysiology of Viral and Bacterial Infections and in Development of Countermeasures to BSL3/4 Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 4-17. <a href="https://doi.org/10.1007/s11307-014-0759-7" title="DOI URL">https://doi.org/10.1007/s11307-014-0759-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-014-0759-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-014-0759-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DApplications%252Bof%252BIn%252BVivo%252BImaging%252Bin%252Bthe%252BEvaluation%252Bof%252Bthe%252BPathophysiology%252Bof%252BViral%252Band%252BBacterial%252BInfections%252Band%252Bin%252BDevelopment%252Bof%252BCountermeasures%252Bto%252BBSL3%25252F4%252BPathogens%26aulast%3DBocan%26aufirst%3DThomas%2BM.%26date%3D2015%26date%3D2014%26volume%3D17%26issue%3D1%26spage%3D4%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Techniques for Central Nervous System (CNS) Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 365-383. <a href="https://doi.org/10.1002/9781118788523.ch17" title="DOI URL">https://doi.org/10.1002/9781118788523.ch17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118788523.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118788523.ch17%26sid%3Dliteratum%253Aachs%26atitle%3DImaging%252BTechniques%252Bfor%252BCentral%252BNervous%252BSystem%252B%252528CNS%252529%252BDrug%252BDiscovery%26aulast%3DZhang%26aufirst%3DLei%26date%3D2015%26date%3D2015%26spage%3D365%26epage%3D383%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DBlood-Brain%252BBarrier%252Bin%252BDrug%252BDiscovery%26aulast%3DDi%26aufirst%3DLi%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariem  Brahim</span>, <span class="hlFld-ContribAuthor ">Imen  Smari</span>, <span class="hlFld-ContribAuthor ">Hamed  Ben Ammar</span>, <span class="hlFld-ContribAuthor ">Bechir  Ben Hassine</span>, <span class="hlFld-ContribAuthor ">Jean-FranÃ§ois  SoulÃ©</span>, <span class="hlFld-ContribAuthor ">Henri  Doucet</span>. </span><span class="cited-content_cbyCitation_article-title">Conditions for palladium-catalyzed direct arylations of 4-bromo and 4-iodo N-substituted pyrazoles without CâBr or CâI bond cleavage. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2015,</strong> <em>2 </em>
                                    (8)
                                     , 917-926. <a href="https://doi.org/10.1039/C5QO00093A" title="DOI URL">https://doi.org/10.1039/C5QO00093A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5QO00093A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5QO00093A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DConditions%252Bfor%252Bpalladium-catalyzed%252Bdirect%252Barylations%252Bof%252B4-bromo%252Band%252B4-iodo%252BN-substituted%252Bpyrazoles%252Bwithout%252BC%2525E2%252580%252593Br%252Bor%252BC%2525E2%252580%252593I%252Bbond%252Bcleavage%26aulast%3DBrahim%26aufirst%3DMariem%26date%3D2015%26date%3D2015%26volume%3D2%26issue%3D8%26spage%3D917%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Honer</span>, <span class="hlFld-ContribAuthor ">Luca  Gobbi</span>, <span class="hlFld-ContribAuthor ">Laurent  Martarello</span>, <span class="hlFld-ContribAuthor ">Robert A.  Comley</span>. </span><span class="cited-content_cbyCitation_article-title">Radioligand development for molecular imaging of the central nervous system with positron emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (12)
                                     , 1936-1944. <a href="https://doi.org/10.1016/j.drudis.2014.08.012" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.08.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.08.012%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRadioligand%252Bdevelopment%252Bfor%252Bmolecular%252Bimaging%252Bof%252Bthe%252Bcentral%252Bnervous%252Bsystem%252Bwith%252Bpositron%252Bemission%252Btomography%26aulast%3DHoner%26aufirst%3DMichael%26date%3D2014%26volume%3D19%26issue%3D12%26spage%3D1936%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus  FridÃ©n</span>, <span class="hlFld-ContribAuthor ">Marie  Wennerberg</span>, <span class="hlFld-ContribAuthor ">Madeleine  Antonsson</span>, <span class="hlFld-ContribAuthor ">Maria  Sandberg-StÃ¤ll</span>, <span class="hlFld-ContribAuthor ">Lars  Farde</span>, <span class="hlFld-ContribAuthor ">Magnus  Schou</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2014,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-014-0050-6" title="DOI URL">https://doi.org/10.1186/s13550-014-0050-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-014-0050-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-014-0050-6%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DIdentification%252Bof%252Bpositron%252Bemission%252Btomography%252B%252528PET%252529%252Btracer%252Bcandidates%252Bby%252Bprediction%252Bof%252Bthe%252Btarget-bound%252Bfraction%252Bin%252Bthe%252Bbrain%26aulast%3DFrid%25C3%25A9n%26aufirst%3DMarkus%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Elena  Drummond</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Julie  Cianfrogna</span>, <span class="hlFld-ContribAuthor ">Susan E.  Drozda</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Vanase-Frawley</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of [3H]PF-7191, a highly specific nociceptin opioid peptide (NOP) receptor radiotracer for in vivo receptor occupancy (RO) studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (22)
                                     , 5219-5223. <a href="https://doi.org/10.1016/j.bmcl.2014.09.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B%25255B3H%25255DPF-7191%25252C%252Ba%252Bhighly%252Bspecific%252Bnociceptin%252Bopioid%252Bpeptide%252B%252528NOP%252529%252Breceptor%252Bradiotracer%252Bfor%252Bin%252Bvivo%252Breceptor%252Boccupancy%252B%252528RO%252529%252Bstudies%26aulast%3DZhang%26aufirst%3DLei%26date%3D2014%26volume%3D24%26issue%3D22%26spage%3D5219%26epage%3D5223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">5-(4-((4-[18F]fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: A selective dual inhibitor for potential PET imaging of Trk/CSF-1R. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (20)
                                     , 4784-4790. <a href="https://doi.org/10.1016/j.bmcl.2014.09.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D5-%2525284-%252528%2525284-%25255B18F%25255Dfluorobenzyl%252529oxy%252529-3-methoxybenzyl%252529pyrimidine-2%25252C4-diamine%25253A%252BA%252Bselective%252Bdual%252Binhibitor%252Bfor%252Bpotential%252BPET%252Bimaging%252Bof%252BTrk%25252FCSF-1R%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2014%26volume%3D24%26issue%3D20%26spage%3D4784%26epage%3D4790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Kehler</span>, <span class="hlFld-ContribAuthor ">John Paul  Kilburn</span>, <span class="hlFld-ContribAuthor ">Sergio  Estrada</span>, <span class="hlFld-ContribAuthor ">SÃ¸ren Rahn  Christensen</span>, <span class="hlFld-ContribAuthor ">Anders  Wall</span>, <span class="hlFld-ContribAuthor ">Alf  Thibblin</span>, <span class="hlFld-ContribAuthor ">Mark  Lubberink</span>, <span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Lise TÃ¸ttrup  Brennum</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  Steiniger-Brach</span>, <span class="hlFld-ContribAuthor ">Claus Tornby  Christoffersen</span>, <span class="hlFld-ContribAuthor ">Stine  Timmermann</span>, <span class="hlFld-ContribAuthor ">Mads  Kreilgaard</span>, <span class="hlFld-ContribAuthor ">Gunnar  Antoni</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Jacob  Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of
              11
              C-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2014,</strong> <em>55 </em>
                                    (9)
                                     , 1513-1518. <a href="https://doi.org/10.2967/jnumed.114.140178" title="DOI URL">https://doi.org/10.2967/jnumed.114.140178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.114.140178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.114.140178%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252B11%252BC-Lu%252BAE92686%252Bas%252Ba%252BRadioligand%252Bfor%252BPET%252BImaging%252Bof%252BPhosphodiesterase10A%252Bin%252Bthe%252BBrain%26aulast%3DKehler%26aufirst%3DJan%26date%3D2014%26date%3D2014%26volume%3D55%26issue%3D9%26spage%3D1513%26epage%3D1518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm400312y&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm400312y%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=111&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="âtrueâ" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CNS PET Ligand Database: target type distribution of validated CNS PET ligands (âYesâ category, <i>N</i> = 62) and negative controls (âNoâ category, <i>N</i> = 15).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CNS MPO and CNS PET MPO comparison of validated CNS PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Distribution of calculated physicochemical properties, ClogD, ClogP, and TPSA, for validated PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of RRCK <i>P</i><sub>app</sub> AB and MDR1 BA/AB properties of validated CNS PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis of fractions unbound in brain (Fu_b) and fractions unbound in plasma of validated PET ligands (âYesâ category) and negative controls (âNoâ category).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. CNS PET MPO scores versus alignment of in vitro ADME properties for CNS PET ligands and a broader compound set. (A) PET ligand set. (B) Broad Pfizer compound set.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Preferred design and selection parameters for novel CNS PET ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Alignment of the proposed set of criteria with 10 high-performing CNS PET ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Data mining process for the identification of PDE2A PET leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Six PET-Specific PDE2A Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, EtOH/water, reflux; (b) 1,2,4-triazole, POCl<sub>3</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, then Et<sub>3</sub>N, <b>10</b>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of [<sup>18</sup>F]<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, 4-trifluoromethylphenyl boronic acid, K<sub>3</sub>PO<sub>4</sub>, EtOH/water, reflux, 40%; (b) 1,2,4-triazole, POCl<sub>3</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, then Et<sub>3</sub>N, 4-hydroxyazetidine hydrochloride salt, CH<sub>2</sub>Cl<sub>2</sub>, 87%; (c) TsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 57%; (d) TBA[<sup>18</sup>F], <i>t</i>-amyl alcohol, 110 Â°C, 30 min, 99.5% radiochemical purity, 540 Â± 152 GBq/Î¼mol (14592 Â± 4095 Ci/mmol) specific activity.</p></p></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/medium/jm-2013-00312y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Representative baseline timeâactivity curves (TACs) from [<sup>18</sup>F]<b>5</b> in cynomolgus monkeys. (b) Representative baseline standard uptake value (SUV) images in transverse and coronal views, summed between 0 and 60 min of PET imaging.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400312y/production/images/large/jm-2013-00312y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400312y&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Phelps, M. E.</span><span> </span><span class="NLM_article-title">PET: The Merging of Biology and Imaging into Molecular Imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=10768568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ivFSmtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=661-681&author=M.+E.+Phelps&title=PET%3A+The+Merging+of+Biology+and+Imaging+into+Molecular+Imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">PET: the merging of biology and imaging into molecular imaging</span></div><div class="casAuthors">Phelps M E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">661-81</span>
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    </div><div class="casAbstract">PET and SPECT are molecular imaging techniques that use radiolabeled molecules to image molecular interactions of biological processes in vivo.  PET imaging technologies have been developed to provide a pathway to the patient from the experimental paradigms of biological and pharmaceutical sciences in genetically engineered and tissue transplanted mouse models of disease.  PET provides a novel way for molecular therapies and molecular diagnostics to come together in the discovery of molecules that can be used in low mass amounts to image the function of a target and, by elevating the mass, to pharmacologically modify the function of the target.  In both cases, the molecules are the same or analogs of each other.  PET can be used to titrate drugs to their sites of action within organ systems in vivo and to assay biological outcomes of the processes being modified in the mouse and the patient.  The goal is to provide a novel way to improve the rates of discovery and approval of radiopharmaceuticals and pharmaceuticals.  Extending this relationship into clinical practice can improve drug use by providing molecular diagnostics in concert with molecular therapeutics.  Diseases are biological processes, and molecular imaging with PET is sensitive and informative to these processes.  This sensitivity is exemplified by the detection of disease with PET without evidence of anatomic changes on CT and MRI.  These biological changes are seen early in the course of disease, even in asymptomatic stages, as illustrated by the metabolic abnormalities detected with PET and FDG in Huntington's and familial Alzheimer's diseases 7 and 5 y, respectively, before symptoms appear.  Differentiation of viable from nonviable tissue is fundamentally a metabolic question, as shown by the use of PET to differentiate patients with coronary artery disease who will benefit from revascularization from those who will not.  Although beginning within a specific organ, cancer is a systemic disease the most devastating consequences of which result from metastases.  Whole-body PET imaging with FDG enables inspection of glucose metabolism in all organ systems in a single examination to improve the detection and staging of cancer, selection of therapy, and assessment of therapeutic response.  In lung and colorectal cancers, melanoma, and lymphoma, PET FDG improves the accuracy of detection and staging from 8% to 43% over conventional work-ups and results in treatment changes in 20%-40% of the patients, depending on the clinical question.  Approximately 65% are upstaged because unsuspected metastases are detected, and 35% are downstaged because a structural diagnosis of lesions is changed from malignant to benign.  Similar results are now being shown for other cancers.  The main difference between CT, sonography, MRI, and PET or SPECT is not technologic but, rather, a difference between detecting and characterizing a disease by its anatomic features as opposed to its biology.  The importance and success of developing new molecular imaging probes is increasing as PET becomes integral to the study of the integrative mammalian biology of disease and as molecular therapies targeting the biological processes of disease are developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTWLVzWjiD60loaUqgkFHkfW6udTcc2eZLwIyXKhgvm7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ivFSmtw%253D%253D&md5=6fb5310a58e1432756db8fa0a37546ed</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26atitle%3DPET%253A%2520The%2520Merging%2520of%2520Biology%2520and%2520Imaging%2520into%2520Molecular%2520Imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D41%26spage%3D661%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Molecular Imaging with PET</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">â</span> <span class="NLM_lpage">1516</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0782426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFShtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1501-1516&author=S.+M.+Ametameyauthor=M.+Honerauthor=P.+A.+Schubiger&title=Molecular+Imaging+with+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Imaging with PET</span></div><div class="casAuthors">Ametamey, Simon M.; Honer, Michael; Schubiger, Pius August</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1501-1516</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgtMhO_aTjrVg90H21EOLACvtfcHk0lj6WT3deW6KQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFShtL0%253D&md5=513a2a8c8779c207122a8c23586fd016</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Fcr0782426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0782426%26sid%3Dliteratum%253Aachs%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DMolecular%2520Imaging%2520with%2520PET%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1501%26epage%3D1516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morgan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Graaf, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltner, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, S. D. A.</span><span> </span><span class="NLM_article-title">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">â</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2Fj.drudis.2011.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=22227532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=419-424&author=P.+Morganauthor=P.+H.+Van+Der+Graafauthor=J.+Arrowsmithauthor=D.+E.+Feltnerauthor=K.+S.+Drummondauthor=C.+D.+Wegnerauthor=S.+D.+A.+Street&title=Can+the+flow+of+medicines+be+improved%3F+Fundamental+pharmacokinetic+and+pharmacological+principles+toward+improving+phase+II+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival</span></div><div class="casAuthors">Morgan, Paul; Van Der Graaf, Piet H.; Arrowsmith, John; Feltner, Doug E.; Drummond, Kira S.; Wegner, Craig D.; Street, Steve D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">419-424</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In an effort to uncover systematic learnings that can be applied to improve compd. survival, an anal. was performed on data from Phase II decisions for 44 programs at Pfizer.  It was found that not only were the majority of failures caused by lack of efficacy but also that, in a large no. of cases (43%), it was not possible to conclude whether the mechanism had been tested adequately.  A key finding was that an integrated understanding of the fundamental pharmacokinetic/pharmacodynamic principles of exposure at the site of action, target binding and expression of functional pharmacol. activity (termed together as the three Pillars of survival') all det. the likelihood of candidate survival in Phase II trials and improve the chance of progression to Phase III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFyWWmU_ARMLVg90H21EOLACvtfcHk0lj6WT3deW6KQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D&md5=18816036124edb3d50c4e063fdc40614</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DVan%2BDer%2BGraaf%26aufirst%3DP.%2BH.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DFeltner%26aufirst%3DD.%2BE.%26aulast%3DDrummond%26aufirst%3DK.%2BS.%26aulast%3DWegner%26aufirst%3DC.%2BD.%26aulast%3DStreet%26aufirst%3DS.%2BD.%2BA.%26atitle%3DCan%2520the%2520flow%2520of%2520medicines%2520be%2520improved%253F%2520Fundamental%2520pharmacokinetic%2520and%2520pharmacological%2520principles%2520toward%2520improving%2520phase%2520II%2520survival%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D419%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Frank, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LÃ¥ngstrÃ¶m, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agdeppa, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendizabal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderheyden, J.-L.</span><span> </span><span class="NLM_article-title">The imaging continuum: bench to biomarkers to diagnostics</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">â</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1002%2Fjlcr.1444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jsL%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=746-769&author=R.+A.+Frankauthor=B.+L%C3%A5ngstr%C3%B6mauthor=G.+Antoniauthor=M.+C.+Montaltoauthor=E.+D.+Agdeppaauthor=M.+Mendizabalauthor=I.+A.+Wilsonauthor=J.-L.+Vanderheyden&title=The+imaging+continuum%3A+bench+to+biomarkers+to+diagnostics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The imaging continuum: bench to biomarkers to diagnostics</span></div><div class="casAuthors">Frank, Richard A.; Longstrom, Bengt; Antoni, Gunnar; Montalto, Michael C.; Agdeppa, Eric D.; Mendizabal, Marivi; Wilson, Ian A.; Vanderheyden, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">746-769</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Innovation in basic and applied science has brought radiotracers to fruition as diagnostics.  Non-invasive, longitudinal, and quantifiable mol. imaging is the key to diagnosing and monitoring numerous illnesses, with more to come from characterization of the clin. relevance of findings from genomics research.  Radiotracers enable real-time in vivo studies of the effects of drug candidates on receptors, pathways, pharmacodynamics, and clin. relevant endpoints, thereby providing both early detection of pathophysiol. to enable early intervention, and then monitoring of treatment responses to enable individualization of treatment regimens.  We review developments which have translated imaging from 'bench to bedside', or 'biomarkers to diagnostics'.  Notable developments include (1) synthesis methods for rapid 11C labeling of biomols. to high specific radioactivity; (2) ligand-binding assays for screening mol. imaging agents rather than drugs; (3) in vivo imaging of radiotracers in animals; (4) discovering the imaging advantages of 99mTc, 11C, and 18F; (5) co-registration and automated quant. assessment of high spatial resoln. CT and MR images with mol. images from PET for longitudinal studies of treatment effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpX1uF1bzrvbVg90H21EOLACvtfcHk0lj6WT3deW6KQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jsL%252FM&md5=e867959e4c1b01b60d78adc0f551c30d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1444%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DR.%2BA.%26aulast%3DL%25C3%25A5ngstr%25C3%25B6m%26aufirst%3DB.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DMontalto%26aufirst%3DM.%2BC.%26aulast%3DAgdeppa%26aufirst%3DE.%2BD.%26aulast%3DMendizabal%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DVanderheyden%26aufirst%3DJ.-L.%26atitle%3DThe%2520imaging%2520continuum%253A%2520bench%2520to%2520biomarkers%2520to%2520diagnostics%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2007%26volume%3D50%26spage%3D746%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a mini-review</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">â</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+mini-review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0lhEHVVYp7AZtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520mini-review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. Y.</span><span> </span><span class="NLM_article-title">Positron emission tomography: imaging and quantification of neurotransporter availability</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2FS1046-2023%2802%2900085-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=12183117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtFWhs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=287-299&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Y.+Huang&title=Positron+emission+tomography%3A+imaging+and+quantification+of+neurotransporter+availability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography: imaging and quantification of neurotransporter availability</span></div><div class="casAuthors">Laruelle, Marc; Slifstein, Mark; Huang, Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">287-299</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review.  Over the last decade, a large no. of radiotracers have been developed to image and quantify transporter availability with positron emission tomog. (PET) or single-photon emission computed tomog. (SPECT).  Radiotracers suitable to image dopamine transporters (DATs) and serotonin transporters (SERTs) have been the object of most efforts.  Following a brief overview of DAT and SERT radiotracers that have been demonstrated to be suitable for quant. anal. in vivo, this article describes the principal methods that have been used for the anal. of these data.  Kinetic modeling is the most direct implementation of the compartment models, but with some tracers accurate input function measurement and good compartment configuration identification can be difficult to obtain.  Other methods were designed to overcome some particular vulnerability to error of classic kinetic modeling, but introduced new vulnerabilities in the process.  Ref. region methods obviate the need for arterial plasma measurement, but are not as robust to violations of the underlying modeling assumptions as methods using the arterial input function.  Graphical methods give ests. of distribution vols. without the requirement of compartment model specification, but provide a biased estimator in the presence of statistical noise.  True equil. methods are quite robust, but their use is limited to expts. with tracers that are suitable for const. infusion.  In conclusion, no universally "best" method is applicable to all neurotransporter imaging studies, and careful evaluation of model-based methods is required for each radiotracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3jdsXbliaMLVg90H21EOLACvtfcHk0lhEHVVYp7AZtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtFWhs74%253D&md5=1ec923e982f1769d80fd74b68d7b05ed</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1046-2023%2802%2900085-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-2023%252802%252900085-3%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%2BY.%26atitle%3DPositron%2520emission%2520tomography%253A%2520imaging%2520and%2520quantification%2520of%2520neurotransporter%2520availability%26jtitle%3DMethods%26date%3D2002%26volume%3D27%26spage%3D287%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">â</span> <span class="NLM_lpage">572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2FS0969-8051%2801%2900211-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=11516700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVGrtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=561-572&author=J.+S.+Fowlerauthor=N.+D.+Volkowauthor=G.-J.+Wangauthor=S.+J.+Gatleyauthor=J.+Logan&title=%5B11C%5DCocaine%3A+PET+studies+of+cocaine+pharmacokinetics%2C+dopamine+transporter+availability+and+dopamine+transporter+occupancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">[11C]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy</span></div><div class="casAuthors">Fowler, J. S.; Volkow, N. D.; Wang, G.-J.; Gatley, S. J.; Logan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-572</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Cocaine was initially labeled with carbon-11 in order to track the distribution and pharmacokinetics of this powerful stimulant and drug of abuse in the human brain and body.  It was soon discovered that [11C]cocaine was not only useful for measuring cocaine pharmacokinetics and its relationship to behavior but that it is also a sensitive radiotracer for dopamine transporter (DAT) availability.  Measures of DAT availability were facilitated by the development of a graphical anal. method (Logan Plot) for reversible systems which streamlined kinetic anal.  This expanded the applications of [11C]cocaine to studies of DAT availability in the human brain and allowed the first comparative measures of the degree of DAT occupancy by cocaine and another stimulant drug methylphenidate.  This article will summarize preclin. and clin. research with [11C]cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQaCi9sqkBwrVg90H21EOLACvtfcHk0lixI4lpmeA61Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVGrtrw%253D&md5=a8fcb29ec74058ddf5dfa72a8395c8a2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900211-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900211-6%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.-J.%26aulast%3DGatley%26aufirst%3DS.%2BJ.%26aulast%3DLogan%26aufirst%3DJ.%26atitle%3D%255B11C%255DCocaine%253A%2520PET%2520studies%2520of%2520cocaine%2520pharmacokinetics%252C%2520dopamine%2520transporter%2520availability%2520and%2520dopamine%2520transporter%2520occupancy%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D561%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the bloodâbrain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood%E2%80%93brain+barrier+and+surviving+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">â</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+to+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score â¥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lixI4lpmeA61Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cunningham, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">PET studies in drug development: methodological considerations</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=311-315&author=V.+J.+Cunninghamauthor=C.+A.+Parkerauthor=E.+A.+Rabinerauthor=A.+D.+Geeauthor=R.+N.+Gunn&title=PET+studies+in+drug+development%3A+methodological+considerations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DV.%2BJ.%26aulast%3DParker%26aufirst%3DC.%2BA.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGee%26aufirst%3DA.%2BD.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DPET%2520studies%2520in%2520drug%2520development%253A%2520methodological%2520considerations%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2005%26volume%3D2%26spage%3D311%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camenisch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chretien, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raevsky, O. A.</span><span> </span><span class="NLM_article-title">Estimation of BloodâBrain Barrier Crossing of Drugs Using Molecular Size and Shape, and H-Bonding Descriptors</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">â</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.3109%2F10611869808997889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=9886238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=151-165&author=H.+Van+de+Waterbeemdauthor=G.+Camenischauthor=G.+Folkersauthor=J.+R.+Chretienauthor=O.+A.+Raevsky&title=Estimation+of+Blood%E2%80%93Brain+Barrier+Crossing+of+Drugs+Using+Molecular+Size+and+Shape%2C+and+H-Bonding+Descriptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span></div><div class="casAuthors">Van de Waterbeemd, Han; Camenisch, Gian; Folkers, Gerd; Chretien, Jacques R.; Raevsky, Oleg A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-165</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The influence of physicochem. properties, including lipophilicity, H-bonding capacity and mol. size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs.  It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential.  A combination of a H-bonding and a mol. size descriptor, i.e., the major components of lipophilicity and permeability, avoiding knowledge of distribution coeffs., is proposed to est. brain penetration potential of new drug candidates.  Previously reported exptl. surface activity data appear to be strongly correlated to mol. size of the drug compds.  Present anal. offers a modern basis for property-based design and targeting of CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0yCKmlzsa37Vg90H21EOLACvtfcHk0liyTo8wuEXu9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D&md5=9106ff6aa0755ff76fd0634822857d4a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3109%2F10611869808997889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611869808997889%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DChretien%26aufirst%3DJ.%2BR.%26aulast%3DRaevsky%26aufirst%3DO.%2BA.%26atitle%3DEstimation%2520of%2520Blood%25E2%2580%2593Brain%2520Barrier%2520Crossing%2520of%2520Drugs%2520Using%2520Molecular%2520Size%2520and%2520Shape%252C%2520and%2520H-Bonding%2520Descriptors%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D1998%26volume%3D6%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briard, E.</span><span> </span><span class="NLM_article-title">A rapid vesicle electrokinetic chromatography method for the in vitro prediction of non-specific binding for potential PET ligands</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">â</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2Fj.jpba.2010.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=21126842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2mtrrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=722-729&author=Z.+Jiangauthor=J.+Reillyauthor=B.+Everattauthor=E.+Briard&title=A+rapid+vesicle+electrokinetic+chromatography+method+for+the+in+vitro+prediction+of+non-specific+binding+for+potential+PET+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid vesicle electrokinetic chromatography method for the in vitro prediction of non-specific binding for potential PET ligands</span></div><div class="casAuthors">Jiang, Zhengjin; Reilly, John; Everatt, Brian; Briard, Emmanuelle</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">722-729</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High non-specific binding (NSB) is one of the most common reasons for candidate failure in potential positron emission tomog. (PET) radiotracer development.  It is of interest to develop high throughput in vitro methods for predicting non-specific binding prior to radiolabeling, which would help guide radiotracer candidate selection and assist decision making in new radiotracer discovery.  We evaluated several electrokinetic chromatog. (EKC) systems to help identify PET ligands with low non-specific binding characteristics by mimicking the ligand-brain tissue interaction.  The measured retention factors of tracers in clin. use or terminated candidates within AOT vesicle EKC systems were compared with literature in vitro or in vivo NSB data.  We conclude that there is a statistical correlation between the chromatog. retention parameters of tested drugs and their NSB.  The AOT vesicle EKC method can provide NSB in vitro trend anal. for a large no. of drug candidates early in the novel radiotracer discovery process with minimal resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphoegUxlpyHrVg90H21EOLACvtfcHk0lgU6jEStcqBrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2mtrrO&md5=dd95312fc52995ed2233f2d9ccf7012a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2010.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2010.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DEveratt%26aufirst%3DB.%26aulast%3DBriard%26aufirst%3DE.%26atitle%3DA%2520rapid%2520vesicle%2520electrokinetic%2520chromatography%2520method%2520for%2520the%2520in%2520vitro%2520prediction%2520of%2520non-specific%2520binding%2520for%2520potential%2520PET%2520ligands%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2011%26volume%3D54%26spage%3D722%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R. E.</span><span> </span><span class="NLM_article-title">An In Vitro Assay for Predicting Successful Imaging Radiotracers</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1016%2FS1536-1632%2803%2900041-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=14499146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A280%3ADC%252BD3svktFGmsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=65-71&author=S.+Patelauthor=T.+Hamillauthor=E.+Hostetlerauthor=H.+D.+Burnsauthor=R.+E.+Gibson&title=An+In+Vitro+Assay+for+Predicting+Successful+Imaging+Radiotracers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro assay for predicting successful imaging radiotracers</span></div><div class="casAuthors">Patel Shil; Hamill Terence; Hostetler Eric; Burns H Donald; Gibson Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">PURPOSE:  To develop an in vitro binding assay able to predict whether a radiolabel is likely to be a useful clinical tracer for positron emission tomography (PET).  PROCEDURES:  Rodent and rhesus brain sections were incubated with radioligands, most of which are tritiated or iodinated versions of known clinical PET radiotracers, and assayed for binding to brain receptors for a 20-minute period using a no-wash protocol (n=>/=3).  RESULTS:  Radiolabeled flumazenil (RO-151788), WAY100635, N-methylscopolamine, N-methylspiperone, raclopride, citalopram, (1-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI), paroxetine, and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-flurobenzamido]ethyl]piperazine (MPPF) were assessed for binding to either rhesus caudate putamen, and/or frontal cortex, or rat whole brain sections.  Specific binding for these compounds ranged from 0 to 94% by 20 minutes.  Those with %-specific binding less than 10% have also been shown to not be effective as in vivo PET radiotracers.  In addition, successful PET radiotracers incubated in tissue sections with target receptor either absent or present in low density behaved poorly in this assay, as expected, as did radiolabels previously shown to possess high non-specific binding.  CONCLUSIONS:  An in vitro binding assay using rodent and rhesus brain sections has been developed that, within the currently assayed radiotracers, is able to rapidly predict whether a radiolabeled compound is a useful clinical PET radiotracer.  This method suggests significant potential for the rapid in vitro evaluation of potential in vivo PET radiotracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxu1swsKtr4AMthz5_Rx5rfW6udTcc2eaQuHaIJ5pzOrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svktFGmsQ%253D%253D&md5=4fe5e7e7ebdd730cad9a149782f7b0eb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1536-1632%2803%2900041-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1536-1632%252803%252900041-6%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DHamill%26aufirst%3DT.%26aulast%3DHostetler%26aufirst%3DE.%26aulast%3DBurns%26aufirst%3DH.%2BD.%26aulast%3DGibson%26aufirst%3DR.%2BE.%26atitle%3DAn%2520In%2520Vitro%2520Assay%2520for%2520Predicting%2520Successful%2520Imaging%2520Radiotracers%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosso, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, I. R.</span><span> </span><span class="NLM_article-title">Ab initio Computational Study of Positron Emission Tomography Ligands Interacting with Lipid Molecule for the Prediction of Nonspecific Binding</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">â</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=2397-2405&author=L.+Rossoauthor=A.+D.+Geeauthor=I.+R.+Gould&title=Ab+initio+Computational+Study+of+Positron+Emission+Tomography+Ligands+Interacting+with+Lipid+Molecule+for+the+Prediction+of+Nonspecific+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosso%26aufirst%3DL.%26aulast%3DGee%26aufirst%3DA.%2BD.%26aulast%3DGould%26aufirst%3DI.%2BR.%26atitle%3DAb%2520initio%2520Computational%2520Study%2520of%2520Positron%2520Emission%2520Tomography%2520Ligands%2520Interacting%2520with%2520Lipid%2520Molecule%2520for%2520the%2520Prediction%2520of%2520Nonspecific%2520Binding%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2008%26volume%3D29%26spage%3D2397%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1715</span><span class="NLM_x">â</span> <span class="NLM_lpage">1723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1715-1723&author=Q.+Guoauthor=M.+Bradyauthor=R.+N.+Gunn&title=A+Biomathematical+Modeling+Approach+to+Central+Nervous+System+Radioligand+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DBrady%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DA%2520Biomathematical%2520Modeling%2520Approach%2520to%2520Central%2520Nervous%2520System%2520Radioligand%2520Discovery%2520and%2520Development%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D1715%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">For selection of the negative control compounds and their references, please see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Applications to the Prediction of Drug Transport Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">â</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+Calculation+of+Molecular+Polar+Surface+Area+as+a+Sum+of+Fragment-Based+Contributions+and+Its+Applications+to+the+Prediction+of+Drug+Transport+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520Calculation%2520of%2520Molecular%2520Polar%2520Surface%2520Area%2520as%2520a%2520Sum%2520of%2520Fragment-Based%2520Contributions%2520and%2520Its%2520Applications%2520to%2520the%2520Prediction%2520of%2520Drug%2520Transport%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">This modified version of the CNS MPO tool, derived from analysis of marketed CNS drugs, was named as CNS PET MPO to reflect its utility in PET ligand design and prioritization. A CNS PET MPO calculator is included as part of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">â</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljupN5F2YM2oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Whalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J.</span><span> </span><span class="NLM_article-title">A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">â</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1002%2Frcm.2469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=16628559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1497-1503&author=K.+Whalenauthor=J.+Gobeyauthor=J.+Janiszewski&title=A+centralized+approach+to+tandem+mass+spectrometry+method+development+for+high-throughput+ADME+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening</span></div><div class="casAuthors">Whalen, Kevin; Gobey, Jason; Janiszewski, John</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1497-1503</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A centralized approach to acquisition and dissemination of tandem mass spectrometry (MS/MS) conditions within an ADME-screening bioanal. mass spectrometry group was developed.  The method development process uses 2 automated software products (Autoscan and Automaton) specifically designed for mass spectrometers manufd. by MDS Sciex.  Both provide the ability to quickly det. selected reaction monitoring (SRM) transitions for hundreds of compds. per day.  Autoscan dets. optimal polarity and collision energy (CE).  Automaton also dets. the optimal declustering potential (DP) as well as the CE.  The resulting optimized conditions are loaded into a central database for access by LC/MS/MS bioanal. workstations in the group.  The effect of DP and CE on the sensitivity was studied.  Optimization of DP improved signal response â¼27% on av.  For â¼10% of compds., signal enhancement was >50% compared to the generic setting.  A generic setting of DP = 25 V can be used for the majority of ADME-screening applications.  Optimization of CE can have a much larger impact on signal intensity and a min. of 3 CE settings should be tested.  CE values of 1, 30 and 45 V provide adequate coverage for most small mol. drug discovery analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYhEOAvOWB7Vg90H21EOLACvtfcHk0ljupN5F2YM2oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D&md5=6e57b4b490527b98931bc58aa871d48c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Frcm.2469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.2469%26sid%3Dliteratum%253Aachs%26aulast%3DWhalen%26aufirst%3DK.%26aulast%3DGobey%26aufirst%3DJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%26atitle%3DA%2520centralized%2520approach%2520to%2520tandem%2520mass%2520spectrometry%2520method%2520development%2520for%2520high-throughput%2520ADME%2520screening%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2006%26volume%3D20%26spage%3D1497%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">RRCK cells were generated in-house (Pfizer Inc., Groton, CT, USA) as a subclone of MardinâDarby canine kidney wild-type (MDCK-WT) cells that displayed low expression of endogenous P-gp (approximately 1â2% of MDCK-WT cells, based on mRNA level). For detailed information, see:</p></div><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPerle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, G. G.</span><span> </span><span class="NLM_article-title">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1111%2Fj.1365-2125.2011.03961.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=21392072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2011&pages=235-246&author=E.+Callegariauthor=B.+Malhotraauthor=P.+J.+Bungayauthor=R.+Websterauthor=K.+S.+Fennerauthor=S.+Kempshallauthor=J.+L.+LaPerleauthor=M.+C.+Michelauthor=G.+G.+Kay&title=A+comprehensive+non-clinical+evaluation+of+the+CNS+penetration+potential+of+antimuscarinic+agents+for+the+treatment+of+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder</span></div><div class="casAuthors">Callegari, Ernesto; Malhotra, Bimal; Bungay, Peter J.; Webster, Rob; Fenner, Katherine S.; Kempshall, Sarah; LaPerle, Jennifer L.; Michel, Martin C.; Kay, Gary G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-246</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS: To assess and compare the mechanisms of central nervous system (CNS) penetration of antimuscarinic overactive bladder (OAB) agents.  METHODS: Phys. properties were computed or compiled from the literature.  Rats were administered 5-hydroxymethyl tolterodine (HMT), darifenacin, oxybutynin, solifenacin, tolterodine or trospium s.c.  At 1 h postdose, plasma, brain and cerebrospinal fluid (CSF) concns. were detd. using LC-MS/MS assays.  Brain and plasma protein binding were detd. in vitro.  Permeability in the presence and absence of the efflux transporter P-glycoprotein (P-gp) was assessed in RRCK and MDCK-MDR1 transwell assays.  RESULTS: Oxybutynin displayed extensive CNS penetration, with brain: plasma ratios (B:P), unbound brain:unbound plasma ratios (Kp,free) and CSF:free plasma ratios each >1.  Tolterodine (B:P = 2.95, Kp,free = 0.23 and CSF:free plasma = 0.16) and solifenacin (B:P = 3.04, Kp,free = 0.28 and CSF:free plasma = 1.41) showed significant CNS penetration but with some restriction from CNS as indicated by Kp,free values significantly <1.5-HMT, darifenacin and trospium displayed much lower B:P (0.03-0.16), Kp,free (0.01-0.04) and CSF:free plasma (0.004-0.06), consistent with poor CNS penetration.  Permeability in RRCK cells was low for trospium (0.63 Ã 10-6 cm s-1), moderate for 5-HMT (11.7 Ã 10-6 cm s-1) and high for darifenacin, solifenacin, tolterodine and oxybutynin (21.5-38.2 Ã 10-6 cm s-1).  In MDCK-MDR1 cells 5-HMT, darifenacin and trospium, were P-gp substrates, whereas oxybutynin, solifenacin and tolterodine were not P-gp substrates.  CONCLUSIONS: Brain penetration was low for antimuscarinics that are P-gp substrates (5-HMT, darifenacin and trospium), and significant for those that are not P-gp substrates (oxybutynin, solifenacin and tolterodine).  CNS adverse events reported in randomized controlled clin. trials show general alignment with the preclin. data described in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9FelRyq-h7Vg90H21EOLACvtfcHk0ljupN5F2YM2oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2qtrrM&md5=dbd56eb7943853a1f58f9d56d92316bb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.03961.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.03961.x%26sid%3Dliteratum%253Aachs%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DMalhotra%26aufirst%3DB.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DFenner%26aufirst%3DK.%2BS.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DLaPerle%26aufirst%3DJ.%2BL.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DKay%26aufirst%3DG.%2BG.%26atitle%3DA%2520comprehensive%2520non-clinical%2520evaluation%2520of%2520the%2520CNS%2520penetration%2520potential%2520of%2520antimuscarinic%2520agents%2520for%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D72%26spage%3D235%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+Vitro+P-glycoprotein+Assays+to+Predict+the+in+Vivo+Interactions+of+P-glycoprotein+with+Drugs+in+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lhoSJVkbW1geQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520Vitro%2520P-glycoprotein%2520Assays%2520to%2520Predict%2520the%2520in%2520Vivo%2520Interactions%2520of%2520P-glycoprotein%2520with%2520Drugs%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species Independence in Brain Tissue Binding Using Brain Homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">â</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+Independence+in+Brain+Tissue+Binding+Using+Brain+Homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lhoSJVkbW1geQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520Independence%2520in%2520Brain%2520Tissue%2520Binding%2520Using%2520Brain%2520Homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Keefer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span> </span><span class="NLM_article-title">An interpretable probability-based confidence metric for continuous QSAR models</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">â</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci300554t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=368-383&author=C.+E.+Keeferauthor=G.+W.+Kauffmanauthor=R.+Gupta&title=An+interpretable+probability-based+confidence+metric+for+continuous+QSAR+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Interpretable, Probability-Based Confidence Metric for Continuous Quantitative Structure-Activity Relationship Models</span></div><div class="casAuthors">Keefer, Christopher E.; Kauffman, Gregory W.; Gupta, Rishi Raj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A great deal of research has gone into the development of robust confidence in prediction and applicability domain (AD) measures for quant. structure-activity relationship (QSAR) models in recent years.  Much of the attention has historically focused on structural similarity, which can be defined in many forms and flavors.  A concept that is frequently overlooked in the realm of the QSAR applicability domain is how the local activity landscape plays a role in how accurate a prediction is or is not.  In this work, we describe an approach that pairs information about both the chem. similarity and activity landscape of a test compd.'s neighborhood into a single calcd. confidence value.  We also present an approach for converting this value into an interpretable confidence metric that has a simple and informative meaning across data sets.  The approach will be introduced to the reader in the context of models built upon four diverse literature data sets.  The steps we will outline include the definition of similarity used to det. nearest neighbors (NN), how we incorporate the NN activity landscape with a similarity-weighted root-mean-square distance (wRMSD) value, and how that value is then calibrated to generate an intuitive confidence metric for prospective application.  Finally, we will illustrate the prospective performance of the approach on five proprietary models whose predictions and confidence metrics have been tracked for more than a year.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqvcorWVQ5O7Vg90H21EOLACvtfcHk0lhoSJVkbW1geQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D&md5=14d2b7d42f91b5e4e90fa53b6266a178</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fci300554t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300554t%26sid%3Dliteratum%253Aachs%26aulast%3DKeefer%26aufirst%3DC.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DGupta%26aufirst%3DR.%26atitle%3DAn%2520interpretable%2520probability-based%2520confidence%2520metric%2520for%2520continuous%2520QSAR%2520models%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D368%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">In silico model-derived ADME values were employed in the analysis, except for compounds that were part of the Pfizer compound collection (21 of the 62 ligands in the âYesâ category and 5 of the 15 ligands in the âNoâ category), in which case experimentally measured values were used. Information on the origin of data for specific compounds can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cella, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhouse, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fray, A. E.</span><span> </span><span class="NLM_article-title">A novel method for the assessment of potential PET ligands using an in vitro assay of non-specific binding</span> <span class="citation_source-journal">FENS Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">A059.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=A059.4&author=C.+V.+Cellaauthor=S.+M.+Woodhouseauthor=R.+A.+Lewisauthor=A.+E.+Fray&title=A+novel+method+for+the+assessment+of+potential+PET+ligands+using+an+in+vitro+assay+of+non-specific+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCella%26aufirst%3DC.%2BV.%26aulast%3DWoodhouse%26aufirst%3DS.%2BM.%26aulast%3DLewis%26aufirst%3DR.%2BA.%26aulast%3DFray%26aufirst%3DA.%2BE.%26atitle%3DA%2520novel%2520method%2520for%2520the%2520assessment%2520of%2520potential%2520PET%2520ligands%2520using%2520an%2520in%2520vitro%2520assay%2520of%2520non-specific%2520binding%26jtitle%3DFENS%2520Abstr.%26date%3D2004%26volume%3D2%26spage%3DA059.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">The top 10 performing PET ligands were selected by Pfizerâs PET imaging group, who was blinded to our analysis, based on their experience and literature understanding of PET ligands frequency of use, acceptance in the field, robust test-retest reliability results, and good properties for quantification. Representative references for the 10 high performing CNS PET ligands include:</p></div><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">[<sup>11</sup>C]Raclopride:</p></div><span class="NLM_contrib-group">Ribeiro, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LiÃ¨vre, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottlaender, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gervais, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DollÃ©, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syrota, A.</span><span> </span><span class="NLM_article-title">Biodistribution and radiation dosimetry of [<sup>11</sup>C]raclopride in healthy volunteers</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">â</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1007%2Fs00259-005-1783-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=15841376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A280%3ADC%252BD2MrnslWquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=952-958&author=M.-J.+Ribeiroauthor=M.+Ricardauthor=S.+Bourgeoisauthor=M.-A.+Li%C3%A8vreauthor=M.+Bottlaenderauthor=P.+Gervaisauthor=F.+Doll%C3%A9author=A.+Syrota&title=Biodistribution+and+radiation+dosimetry+of+%5B11C%5Draclopride+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers</span></div><div class="casAuthors">Ribeiro Maria-Joao; Ricard Marcel; Bourgeois Sandrine; Lievre Marie-Angele; Bottlaender Michel; Gervais Philippe; Dolle Frederic; Syrota Andre</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">952-8</span>
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    </div><div class="casAbstract">PURPOSE:  This study reports on the whole-body biodistribution and radiation dosimetry of [11C]raclopride, a dopamine D2 receptor antagonist.  METHODS:  In three healthy male volunteers, whole-body scans were performed up to 2 h following i.v. injection of 320+/-65 MBq [11C]raclopride.  Transmission scans (3 min per step, eight or nine steps according to the height of the subject) in 2D mode were used for subsequent attenuation correction of emission scans.  Emission scans (1 min per step, eight or nine steps) were acquired over 2 h.  Venous blood samples and urine were collected up to 2 h after injection of the radiotracer.  For each subject, the percentage of injected activity measured in regions of interest over brain, intestine, lungs, kidneys and liver was fitted to a mono-exponential model, as an uptake phase followed by a mono-exponential washout, for urinary bladder to generate time-activity curves.  Using the MIRD method, several source organs were considered in estimating residence time and mean effective radiation absorbed doses.  RESULTS:  Blood pressure and ECG findings remained unchanged after tracer injection.  The analysed blood and urine pharmacological parameters did not change significantly after [(11)C]raclopride injection.  The primary routes of clearance were renal and intestinal.  Ten minutes after injection, high activities were observed in the gall-bladder, kidneys and liver.  High activity was observed in the gall-bladder during the whole study.  The kidneys, urinary bladder wall, liver and gall-bladder received the highest absorbed doses.  The average effective dose of [11C]raclopride was estimated to be 6.7+/-0.4 microSv/MBq.  CONCLUSION:  The amount of [11C]raclopride required for adequate dopamine D2 receptor imaging results in an acceptable effective dose equivalent, permitting two or three repeated clinical PET imaging studies, with the injection of 222 MBq for each study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzsc65JCF81L5XHngOXiV_fW6udTcc2eb9XFBmR8UD9Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrnslWquw%253D%253D&md5=428b9fffb57ee9de0c5c1c34519dd429</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1007%2Fs00259-005-1783-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-005-1783-2%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DM.-J.%26aulast%3DRicard%26aufirst%3DM.%26aulast%3DBourgeois%26aufirst%3DS.%26aulast%3DLi%25C3%25A8vre%26aufirst%3DM.-A.%26aulast%3DBottlaender%26aufirst%3DM.%26aulast%3DGervais%26aufirst%3DP.%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26aulast%3DSyrota%26aufirst%3DA.%26atitle%3DBiodistribution%2520and%2520radiation%2520dosimetry%2520of%2520%255B11C%255Draclopride%2520in%2520healthy%2520volunteers%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2005%26volume%3D32%26spage%3D952%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">[<sup>18</sup>F]Fallypride:</p></div><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvogt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¶sch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreckenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ¼nder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span> </span><span class="NLM_article-title">Parametric Mapping of Binding in Human Brain of D<sub>2</sub> Receptor Ligands of Different Affinities</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">964</span><span class="NLM_x">â</span> <span class="NLM_lpage">972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=964-972&author=T.+Siessmeierauthor=Y.+Zhouauthor=H.-G.+Buchholzauthor=C.+Landvogtauthor=I.+Vernalekenauthor=M.+Peilauthor=R.+Schirrmacherauthor=F.+R%C3%B6schauthor=M.+Schreckenbergerauthor=D.+F.+Wongauthor=P.+Cummingauthor=G.+Gr%C3%BCnderauthor=P.+Bartenstein&title=Parametric+Mapping+of+Binding+in+Human+Brain+of+D2+Receptor+Ligands+of+Different+Affinities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DBuchholz%26aufirst%3DH.-G.%26aulast%3DLandvogt%26aufirst%3DC.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DPeil%26aufirst%3DM.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26aulast%3DSchreckenberger%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DBartenstein%26aufirst%3DP.%26atitle%3DParametric%2520Mapping%2520of%2520Binding%2520in%2520Human%2520Brain%2520of%2520D2%2520Receptor%2520Ligands%2520of%2520Different%2520Affinities%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D964%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">[<sup>11</sup>C]Flumazenil:</p></div><span class="NLM_contrib-group">Lassen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevett, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patsalos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. V.</span><span> </span><span class="NLM_article-title">Benzodiazepine receptor quantification in vivo in humans using [<sup>11</sup>C]Flumazenil and PET: application of the steady-state principle</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">â</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1038%2Fjcbfm.1995.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=7798333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVWlsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=152-165&author=N.+A.+Lassenauthor=P.+A.+Bartensteinauthor=A.+A.+Lammertsmaauthor=M.+C.+Prevettauthor=D.+R.+Turtonauthor=S.+K.+Luthraauthor=S.+Osmanauthor=P.+M.+Bloomfieldauthor=T.+Jonesauthor=P.+N.+Patsalosauthor=M.+T.+O%E2%80%99Connellauthor=J.+S.+Duncanauthor=J.+V.+Andersen&title=Benzodiazepine+receptor+quantification+in+vivo+in+humans+using+%5B11C%5DFlumazenil+and+PET%3A+application+of+the+steady-state+principle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle</span></div><div class="casAuthors">Lassen, N. A.; Bartenstein, P. A.; Lammertsma, A. A.; Prevett, M. C.; Turton, D. R.; Luthra, S. K.; Osman, S.; Bloomfield, P. M.; Jones, T.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-65</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">Carbon-11-labeled flumazenil combined with positron emission tomog. (PET) was used to measure the concn. (Bmax) of the benzodiazepine (Bz) receptor in the brain and its equil. dissocn. const. (KD) for flumazenil in five normal subjects.  The steady-state approach was used injecting the tracer as a bolus of high specific activity.  In each subject two studies were carried out.  The first study was performed at essentially zero receptor occupancy, the tracer alone study.  The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged const. infusion of nonlabeled ("cold") flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period.  In this second study the free concn. of unmetabolized flumazenil in plasma water was measured in multiple blood samples.  The obsd. tissue and plasma tracer curves, calibrated in the same units of radioactivity per mm, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding no. of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments.  The noncompartmental and the compartmental analyses gave essentially the same values for the distribution vol. of the tracer, the parameter used for quantitation of the Bz receptor.  As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred.  The five subjects had a mean KD value of 12 nM/L of water and Bmax values of the gray matter ranging from 39 in thalamus to 120 nM/L of brain in occipital cortex.  Most previous studies have been based on the pseudoequil. approach using the brain stem as a receptor-free ref. region.  This yields practically the same KD but lower Bmax values than the steady-state approach presented here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjfURC4GZXWbVg90H21EOLACvtfcHk0lhW0fEWMWLBdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVWlsro%253D&md5=09a333bb64f38f2812e353f9dcb589c8</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1995.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1995.17%26sid%3Dliteratum%253Aachs%26aulast%3DLassen%26aufirst%3DN.%2BA.%26aulast%3DBartenstein%26aufirst%3DP.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DPrevett%26aufirst%3DM.%2BC.%26aulast%3DTurton%26aufirst%3DD.%2BR.%26aulast%3DLuthra%26aufirst%3DS.%2BK.%26aulast%3DOsman%26aufirst%3DS.%26aulast%3DBloomfield%26aufirst%3DP.%2BM.%26aulast%3DJones%26aufirst%3DT.%26aulast%3DPatsalos%26aufirst%3DP.%2BN.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DM.%2BT.%26aulast%3DDuncan%26aufirst%3DJ.%2BS.%26aulast%3DAndersen%26aufirst%3DJ.%2BV.%26atitle%3DBenzodiazepine%2520receptor%2520quantification%2520in%2520vivo%2520in%2520humans%2520using%2520%255B11C%255DFlumazenil%2520and%2520PET%253A%2520application%2520of%2520the%2520steady-state%2520principle%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1995%26volume%3D15%26spage%3D152%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">[<sup>11</sup>C]DASB:</p></div><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span> </span><span class="NLM_article-title">Imaging the serotonin transporter with positron emission tomography: initial human studies with [<sup>11</sup>C]DAPP and [<sup>11</sup>C]DASB</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">â</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1007%2Fs002590000365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=11105830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVWls7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=1719-1722&author=S.+Houleauthor=N.+Ginovartauthor=D.+Husseyauthor=J.+H.+Meyerauthor=A.+A.+Wilson&title=Imaging+the+serotonin+transporter+with+positron+emission+tomography%3A+initial+human+studies+with+%5B11C%5DDAPP+and+%5B11C%5DDASB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB</span></div><div class="casAuthors">Houle, S.; Ginovart, N.; Hussey, D.; Meyer, J. H.; Wilson, A. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-1722</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Two novel radioligands, N,N-dimethyl-2-(2-amino-4-methoxyphenylthio)benzylamine (DAPP) and N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine (DASB), were radiolabeled with carbon-11 and evaluated as in vivo probes of the serotonin transporter (SERT) using positron emission tomog. (PET).  Both compds. are highly selective, with nanomolar affinity for the serotonin transporter and micromolar affinity for the dopamine and norepinephrine transporters.  Six volunteers were imaged twice, once with each of the two radioligands.  Both ligands displayed very good brain penetration and selective retention in regions rich in serotonin reuptake sites.  Both had similar brain uptake and kinetics, but the cyano analog, [11C]DASB, had a slightly higher brain penetration in all subjects.  Plasma anal. revealed that both radiotracers were rapidly metabolized to give mainly hydrophilic species as detd. by reverse-phase HPLC.  Inhibition of specific binding to the SERT was demonstrated in three addnl. subjects imaged with [11C]DASB following an oral dose of the selective serotonin reuptake blocker citalopram.  These preliminary studies indicate that both these substituted phenylthiobenzylamines have highly suitable characteristics for probing the serotonin reuptake system with PET in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGPfVBkfUIjLVg90H21EOLACvtfcHk0lhLXUZyJl7mZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVWls7s%253D&md5=1dae55a52038299f45152063a26e17a3</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1007%2Fs002590000365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590000365%26sid%3Dliteratum%253Aachs%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DHussey%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26atitle%3DImaging%2520the%2520serotonin%2520transporter%2520with%2520positron%2520emission%2520tomography%253A%2520initial%2520human%2520studies%2520with%2520%255B11C%255DDAPP%2520and%2520%255B11C%255DDASB%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D27%26spage%3D1719%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25e"><span><span class="NLM_label">(e) </span><div class="note"><p class="first last">[<sup>11</sup>C]Î²-CFT:</p></div><span class="NLM_contrib-group">Rinne, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laihinen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NÃ¥gren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruottinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruotsalainen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, U. K.</span><span> </span><span class="NLM_article-title">PET examination of the monoamine transporter with [<sup>11</sup>C]Î²-CIT and [<sup>11</sup>C]Î²-CFT in early Parkinsonâs disease</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1995&pages=97-103&author=J.+O.+Rinneauthor=A.+Laihinenauthor=K.+N%C3%A5grenauthor=H.+Ruottinenauthor=U.+Ruotsalainenauthor=U.+K.+Rinne&title=PET+examination+of+the+monoamine+transporter+with+%5B11C%5D%CE%B2-CIT+and+%5B11C%5D%CE%B2-CFT+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DLaihinen%26aufirst%3DA.%26aulast%3DN%25C3%25A5gren%26aufirst%3DK.%26aulast%3DRuottinen%26aufirst%3DH.%26aulast%3DRuotsalainen%26aufirst%3DU.%26aulast%3DRinne%26aufirst%3DU.%2BK.%26atitle%3DPET%2520examination%2520of%2520the%2520monoamine%2520transporter%2520with%2520%255B11C%255D%25CE%25B2-CIT%2520and%2520%255B11C%255D%25CE%25B2-CFT%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSynapse%26date%3D1995%26volume%3D21%26spage%3D97%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25f"><span><span class="NLM_label">(f) </span><div class="note"><p class="first last">[<sup>11</sup>C]MDL100907:</p></div><span class="NLM_contrib-group">Andree, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaquet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Positron Emission Tomographic Analysis of Dose-Dependent MDL 100,907 Binding to 5-Hydroxytryptamine-2A Receptors in the Human Brain</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1097%2F00004714-199808000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=9690698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaK1cXltFSms7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=317-323&author=B.+Andreeauthor=S.+Nybergauthor=H.+Itoauthor=N.+Ginovartauthor=F.+Brunnerauthor=F.+Jaquetauthor=C.+Halldinauthor=L.+Farde&title=Positron+Emission+Tomographic+Analysis+of+Dose-Dependent+MDL+100%2C907+Binding+to+5-Hydroxytryptamine-2A+Receptors+in+the+Human+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25fR"><div class="casContent"><span class="casTitleNuber">25f</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain</span></div><div class="casAuthors">Andree, Bengt; Nyberg, Svante; Ito, Hiroshi; Ginovart, Nathalie; Brunner, Francoise; Jaquet, Francoise; Halldin, Christer; Farde, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Selective 5-hydroxytryptamine-2A (5-HT2A) antagonism has been proposed as a mechanism of atypical antipsychotic drug action.  MDL 100,907, a new selective 5-HT2A receptor antagonist, has high affinity in vitro for 5-HT2A receptors and is being developed as a potential antipsychotic drug.  In this study, neocortical 5-HT2A receptor occupancy was measured in six healthy male volunteers after placebo and escalating single doses (1-72 mg) of MDL 100,907 using positron emission tomog. and the nonspecific radioligand [11C]N-methyl-spiperone ([11C]NMSP).  Receptor occupancy was calcd. using a ratio-equil. anal., assuming that maximal radioligand binding inhibition represents 100% 5-HT2A receptor occupancy.  Plasma concns. of MDL 100,907 were measured with high-pressure liq. chromatog.  The pharmacokinetic parameters area under the curve and peak plasma concn. increased linearly with dose, with rapid absorption and a 6-to 9-h elimination half-life.  The neocortical binding of [11C]NMSP was inhibited dose-dependently.  After administration of 6 mg of MDL 100,907 the inhibition was 70%, corresponding to a 5-HT2A receptor occupancy of 90%.  The calcd. maximal inhibition was 77%.  These observations indicate that MDL 100,907 passes the blood-brain barrier and binds to 5-HT2A receptors in a saturable manner in the living human brain.  Repeated doses of MDL 100,907, 10 mg/day or more, should induce a sustained 5-HT2A receptor occupancy in most patients.  Thus, MDL 100,907 provides a suitable tool to evaluate the potential of selective 5-HT2A receptor antagonism in the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECc-40bFOPbVg90H21EOLACvtfcHk0lhLXUZyJl7mZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFSms7c%253D&md5=8f62fb7f2b597693cb3c19a051caf64a</span></div><a href="/servlet/linkout?suffix=cit25f&amp;dbid=16384&amp;doi=10.1097%2F00004714-199808000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199808000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DAndree%26aufirst%3DB.%26aulast%3DNyberg%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DBrunner%26aufirst%3DF.%26aulast%3DJaquet%26aufirst%3DF.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DPositron%2520Emission%2520Tomographic%2520Analysis%2520of%2520Dose-Dependent%2520MDL%2520100%252C907%2520Binding%2520to%25205-Hydroxytryptamine-2A%2520Receptors%2520in%2520the%2520Human%2520Brain%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1998%26volume%3D18%26spage%3D317%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25g"><span><span class="NLM_label">(g) </span><div class="note"><p class="first last">[<sup>11</sup>C]WAY100635:</p></div><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span> </span><span class="NLM_article-title">Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">â</span> <span class="NLM_lpage">1971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=1965-1971&author=L.+Fardeauthor=H.+Itoauthor=C.+G.+Swahnauthor=V.+W.+Pikeauthor=C.+Halldin&title=Quantitative+analyses+of+carbonyl-carbon-11-WAY-100635+binding+to+central+5-hydroxytryptamine-1A+receptors+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSwahn%26aufirst%3DC.%2BG.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DQuantitative%2520analyses%2520of%2520carbonyl-carbon-11-WAY-100635%2520binding%2520to%2520central%25205-hydroxytryptamine-1A%2520receptors%2520in%2520man%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1998%26volume%3D39%26spage%3D1965%26epage%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25h"><span><span class="NLM_label">(h) </span><div class="note"><p class="first last">[<sup>11</sup>C]Carfentanil:</p></div><span class="NLM_contrib-group">Frost, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglass, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayberg, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Links, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crozier, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, H. N.</span><span> </span><span class="NLM_article-title">Multicompartmental analysis of [<sup>11</sup>C]carfentanil binding to opiate receptors in humans measured by positron emission tomography</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">â</span> <span class="NLM_lpage">409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25h&amp;dbid=16&amp;doi=10.1021%2Fjm400312y&amp;key=10.1038%2Fjcbfm.1989.59" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25h&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=2541148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25h&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADyaL1MXltFWlurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=398-409&author=J.+J.+Frostauthor=K.+H.+Douglassauthor=H.+S.+Maybergauthor=R.+F.+Dannalsauthor=J.+M.+Linksauthor=A.+A.+Wilsonauthor=H.+T.+Ravertauthor=W.+C.+Crozierauthor=H.+N.+Wagner&title=Multicompartmental+analysis+of+%5B11C%5Dcarfentanil+binding+to+opiate+receptors+in+humans+measured+by+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25hR"><div class="casContent"><span class="casTitleNuber">25h</span><div class="casTitle"><span class="NLM_cas:atitle">Multicompartmental analysis of [11C]carfentanil binding to opiate receptors in humans measured by positron emission tomography</span></div><div class="casAuthors">Frost, J. J.; Douglass, K. H.; Mayberg, H. S.; Dannals, R. F.; Links, J. M.; Wilson, A. A.; Ravert, H. T.; Crozier, William C.; Wagner, H. N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">398-409</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">[11C]carfentanil is a high-affinity opiate agonist that can be used to localize mu opiate receptors in humans by positron emission tomog. (PET).  A 4-compartment model was used to obtain quant. ests. of rate consts. for receptor assocn. and dissocn.  PET studies were performed in 5 normal subjects in the absence and presence of 1 mg/kg naloxone.  Arterial plasma concn. of [11C]carfentanil and its labeled metabolites were detd. during each PET study.  The value of k3/k4 = Bmax/kD was detd. for each subject in the presence and absence of naloxone.  There was a significant redn. in the value of k3/k4 from 3.4 to 0.26 in the thalamus and from 1.8 to 0.16 in the frontal cortex.  Mean values of frontal cortex/occipital cortex and thalamus/occipital cortex ratios were detd. for the interval 35-70 min after injection when receptor binding is high relative to nonspecific binding.  The relationship between the measured region/occipital cortex values and the corresponding values of k3/k4 in the presence and absence of naloxone was: regions/occipital cortex = 0.95 (k3/k4) with r = 0.98.  Simulation studies also demonstrated a linear relationship between the thalamus/occipital cortex or frontal cortex/occipital cortex ratio and k3/k4 for <2-fold increases or decreases in k3/k4.  Simulation studies in which thalamic blood flow was varied demonstrated no significant effect on the region/occipital cortex ratio at 35-70 min for a 2-fold increase or 4-fold decrease in blood flow.  Therefore, the region/occipital cortex ratio can be used to quantitate changes in k3/k[4 when tracer kinetic modeling is not feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonFV6GQkCusrVg90H21EOLACvtfcHk0ljrQV4jX0v3Sw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltFWlurw%253D&md5=e23946c3ac098ea3364cac665395fbd5</span></div><a href="/servlet/linkout?suffix=cit25h&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1989.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1989.59%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BJ.%26aulast%3DDouglass%26aufirst%3DK.%2BH.%26aulast%3DMayberg%26aufirst%3DH.%2BS.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DLinks%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DCrozier%26aufirst%3DW.%2BC.%26aulast%3DWagner%26aufirst%3DH.%2BN.%26atitle%3DMulticompartmental%2520analysis%2520of%2520%255B11C%255Dcarfentanil%2520binding%2520to%2520opiate%2520receptors%2520in%2520humans%2520measured%2520by%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1989%26volume%3D9%26spage%3D398%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25i"><span><span class="NLM_label">(i) </span><div class="note"><p class="first last">[<sup>11</sup>C]PHNO:</p></div><span class="NLM_contrib-group">Gurevich, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span> </span><span class="NLM_article-title">Distribution of Dopamine D<sub>3</sub> Receptor Expressing Neurons in the Human Forebrain: Comparison with D<sub>2</sub> Receptor Expressing Neurons</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=60-80&author=E.+V.+Gurevichauthor=J.+N.+Joyce&title=Distribution+of+Dopamine+D3+Receptor+Expressing+Neurons+in+the+Human+Forebrain%3A+Comparison+with+D2+Receptor+Expressing+Neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurevich%26aufirst%3DE.%2BV.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DDistribution%2520of%2520Dopamine%2520D3%2520Receptor%2520Expressing%2520Neurons%2520in%2520the%2520Human%2520Forebrain%253A%2520Comparison%2520with%2520D2%2520Receptor%2520Expressing%2520Neurons%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D60%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25j"><span><span class="NLM_label">(j) </span><div class="note"><p class="first last">[<sup>11</sup>C]ABP688:</p></div><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streffer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagoev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hintermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A.</span><span> </span><span class="NLM_article-title">Human PET Studies of Metabotropic Glutamate Receptor Subtype 5 with <sup>11</sup>C-ABP688</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25j&amp;dbid=8&amp;doi=10.1021%2Fjm400312y&amp;key=17268022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25j&amp;dbid=32&amp;doi=10.1021%2Fjm400312y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVKmsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=247-252&author=S.+M.+Ametameyauthor=V.+Treyerauthor=J.+Strefferauthor=M.+T.+Wyssauthor=M.+Schmidtauthor=M.+Blagoevauthor=S.+Hintermannauthor=Y.+Aubersonauthor=F.+Gaspariniauthor=U.+C.+Fischerauthor=A.+Buck&title=Human+PET+Studies+of+Metabotropic+Glutamate+Receptor+Subtype+5+with+11C-ABP688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25jR"><div class="casContent"><span class="casTitleNuber">25j</span><div class="casTitle"><span class="NLM_cas:atitle">Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688</span></div><div class="casAuthors">Ametamey, Simon M.; Treyer, Valerie; Streffer, Johannes; Wyss, Matthias T.; Schmidt, Mark; Blagoev, Milen; Hintermann, Samuel; Auberson, Yves; Gasparini, Fabrizio; Fischer, Uta C.; Buck, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-252</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime (11C-ABP688), a noncompetitive and highly selective antagonist for the metabotropic glutamate receptor subtype 5 (mGluR5), was evaluated for its potential as a PET agent.  Methods: Six healthy male volunteers (mean age, 25 y; range, 21-33 y) were studied.  Brain perfusion (15O-H2O) was measured immediately before each 11C-ABP688 PET scan.  For anat. coregistration, T1-weighted MRI was performed on each subject.  Arterial blood samples for the detn. of the arterial input curve were obtained at predefined time points, and 11C-ABP688 uptake was assessed quant. using a 2-tissue-compartment model.  Results: An initial rapid uptake of radioactivity followed by a gradual clearance from all examd. brain regions was obsd.  Relatively high radioactivity concns. were obsd. in mGluR5-rich brain regions such as the anterior cingulate, medial temporal lobe, amygdala, caudate, and putamen, whereas radioactivity uptake in the cerebellum and white matter, regions known to contain low densities of mGluR5, was low.  Specific distribution vol. as an outcome measure of mGluR5 d. in the various brain regions ranged from 5.45 Â± 1.47 (anterior cingulate) to 1.91 Â± 0.32 (cerebellum), and the rank order of the corresponding specific distribution vols. of 11C-ABP688 in cortical regions was temporal > frontal > occipital > parietal.  The metab. of 11C-ABP688 in plasma was rapid; at 60 min after injection, 25% Â± 0.03% of radioactivity measured in the plasma of healthy volunteers was intact parent compd.  Conclusion: The results of these studies indicate that 11C-ABP688 has suitable characteristics and is a promising PET ligand for imaging mGluR5 distribution in humans.  Furthermore, it could be of great value for the selection of appropriate doses of clin. relevant candidate drugs that bind to mGluR5 and for PET studies of patients with psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQUZCrGnQChLVg90H21EOLACvtfcHk0ljrQV4jX0v3Sw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVKmsb0%253D&md5=be3ec54c117f3789e4482b1e138568b3</span></div><a href="/servlet/linkout?suffix=cit25j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DTreyer%26aufirst%3DV.%26aulast%3DStreffer%26aufirst%3DJ.%26aulast%3DWyss%26aufirst%3DM.%2BT.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBlagoev%26aufirst%3DM.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DAuberson%26aufirst%3DY.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DFischer%26aufirst%3DU.%2BC.%26aulast%3DBuck%26aufirst%3DA.%26atitle%3DHuman%2520PET%2520Studies%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520with%252011C-ABP688%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Repaske, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goy, M. F.</span><span> </span><span class="NLM_article-title">A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">â</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=673-686&author=D.+R.+Repaskeauthor=J.+G.+Corbinauthor=M.+Contiauthor=M.+F.+Goy&title=A+cyclic+GMP-stimulated+cyclic+nucleotide+phosphodiesterase+gene+is+highly+expressed+in+the+limbic+system+of+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRepaske%26aufirst%3DD.%2BR.%26aulast%3DCorbin%26aufirst%3DJ.%2BG.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DGoy%26aufirst%3DM.%2BF.%26atitle%3DA%2520cyclic%2520GMP-stimulated%2520cyclic%2520nucleotide%2520phosphodiesterase%2520gene%2520is%2520highly%2520expressed%2520in%2520the%2520limbic%2520system%2520of%2520the%2520rat%2520brain%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D56%26spage%3D673%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Boess, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Staay, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staveren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">â</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.-J.+van+der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+van+Staverenauthor=J.+de+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+phosphodiesterase+2+increases+neuronal+cGMP%2C+synaptic+plasticity+and+memory+performance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.-J.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3Dvan%2BStaveren%26aufirst%3DW.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520increases%2520neuronal%2520cGMP%252C%2520synaptic%2520plasticity%2520and%2520memory%2520performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D1081%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Helal, C. J.; Chappie, T. A.; Humphrey, J. M.; Verhoest, P. R.; Yang, E.</span><span> </span><span class="NLM_article-title">Preparation of imidazo[5,1-<i>f</i>][1,2,4]triazines for the treatment of neurological disorders</span>. U.S. Patent 20120214791 A1, <span class="NLM_month">Aug</span><span class="NLM_day">23</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Helal&author=T.+A.+Chappie&author=J.+M.+Humphrey&author=P.+R.+Verhoest&author=E.+Yang&title=Preparation+of+imidazo%5B5%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+for+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520of%2520imidazo%255B5%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520for%2520the%2520treatment%2520of%2520neurological%2520disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">The synthesis of intermediate <b>8</b> has been previously disclosed. For detailed synthetic information, please see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Compound <b>5</b> was screened in a PDE selectivity panel consisting of 10 PDE subtypes and exhibited the following activity values: PDE1b (IC<sub>50</sub> > 30 Î¼M), PDE3a (IC<sub>50</sub> > 30 Î¼M), PDE4d (IC<sub>50</sub> > 30 Î¼M), PDE5a (IC<sub>50</sub> = 26 Î¼M), PDE6a (IC<sub>50</sub> > 10 Î¼M), PDE7b (IC<sub>50</sub> = 12 Î¼M), PDE8b (IC<sub>50</sub> > 10 Î¼M), PDE9a (IC<sub>50</sub> > 10 Î¼M), PDE10a (IC<sub>50</sub> = 3.9 Î¼M), and PDE11 (IC<sub>50</sub> > 10 Î¼M).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">Compound <b>5</b> was screened in a CEREP broad selectivity panel of 79 targets and exhibited <30% inhibition at 1 Î¼M for all targets. This corresponds to >1800-fold selectivity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterases in the CNS: targets for drug development</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">660</span><span class="NLM_x">â</span> <span class="NLM_lpage">670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=660-670&author=F.+S.+Mennitiauthor=W.+S.+Faraciauthor=C.+J.+Schmidt&title=Phosphodiesterases+in+the+CNS%3A+targets+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DFaraci%26aufirst%3DW.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterases%2520in%2520the%2520CNS%253A%2520targets%2520for%2520drug%2520development%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D660%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><div class="note"><p class="first last">During the preparation of this manuscript, a PET ligand with a mixed PDE2/PDE10 pharmacology (PDE2 pIC<sub>50</sub> = 8.86, PDE10 pIC<sub>50</sub> = 7.96) was reported in the patent literature.</p></div><span class="NLM_contrib-group">AndrÃ©s-Gil, J. I.; Rombouts, F. J. R.; Trabanco-SuÃ¡rez, A. A.; Vanhoof, G. C. P.; De Angelis, M.; Buijnsters, P. J. J. A.; Guillemont, J. E. G.; Bormans, G. M. R.; Celen, S. J. L.; Vliegen, M.</span><span> </span><span class="NLM_article-title">1-Aryl-4-methyl-[1,2,4]triazolo[4,3-<i>a</i>]quinoxaline derivatives</span>. WO 2013/000924, <span class="NLM_month">January</span><span class="NLM_day">3</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+I.+Andr%C3%A9s-Gil&author=F.+J.+R.+Rombouts&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+C.+P.+Vanhoof&author=M.+De+Angelis&author=P.+J.+J.+A.+Buijnsters&author=J.+E.+G.+Guillemont&author=G.+M.+R.+Bormans&author=S.+J.+L.+Celen&author=M.+Vliegen&title=1-Aryl-4-methyl-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dquinoxaline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s-Gil%26aufirst%3DJ.%2BI.%26atitle%3D1-Aryl-4-methyl-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dquinoxaline%2520derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span> </span><span class="NLM_article-title">Simplified Reference Tissue Model for PET Receptor Studies</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=153-158&author=A.+A.+Lammertsmaauthor=S.+P.+Hume&title=Simplified+Reference+Tissue+Model+for+PET+Receptor+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DHume%26aufirst%3DS.%2BP.%26atitle%3DSimplified%2520Reference%2520Tissue%2520Model%2520for%2520PET%2520Receptor%2520Studies%26jtitle%3DNeuroImage%26date%3D1996%26volume%3D4%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a href="/doi/suppl/10.1021/jm400312y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87127"></div></div></div></div></div><hr /></hr><p class="last">The full data set of the PET ligand database, an extended version of Table <a class="ref showTableEvent internalNav" href="#tbl2">2</a> with individual parameters of CNS PET MPO (ClogP, ClogD, MW, HBD, TPSA, and p<i>K</i><sub>a</sub>), and a CNS PET MPO calculator in Excel format.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400312y/suppl_file/jm400312y_si_001.pdf">jm400312y_si_001.pdf (200.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400312y/suppl_file/jm400312y_si_003.xls">jm400312y_si_003.xls (34.0 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400312y&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm400312y%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400312y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995010b908247f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
